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Abstract 
The dynamics of protein turnover is central to the regulation of protein 
expression. The steady-state level of a protein is the net outcome of the change 
in its rate of synthesis and degradation. Different biological states or perturbations 
cause changes in the expression of specific proteins, which can be assessed by 
proteomic analysis to reveal links between genotype and phenotype. Unlike other 
conventional proteomic methods, which measure the amount of proteins in the 
system at a specific point in time, pulse-chase stable isotope labelling by amino 
acids in cell culture (pcSILAC) can reveal changes in the rates of protein synthesis 
and degradation over time.  
The causative agent of Leishmaniasis, Leishmania, has a digenetic lifestyle 
involving an extracellular flagellated promastigote living in the mid-gut of the 
sand fly vector and an aflagellated intracellular amastigote residing in the 
macrophage of the mammalian host. As they live in a different niche their protein 
expression could give insight into their adaptation and survival. The intricate 
interaction between the human host and the Leishmania parasite is key to 
pathology and may present new targets for chemotherapeutic development. 
Employing high-resolution mass spectrometry coupled with pulse-chase SILAC 
technique, we delved into the investigation of proteome changes in L. mexicana-
infected macrophages.  
The first part of the thesis discusses the quantitative proteomic analysis of L. 
mexicana promastigote and amastigote stage. In this work, stable isotope 
dimethyl labelling was employed to differentially labelled promastigotes and 
axenic amastigotes. Our results revealed transformation from promastigote to 
amastigote were accompanied by: i) reduced glycolytic and gluconeogenesis 
pathway, ii) increased fatty acid oxidation, iii) increased mitochondrial 
respiration, iv) reduced expression of proteins that may have flagellar role (e.g. 
flagellar connector protein, flagellum targeting protein KHARON1), v) reduced 
stress response proteins, vi) increased protein synthesis, and vii) increased 
proteolytic proteins. The findings reported here substantially advance our 
knowledge on the differences of protein expression in different life cycle stage of 
L. mexicana and could be useful in finding drug targets. 
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Another part of the thesis discusses the establishment and application of pulse-
chase SILAC. In this work, a human macrophage-like cell line (THP-1) was grown 
in media containing L-Arg-13C6 and L-Lys-13C6 until isotope incorporation of >98% 
was achieved. Media was then replaced with light arginine and lysine so that light 
amino acids were pulsed into cells for 24 and 48 hours. In other words, protein 
synthesis is ‘chased’ with unlabelled amino acids. Synchronous with the switch 
from pulse to chase, the macrophages were infected with L. mexicana. This 
approach provides the ability to monitor the rates of heavy-label loss, hence 
determining protein degradation rates and half-lives.  
At 24-hour post-infection, when compared to mock-infected cells, 2016 proteins 
were identified, 761 were quantified, and 51 were significantly modulated at p-
value < 0.05. Interestingly, proteins involved in glycolysis were markedly 
downregulated in synthesis after infection while oxidative phosphorylation and 
fatty acid β-oxidation had increased synthesis, suggesting a subversion of host cell 
metabolism by Leishmania which proposed to play a key role in microbial growth 
and persistence. Additionally, pro-apoptotic proteins such as apoptosis regulator 
BAX and caspase 3 had increased translation in cells infected for 24 hour. This was 
accompanied by the overexpression of STAT1 which could result in modulation of 
apoptotic pathways. These characteristics advocate that THP-1 cells most likely 
exhibit an M2 macrophage phenotype following 24-hour infection.  
Temporal proteomic data revealed some striking changes in metabolisms of the 
host at 24 and 48-hour post-infection. After 48 hours of infection, 2104 proteins 
were identified, and 84 were significantly modulated post-infection at p-value < 
0.05. After 48 hours of infection, relative to levels at 24 hours of infection, host 
cells increased the synthesis of glycolytic enzymes and reduced oxidative 
phosphorylation synthesis. Further, a total of 400 newly synthesized proteins were 
selected based on stringent criteria to measure synthesis rates, degradation rate 
constant (kdeg) and half-lives. These include several ribosomal proteins, pyruvate 
kinase, L-lactate dehydrogenase, moesin, several glycolytic enzymes such as 
glucose-6-phosphate isomerase and alpha enolase, gelsolin, galectin-9, catalase 
and lamin-B. We found that globally kdeg values in THP-1 were low ranging from 
0.01 to 0.04 h-1. Our degradation data indicated that proteins involved in 
mitochondrial related functions (TCA, oxidative phosphorylation) as well as other 
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energy production pathways were more stable and have longer half-lives. For the 
400 proteins, the mean half-life for uninfected 24 h, 24 hpi, uninfected 48h and 
48 hpi were 21.74 h, 20.51 h, 47.39 h and 47.33 h, respectively. Intriguingly, newly 
synthesized proteins involved in immune responses, including HLA complexes, 
were rapidly degraded in infected cells, despite having decreased synthesis rates 
after 48 hours of infection. Collectively, most proteins in the present study had 
decreased kdeg and longer half-lives following longer exposure of THP-1 to L. 
mexicana. Our data show the potential of pulse-chase SILAC to dissect the 
response of macrophages to Leishmania infection. To our knowledge, no studies 
have reported the proteome turnover of macrophage in response to Leishmania 
infection.  
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1 Introduction 
1.1 The Leishmania parasite 
Trypanosomatids are ubiquitous unicellular protozoa that are ancient survivors on 
the Earth. They probably diverged from their evolutionary branch more than 500 
million years ago (Stevens & Gibson 1999). Members of this group are flagellated 
and exclusively parasitic and found primarily dwelling in insects (Podlipaev 2001). 
Some of them have life-cycles involving a secondary host. The order kinetoplastids 
are characterized by several unique features that differ remarkably from their 
mammalian hosts. Paramount among these are the kinetoplast, which contains the 
mitochondrial DNA (Jensen & Englund 2012), compartmentalization of glycolysis 
within the glycosome (Michels et al. 2006) and the trans-splicing of a highly 
conserved short RNA leader sequence which participates in mRNA maturation in 
kinetoplastids (Simpson et al. 2000). 
There is one family in this order, which is Trypanosomatidae. Three genera in this 
family are dixenous organisms that parasitize vertebrate (Trypanosome and 
Leishmania) and plant (Phytomonas) hosts (Wallace 1966; Vermelho et al. 2010). 
However, only two genera are found in humans and are etiologic agents of major 
human diseases; Trypanosoma and Leishmania (Maslov et al. 2013). The genus 
Leishmania is widely distributed in nature and one of the most species-rich groups 
of Trypanosomatidae (Figure 1.1). These species are nearly morphologically 
identical but they have different geographic distributions, different vectors and 
different manifestations of disease. Presently, approximately 30 different species 
of Leishmania are known to exist. At least 21 species of Leishmania are known to 
infect humans that threatened to decimate most parts of the world (Sharma & 
Singh 2009).  
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Figure 1.1: Outline classification of Leishmania illustrating the three subgenera.  
Genus Leishmania are divide to three subgenera: Leishmania, Viannia and Sauroleishmania. 
Parasites in the subgenera Leishmania and Viannia infect mammals, whereas the Sauroleishmania 
infect reptiles as their vertebrate hosts. Over 30 species have been named in the genus including 
many that are non-pathogenic or of minor medical importance (of limited range or small numbers of 
recorded cases). The species named above are not comprehensive and only show some of the well-
known species that are the focus of biomedical research. (Bates & Tetley 1993). 
 
1.1.1 The Leishmania life cycle 
Leishmania has a digenetic life cycle alternating between the motile, extracellular 
promastigote and non-flagellate, intracellular amastigote stages. Promastigotes 
have an elongated shape with long flagella. Fully developed promastigotes 
measure 10-20 µm in length and 1.5 - 3.5 µm in breadth. Promastigotes live in the 
digestive tract of the insect vector (sand flies). Amastigotes reside in the cells of 
reticuloendothelial system (macrophages, monocytes, polymorphonuclear 
leucocytes, or endothelial cells) of the vertebrate mammal host. Amastigote are 
non-motile, have a round or oval body measuring 3-7 µm in diameter along the 
longitudinal axis. As with promastigotes, amastigotes also have nucleus and 
kinetoplast (Awasthi et al. 2004). There are also two separate, consecutive growth 
phases during the development of Leishmania in sand flies involving four distinct 
life cycle stages. The first growth cycle is initiated by procyclic promastigotes, 
which divide in the bloodmeal in the abdominal midgut of the vectors. Procyclic 
promastigoes give rise to the non-dividing nectomonad promastigotes that will 
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migrate to the anterior abdomen and subsequently transform into leptomonad 
promastigotes. This will initiate a second growth cycle in the anterior midgut. 
Finally, leptomonad promastigotes differentiate into non-dividing metacyclic 
promastigote which is the mammal-infective stage (Figure 1.2) (Gossage et al. 
2010). It has been shown that metacyclogenesis in Leishmania is induced in vitro 
by low pH and nutrient exhaustion (Bates 2007). Both the metacyclic and procyclic 
forms generated in vitro are morphologically similar to their insect counterparts 
(Sacks 1989; Debrabant et al. 2004). Morphologically, metacyclics are small, short 
and slender cells with a flagellum measuring at least twice the length of cell body 
(Gossage et al. 2010).  
 
Figure 1.2: Development of Leishmania (Leishmania) species in the sand fly vector.  
(a) The morphology of amastigotes and promastigotes. Each form has a nucleus (N), kinetoplast (K) 
and flagellum (F). The kinetoplast contains mitochondrial genome. The flagellum in amastigotes is 
internal and non-functional, whereas in promastigotes, the flagellum extends from the cell body, 
beats and pulls the organism in the direction shown, emerging from the anterior end of the cell. (b) 
The developmental sequence of the five major promastigote forms: procyclic promastigotes, 
nectomonad promastigotes, leptomonad promastigotes, haptomonad promastigotes and metacyclic 
promastigotes (Bates 1994). 
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When the sand fly is having a blood meal on the mammalian skin, metacyclic 
promastigotes are deposited into the mammalian skin through the proboscis. 
Macrophages will engulf and phagocytosed the promastigotes which will rapidly 
transformed into amastigotes (Walker et al. 2013). The macrophages become a 
host for amastigotes to replicate slowly by binary fission until it ruptures and 
releases the amastigotes to infect new macrophages (Figure 1.3). The parasites 
now are liberated into the circulation and can progress to other organs such as 
liver, spleen and bone marrow. When new sand fly takes blood meal from the 
infected host, it may take up infected macrophages and releases them into the 
midgut of the insect. The amastigotes will then transformed into promastigotes 
form and divide by binary fission before migrating to the insect’s proboscis, where 
they are poised to infect a new human host through another blood meal (Awasthi 
et al. 2004). A recent work by Inbar et al. (2013) has demonstrated that L. major 
strains have sexual competency and that sex is a normal aspect of their 
reproductive strategy. Akopyants et al. (2009) discovered that Leishmania 
promastigotes can mate in the sand fly vector and the hybrids could be 
transmitted to the mammalian host by sand fly bite. The exchange of genetic 
materials is a significant factor as this allows the parasite to adapt to new 
ecological niches, vectors and hosts.  
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Figure 1.3: The lifecycle of Leishmania.  
A small number of infectious metacyclic promastigotes are injected into host’s skin through the bite 
of an infected sand flies. These promastigotes are then taken up by macrophages, where they reside 
in phagolysosomes and transform into replicating amastigotes. Infected macrophages are taken up 
by sand flies during blood feeding. These macrophages are lysed in the fly midgut, releasing 
parasites that transform into rapidly dividing, non-infectious-stage promastigotes. These forms 
undergo a process of differentiation to non-dividing, metacyclic promastigotes that can be transmitted 
when the sand fly takes another blood meal (Sacks & Noben-Trauth 2002). Permission to reproduce 
this image has been granted by Elsevier. 
 
1.1.2 Transmitting vector 
Like other kinetoplastids, Leishmania spp. are transmitted by phytophagous 
arthropods. Known collectively as Phlebotomines, there are over 500 species of 
sand flies have been described from numerous parts of the world, with most being 
assigned to three genera: Phlebotomus and Sergentomyia of the Old World, and 
Lutzomyia of the New World (Figure 1.4). The Old-World sand flies are habitually 
found in the Mediterranean, Southern Europe, Africa, the Middle East, Central Asia 
and South Asia. The Lutzomyia spp. are found throughout the Americas and North 
America.  
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There are three unique features that make them recognizable: when at rest, they 
characteristically hold their wings at an angle above the abdomen; they are hairy; 
and, they hop along the hosts’ skin before settling down to bite. Unlike 
mosquitoes, their attack is silent and often unnoticed. Adult sand flies are small 
sized about 1.5-3 mm long. They are nocturnal and are weak flyers (Killick-
Kendrick 1999). 
As with all true Diptera flies, sand flies undergo complete metamorphosis and 
exhibit four complete life stages which are egg, larva, pupa and the adult. 
Dissimilar with mosquitoes, the immature stages do not require standing water to 
complete development, though they do require relatively warm, moist 
environments (Bates et al. 2015). Both female and male sand fly adults obtain 
carbohydrate nutrition from plant juices. In most species of sand fly only the 
female is responsible for biting and sucking the blood of mammals, reptiles and 
birds as she requires the protein in the blood to complete development of egg 
batches. Though some are autogenous (able to produce viable eggs without a 
blood meal). When a female bite, she injects saliva into the skin which not only 
gives rise to an allergic reaction in some individuals, but is believed to play a part 
in the successful establishment of Leishmania at the site of the bite (Bates et al. 
2015).  
 
Figure 1.4: The image of sand fly from genus Phlebotomines and Lutzomyia  
(from http://www.infectionlandscapes.org/2011/05/leishmaniasis.html).  
Sand flies are the vector responsible for transmitting Leishmania spp. Two of the genera are 
Phlebotomines (the Old World) and Lutzomyia (the New World).  
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1.2 Leishmaniasis: a global threat 
1.2.1 Leishmaniasis, clinical manifestations and epidemiology 
The World Health Organization (WHO) has designated leishmaniasis as a category 
1 (emerging and uncontrolled) and neglected disease. Leishmaniasis is the ninth 
greatest global burden of disease among individual infectious diseases. It is a 
collection of diseases, each with its own clinical manifestations and epidemiology. 
Infection is initiated by the bite of an infected sand fly vector and parasites 
disseminate from the site of infection in the skin to reside and propagate within 
macrophages of the liver, spleen and bone marrow and in the skin of cutaneous 
leishmaniasis (McConville & Handman 2007). The nature and severity of the 
disease depends on the causative species, with spectrum of pathologies ranging 
from benign self-healing lesions of cutaneous leishmaniasis (CL) to metastasizing 
lesions of mucocutaneous leishmaniasis (MCL) and the severe visceral 
leishmaniasis (VL). L. major, L. tropica and L. mexicana causes CL which manifests 
as localised cutaneous lesions that generally self-heal. It can subsequently 
metastasise into MCL as it often does in the case of L. braziliensis. Whereas VL 
caused by L. donovani and L. infantum involves a chronic disseminating disease of 
the liver and spleen, which is often fatal if left untreated (Olliaro et al. 2013). 
Furthermore, the form and severity of the disease depends on the host immune 
system and the poorly understood interplay between host-parasite-vector. 
Leishmaniasis is endemic in 88 countries, 72 of which are developing countries, 
and it has affected an estimated 12 million people each year with an annual 
mortality rate of 60,000 (Figure 1.5 and Figure 1.6) (Alvar et al. 2012). However, 
these numbers are not accurate as extensive numbers of cases are not recorded 
because notification of the incidence is compulsory in only 40 of the 88 affected 
countries. In addition, many leishmaniasis cases are either asymptomatic or 
misdiagnosed. On top of that, outbreaks often go unreported because they occur 
in zones of extreme conflict or in remote rural areas seldom visited by journalists 
or government officials. The disease primarily affects underprivileged population 
in Africa, Asia and Latin America, especially remote places that are not accessible 
to health facilities. Furthermore, there is limited investment in drugs and vaccines 
in those countries. The infection is also concomitant with socio-economic 
conditions such as lack of proper domestic sanitation and clean water, poor 
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housing and lack of resources. This combination of conditions is conducive to 
transmission of vector-borne diseases. Sand flies are attracted to crowded housing 
as these provide a good source of blood-meals. Infection can also increase due to 
environmental changes including urbanization and deforestation as well as 
climatic changes such as changes in temperature, rainfall and humidity that would 
bring about drought and global warming. Epidemics of both CL and VL are often 
associated with migration and the mobility of non-immune population into areas 
with existing transmission cycles. On top of that, the advent of the human 
immunodeficiency virus (HIV) is contributing to leishmaniasis becoming an 
opportunistic infection in AIDS patients (Diro et al. 2014). Leishmaniasis outbreaks 
have also become the new hallmark of late 20th or 21st century wars. CL in 
particular is a common scourge among civilian victims in the civil war in Syria, 
Iraq, Afghanistan and elsewhere in the Middle East and Central Asia (Hotez 2014). 
This disease has also affected military troops in Iraq and Afghanistan. When the 
infected patient succumbs to death they act as a reservoir of infection, passing 
on the parasite to other people through the bite of sand flies (Hailu et al. 2005). 
Animals such as dogs are also important reservoirs of human VL and most reported 
cases were in dogs that had originated in or travelled from areas where 
leishmaniasis is endemic (Reguera et al. 2016).  
CL is more widely distributed, with about one-third of cases occurring in each of 
three epidemiological regions specifically the Americas, the Mediterranean basin, 
and western Asia from the Middle East to Central Asia. The ten countries with the 
highest estimated case counts are Afghanistan, Algeria, Brazil, Colombia, Costa 
Rica, Ethiopia, Iran, Peru, Sudan and Syria, and together account for 70 to 75% of 
global estimated CL incidence (WHO 2015). 
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Figure 1.5: The distribution of visceral leishmaniasis in the world.  
Source: WHO 2015. 
 
Figure 1.6: The distribution of cutaneous leishmaniasis worldwide.  
Source: WHO 2015. 
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Table 1.1: Leishmania species causing human disease, reservoir hosts and vectors 
 (Oryan 2015) 
 
VL: Visceral leishmaniasis; PKDL: Post-kala azar dermal leishmaniasis; P: Phlebotomus; ML: 
Mucosal leishmaniasis; CL: Cutaneous leishmaniasis; L: Lutzomyia; DCL: Diffuse cutaneous 
leishmaniasis; MCL: Mucocutaneous leishmaniasis. 
 
1.2.2 Diagnosis, treatment, vaccination and prevention 
To date, a variety of diagnostic methods have been developed for diagnosis and 
identification of Leishmania. It has proven challenging to diagnose the symptoms 
of leishmaniasis in the early phase as the parasites could live inside the host for 
months asymptomatically. Furthermore, confirmation of diagnosis by laboratory 
methods is difficult in remote areas. Traditionally, Leishmania in clinical samples 
is detected microscopically but this method is not only insensitive but also 
laborious. Although the conventional molecular approaches such as PCR, RT-PCR 
and RFLP improve diagnosis and produce quantitative results, however, they are 
expensive and complex (Carson et al. 2010). Other techniques that use monoclonal 
antibodies such as ELISA, Southern, Dot, Spot, or Squash Blots are not feasible due 
to lack of specificity, sensitivity and rapidity for the isolates (Lockwood & Sundar 
2006). Recently, Sattarahmady et al. (2016) have developed a new method of 
diagnosing leishmaniasis based on hybridization of gold nanoparticles linked to a 
Leishmania species Infection 
Geographical 
location Reservoir Vector 
L. donovani VL, PKDL 
Old world, except 
Europe Humans, rodents 
Phlebotomus 
argentipes, P. 
orinntalis, P. martini 
L. infantum VL, CL, ML 
New world for VL, 
old world for CL 
and ML 
Rodents, dogs, foxes, 
jackals 
P. pcniciosufi, P. arias, 
Lutzomyia longipalpis 
L. chagasi VL New world  Foxes, dogs, opossums L. longipalpis 
L. major CL, ML Old world  Rodents, gerbils P. papatasi, P. duboscqi 
L. tropica CL, ML, VL Old world  Humans  P. sergenti 
L. aethiopica 
CL, DCL, 
MCL Old world  Hyraxes P. longipes, P. pedifer 
L. mexicana 
CL, DCL, 
MCL New world  Forest rodents L. olmeca 
L. amazonensis 
CL, DCL, 
MCL New world  Forest rodents L. flaviscutellata 
L. braziliensis CL, MCL New world  
Forest rodents, peri 
domestic anteaters Lutzomyia spp. 
L. guyanemis CL, MCL New world  Sloths arboreal anteaters L. umbratilis 
L. panamensis CL, MCL New world  Sloths L. trapidoictal 
L. peruviana MCL New world  Dogs 
L. verrucarun, L. 
pvmenis 
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specific ssDNA probe from non-protein coding region of L. major minicircle 
kinetoplast DNA.   
The current mainstay of treatment is based on chemotherapy, which relies on a 
handful of drugs. The gold standard against leishmaniasis that has been used for 
the last six decades is pentavalent antimonial. In some cases, other drugs such as 
amphotericin B, pentamidine, miltefosine, aminosidine, paromomycin, 
allopurinol, and sitamaquine can be used (Figure 1.7) (Monzote 2009). However, 
the therapeutic arsenal against leishmaniasis is currently limited due to low 
efficacy, emergence of resistant parasites, high toxicity of drugs that causes life 
threatening side-effects, high cost especially to the less developed countries, and 
difficulties of administration of the drugs (Mohapatra 2014). Therefore, there is a 
dire need for new chemotherapeutic agents against this perilous disease.  
  
Figure 1.7: Chemical structure of antimonial drugs, amphotericin B and pentamidine. 
 
Amphotericin B and pentamidine are among the most frequently used drugs in leishmanial infection. 
Amphotericin B binds to ergosterol, which is an essential component of the fungal cell membrane. 
This binding cause depolarization of the membrane and altering cell membrane permeability. This 
leads to leakage of important intracellular components, cell rupture, and eventually cell death. This 
agent may also induce oxidative damage in fungal cells and has been reported to stimulate host 
immune cells. Pentamidine is a synthetic derivative of amidine with antiprotozoal and antifungal 
activities. Although the precise mode of action of pentamidine is unclear, it appears to interact directly 
with the pathogen genome by binding to AT-rich regions of duplex DNA and the minor groove of 
DNA, thereby interfering with DNA replication.  
Source: https://pubchem.ncbi.nlm.nih.gov/compound/ 
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In recent years, there have been several promising compounds that show anti-
leishmanial properties and are in different stages of drug development and clinical 
trials. These include 2-substituted quinolone, 8-aminoquinolines as well as drugs 
that targeting the metabolic pathways and biochemical structures of the parasite 
(Mohapatra 2014). As the key regulatory proteins, protein kinases have been 
targeted for the development of anti-leishmanial compounds. L. mexicana 
mitogen activated protein kinases-1 (LmxMPK-1) and mitogen activated protein 
kinases-2 (LmxMPK-2) were found to be essential for the survival of amastigotes 
in the host (Wiese 2007). There are also a growing interest in alternative natural 
products and plant compounds for the treatment of leishmaniasis (Oryan 2015). 
On the other hand, vaccines have not been successful so far due to the complexity 
of the immune response caused by the parasite. To date there is still no effective 
vaccine available despite substantial efforts by many laboratories (Gillespie et al. 
2016). Traditionally, leishmanization process which involves inoculation with live 
parasites has been given as vaccination in Asia, however in some cases this can 
lead to a chronic infection. Research has been carried out with heat-inactivated 
adjuvant-supplemented Leishmania or Leishmania fractions, genetically modified 
or live attenuated vaccines, as well as DNA vaccines (Rezvan & Moafi 2015). 
However, these researches are still undergoing clinical trials for safety, efficacy 
and immunogenicity. Another vaccine approach targets the parasite vector, i.e. 
selected sand fly salivary gland antigens, which can exacerbate Leishmania 
infection (Oliveira et al. 2015). One of the candidates that has succeed into phase 
I and II clinical trials is LEISH-F1 + MPL-SE fusion vaccine which is composed of the 
recombinant Leishmania polyprotein LEISH-F1 antigen that includes three proteins 
derived from Leishmania (elongation initiation factor, thiol-specific antioxidant, 
and stress-inducible protein 1) and the monophosphoryl lipid A-stable emulsion 
(MPL®-SE adjuvant) (Chakravarty et al. 2011). This vaccine has been shown to 
elicit a T helper 1 (Th1) immune response.  
Besides trying to combat leishmaniasis, prevention steps are more important to 
circumvent spreading the infection. Measures to control transmission of infection 
vary according to local epidemiology. Some of the controlling strategies that have 
been used to combat leishmaniasis focussed on vector control, control of animal 
reservoirs and personal protection. Spraying houses with residual insecticide 
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containing DTT (dichloro-diphenyl-trichloroethane) has been an important 
measure to control the vector in the past. However, it has become inefficient 
because sand flies has become resistant (Coleman et al. 2015). Moreover, DTT was 
banned in the United States and many other developed countries. In areas where 
sand flies bite at night, the usage of insecticide-impregnated bed nets has 
decreased the incidence of leishmaniasis. However, one major problem limiting 
the use of conventional bed nets is the cost (Guerin et al. 2002). 
Intense researches have been conducted on the vectors including identifying the 
location of metacyclic forms of Leishmania in specific parts of the sand fly gut, 
prevention of Leishmania attachment to the sand fly mid-gut (i.e. the role of 
lipophosphoglycan (LPG) and flagellar-specific protein), investigating the 
mechanics of sand fly biting as well as investigating the vector’s saliva as mode of 
transmission (Bates et al. 2015).  
Meanwhile in the Mediterranean basin and Brazil, as the principal reservoirs, the 
dog population has been targeted as preventative measures. It has been reported 
that the use of deltamethrin-impregnated dog collars gives up to 86% protection 
of dogs in seasons of high transmission (Maroli et al. 2001). Although this is a 
crucial epidemiological control, this approach presents logistical concerns. Recent 
reports revealed that domestic cats were infected with Leishmania sp. mainly L. 
infantum in urban areas of Brazil (Metzdorf et al. 2017).  
Nevertheless, despite many efforts, disease control has proven very difficult to 
achieve given the myriad of epidemiological situations, the multiplicity of factors 
that influence disease transmission and continuing uncertainty about the biology 
of the parasite, its vector and its reservoir hosts.  
Resistance to infection has been associated with a Th1-mediated immune 
response. However, cumulative evidence suggests that true protection from 
disease will require the involvement of both a Th1-mediated and a Th2-mediated 
immune response from vaccination (Nagill & Kaur 2011). Hence, understanding 
the drug resistance mechanism, the immune responses in host and the interaction 
between parasites, vectors and host, may provide ways to exploit many 
intracellular targets, which will provide clues for designing newer drugs. 
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1.3 Host-Parasite Interplay complexity 
The host-parasite relationship is by far the most important factor in elucidating 
pathogenicity. It determines whether the host can control the infection or fail to 
resolve infection making parasite to progress and disseminate (de Morais et al. 
2015). Three domains must be combined to fight against pathogens: (i) a 
comprehensive picture of the host immune response, (ii) comprehensive 
knowledge of the immune evasion mechanisms of the pathogens, and (iii) 
pathogen drug resistance mechanisms (Horvatić et al. 2016). Several mechanisms 
are involved in this complex interaction. Some pathogens including Leishmania, 
Trypanosoma cruzi and Salmonella have evolved evasive mechanism (Olivier et al. 
2005; Walker et al. 2013; Eriksson et al. 2003).  
1.3.1 Development of host immune response directed to 
Leishmania 
The innate response of immune system is based on the recognition of pathogen-
associated molecular pattern molecules (PAMPs) that serve as an exogenous signal 
that alerts the host of the presence of pathogens (Schenten & Medzhitov 2011). 
This initiate signalling cascade that leads to the activation of transcription factors 
in innate immune cells involving macrophages, dendritic cells (DCs), mast cells 
and neutrophils. The initial binding and internalization of promastigotes involves 
macrophage plasma membrane structures including complement component 3 
subunits C3b and C3bi, Fc receptors, lectin receptors and integrin. At the same 
time, the major surface molecules of Leishmania that involves in this interaction 
include gp63, LPG and glycosylinositol phospholipids (GPIs) (de Morais et al. 2015). 
Following entrance of Leishmania into the host skin, their first encounter will be 
resident cells such as dermal macrophages, keratinocytes and Langerhans cells 
(Liu & Uzonna 2012). It has been shown that keratinocytes play a critical role in 
the commencement of a protective immune response towards Leishmania by 
secreting immunomodulatory mediators such as interleukin-12 (IL-12), IL-1β, IL-4 
and IL-6 (Ehrchen et al. 2010). Moreover, two-photon intravital imaging of mouse 
skin following inoculation of L. major has proved that dermal DCs take up parasites 
within the first few hours (Ng et al. 2008). As the number of dermal DCs are too 
limited to sustain parasite multiplication, the progression of infection requires the 
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recruitment of monocytes, which is facilitated by neutrophils (Kaye & Scott 2011). 
During a sand fly blood meal, haemorrhagic pool caused by the bite attracts 
neutrophils and monocytes to rush to the site of infection (de Menezes et al. 
2016). Interestingly, while parasites used the monocytes as host, monocytes also 
upregulate the expression of major histocompatibility complex class II (MHC class 
II) molecules that act as antigen presenting cells (van Zandbergen et al. 2004; Ng 
et al. 2008). 
Neutrophils are recruited to the site of infection due to the release of alarmins 
(signal for tissue damage), cytokines and chemokines (Kaye & Scott 2011). These 
cells then produce reactive oxygen species (ROS), neutrophil elastase (NE) and 
neutrophil extracellular traps (NETs) (de Morais et al. 2015). Neutrophils also 
secrete IL-8 to attract more neutrophils, while functioning as phagocytic cells 
ingesting Leishmania (Teixeira et al. 2006). However, if Leishmania can evade 
these mechanisms, they will stay in neutrophils until neutrophils undergo 
apoptosis and phagocytized by macrophages (de Morais et al. 2015). Engulfment 
by macrophages triggers anti-inflammatory signal pathways. Furthermore, by 
staying in neutrophils before being phagocytized by macrophages result in silent 
entry of the parasites inside macrophages, thereby hiding them from anti-
inflammatory attacks.  
Macrophages, together with DCs and Natural Killer cells (NK) are considered to 
play important roles in the immune response to Leishmania infection. The role of 
macrophages is to destroy foreign microorganisms, cellular debris, as well as 
senescent and damaged cells. Apart from phagocytized cells, macrophages also 
act as antigen presenting cell (APC), which is necessary for their efficient 
interaction with effector T cells and the delivery of cytokines to induce 
bactericidal activity through the involvement of Toll-like receptors (TLRs) 
molecule signalling (Meier et al. 2003). NK cells are recruited to the site of 
infection to produce interferon-gamma (IFN-γ) and CD4+ cells that will restrict 
early parasite dissemination (Gupta et al. 2014). These cells also secrete IL-12 
which is important for the induction of a host-protective T helper 1 (Th1) type 
response (Kaye & Scott 2011). TLR2 expressed on host macrophages recognize LPG 
from Leishmania resulted in the production of IL-12, nitric oxide (NO) and ROS 
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thereby inducing host protective immune response (Kavoosi et al. 2009; 
Bhattacharya et al. 2010). 
Aside from innate response, adaptive response involving T and B lymphocytes also 
responsible in protecting host from harmful pathogens. Generally, IFN-γ-producing 
Th1 cells are required for resolution of infection. IFN-γ signals through JAK/STAT 
pathway is critical for the induction of NO (Jayakumar et al. 2008). While immune 
modulators such as IL-12, IFN-γ and tumour necrosis factor-alpha (TNF-α) mediate 
parasite clearance, others that dampen the immune response or activate immune 
response that will favour parasite persistence are associated with Th2 type 
response. These includes expression of IL-4, IL-10, IL-13 and transforming growth 
factor-β (TGF-β) (Gupta et al. 2014). Similar to TNF, IL-1β can lead to either 
protective or pathogenic effects during Leishmania infection (Figure 1.8) (Scott & 
Novais 2016). 
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Figure 1.8: IL-1β and TNF can be protective or pathogenic in cutaneous leishmaniasis. 
Reactive oxygen species (ROS) are induced following phagocytosis of Leishmania by innate cells. 
ROS can induce parasite elimination as well as activate the NLRP3 (NOD-, LRR- and pyrin domain-
containing 3) inflammasome. Pro-IL-1β is processed by the inflammasome in the skin and its mature 
form can function in several ways during Leishmania infection. IL-1β is important in T helper 1 (Th1) 
cell expansion by promoting IL-12 production, thereby inducing nitric oxide (NO) activation either 
directly, by activating macrophages, or indirectly, by promoting Th1-type responses and interferon-γ 
(IFN-γ) production. IL-1β can also induce tumour necrosis factor (TNF), which can be protective 
when synergizing with IFN-γ and thus increasing inducible NO synthase (iNOS) production in innate 
cells. NO can promote parasite control in the iNOS-expressing cell, but it can also diffuse through 
tissue and act on neighbouring cells. In contrast to their protective roles, IL-1β and TNF can also 
enhance the production of several chemokines and cytokines therefore promote the expression of 
adhesion molecules, leading to the amplified recruitment of cells from the blood. This enhanced 
inflammation results in tissue destruction and disease severity. (adapted from Scott & Novais 2016). 
 
1.3.2 Macrophage diversity 
Macrophages are well known for their ability to respond to environmental stimuli 
and dramatically change their form and physiology. However, not all macrophage 
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activation responses are the same (Mosser & Edwards 2008). The innate immune 
response that is orchestrated by a series of signalling pathways involving TLR, IL 
and NF-κB will define the macrophages response towards pathogen infection. The 
flexibility of macrophages towards in vivo environments results in the induction 
of various types of macrophages during infections and differentially affects the 
course of disease. Because the macrophage activation states correspond to their 
functional phenotypes during infection with pathogens, it provides a useful 
framework to understand how the expressed proteome of these cells correspond 
to their physiological functions (Chawla 2010). Essentially, there are at least three 
distinct populations of macrophages that have been extensively studied: 
classically activated macrophages (M1), alternatively activated macrophages (M2) 
and type II-activated macrophage (Figure 1.9). Each cell type appears to have 
different biological roles. The metabolic screening of cell extracts done by Lamour 
et al. (2012) has revealed clear metabolic differences between M1 and M2 
macrophages in L. major infected and uninfected state. 
M1 macrophages have been comprehensively characterized and well described 
among macrophage population (Gordon 2007; Martinez et al. 2009). These cells 
are important in host defence by propagating inflammatory responses. They are 
formed in response to IFN-γ and TNF, also referred as Th1 cytokines (Mosser & 
Zhang 2010). The activation process involves two steps. The first step occurs when 
IFN-γ induces macrophage to exhibit enhanced MHC class II expression and antigen 
presentation. The second step involves the activation of TLRs by stimulus such as 
lipopolysaccharide (LPS). The activation of TLRs induces the production of TNF 
and this cytokine acts in an autocrine manner to stimulate macrophages (Mosser 
& Zhang 2010). M1 macrophages are essential for rapid clearance of invading 
pathogens by producing NO and its derivatives. In addition to secreting NO, they 
also upregulate MHC-II and co-stimulatory molecules such as CD40, and produce 
many other inflammatory cytokines and mediators (Lamour et al. 2012). The 
immunoregulatory cytokines TGF-β and IL-10 play an important role in dampening 
macrophage activation (Mosser 2003). 
In contrast with M1 macrophages, macrophage exposure to IL-4, IL-13, and IL-21 
(representing Th2 cytokines) stimulates the transcription of arginase and 
polyamines which are used as substrates for parasite growth and replication. 
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These macrophages are known as M2 macrophages (Kropf et al. 2005). M2 
macrophages do not require a priming stage as opposed to M1. They do not 
produce NO that is responsible for microbial killing. Although they upregulate 
some MHC class II molecules, they are not efficient at antigen presentation, and 
may inhibit T cell proliferation (Mosser 2003). Arginase 1 is responsible for the 
hydrolysis of L-arginine into ornithine which is the building block for polyamines 
production. High level of polyamines contributes to the inefficient host defence 
by inhibiting the secretion of proinflammatory cytokines in host (Kropf et al. 
2005). 
Like the M1 macrophages described above, the type II activation phenotype 
required two signals. The first signal is the ligation of Fc-gamma receptors (FcγRs).  
Second signal comes from macrophage stimulatory signal (CD40 or CD44) through 
TLRs (Mosser 2003). Ligation of FcγRs on these macrophages turned off IL-12 
synthesis and induced the secretion of large amounts of IL-10 (Sutterwala et al. 
1997; Sutterwala et al. 1998). Additionally, the production of other M1-associated 
cytokines, such as TNF, IL-1 and IL-6, remains intact (Gerber & Mosser 2001). 
Furthermore, the dramatic induction of IL-10 by these macrophages suggested 
that they would have anti-inflammatory properties (Sutterwala et al. 1998). The 
ligation of FcγR on activated macrophages by antigen-IgG complexes induced T 
cells to produce IL-4, which in turn induced B cells which produced Th2-like 
responses (Anderson & Mosser 2002). 
  20 
 
 
Figure 1.9: Cytokines produced by immune cells can give rise to macrophages with distinct 
physiologies.  
Classically activated macrophages arise in response to interferon-γ (IFN-γ), which can be produced 
during an adaptive immune response by T helper 1 (Th1) cells or CD8+ T cells (not shown) or during 
an innate immune response by natural killer (NK) cells, and tumour-necrosis factor (TNF), which is 
produced by antigen-presenting cells (APCs). Wound-healing (alternatively activated) macrophages 
arise in response to interleukin-4 (IL-4), which can be produced during an adaptive immune response 
by Th2 cells or during an innate immune response by granulocytes. Regulatory macrophages are 
generated in response to various stimuli, including immune complexes, prostaglandins, G-protein 
coupled receptor (GPCR) ligands, glucocorticoids, apoptotic cells or IL-10. Each of these three 
populations has a distinct physiology. Classically activated macrophages have microbicidal activity, 
whereas regulatory macrophages produce high levels of IL-10 to suppress immune responses. 
Wound-healing macrophages are similar to the previously described alternatively activated 
macrophages and have a role in tissue repair (adapted from Mosser & Edwards 2008). 
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1.3.3 Metabolic reprogramming in macrophages 
Moreira et al. (2015) demonstrated that Leishmania can hijack mitochondrial 
pathways required for glucose metabolism. Early during infection, L. infantum 
was found to augment aerobic glycolysis, which was followed by a switch to 
mitochondrial metabolism and oxidative phosphorylation later during infection 
(Moreira et al. 2015). Of note, neutrophils depend on aerobic glycolysis for ATP 
production (Rossi & Zatti 1964). LPS produced by Gram-negative bacteria activates 
TLR4 in neutrophils and increases glucose consumption as well as oxygen 
consumption which is used to produce ROS (Guthrie et al. 1984). Pro-inflammatory 
stimuli induced by LPS activates macrophages and DCs that causes them to utilise 
more glycolysis and reduce oxidative phosphorylation (Kelly & O’Neill 2015a). 
Infection with Mycobacterium bovis BCG showed continual generation of NO 
following stimulation by LPS and IFN-γ (Qualls et al. 2013). NO expression induced 
by inducible nitric oxide synthase (iNOS) inhibit mitochondrial respiration through 
nitrosylation of iron-sulfur proteins present in electron transport chain complexes 
(Kelly & O’Neill 2015a). In macrophages activated by LPS and IFN-γ or infection, 
arginine is metabolized to NO and citrulline by iNOS. When arginine is scarce, 
citrulline is recycled to arginine via argininosuccinate synthase (Ass1) and 
argininosuccinate lyase (Asl) (Qualls et al. 2013). This is important to control 
infection. Therefore, some pathogens including Leishmania have mechanisms for 
depleting arginine by expressing arginase to inhibit NO production (Boitz et al. 
2017). In fact, many metabolic enzymes involved in glycolysis, TCA cycle and fatty 
acid metabolism are S-nitrosylated on cysteine residues by NO (Doulias et al. 
2014). For example, when very long-chain acyl-CoA dehydrogenase (VLCAD) was 
nitrosylated, its activity was increased thereby boosting fatty acid metabolism in 
β-oxidation of fatty acids pathway (Doulias et al. 2014). 
However, another type of macrophages which is the M2 (alternatively activated 
macrophages) have different metabolic profile than M1 (classically activated 
macrophages) macrophages (Mosser & Edwards 2008). It has been reported that 
M2 macrophages exhibit increased oxidative phosphorylation but have decreased 
production of NO and TNF-α (Doyle et al. 1994). While M1 macrophages are fuelled 
by glycolysis, M2 macrophages are fuelled by fatty acid uptake and oxidation in 
the mitochondria which are induced by IL-4 and IL-13 via signal transducer and 
activator of transcription 6 (STAT6) (Szanto et al. 2010).  
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1.3.4 Mechanisms of immune evasion by Leishmania 
The balance between Th1 and Th2 type response could be exploited by pathogens 
to evade host immune responses. Leishmania have found ways to escape the 
innate immune response, permitting its persistence within the mammalian host. 
A significant number of virulence factors have been discovered in Leishmania 
(Gupta et al. 2013).  
Leishmania are most vulnerable when they have just entered a mammalian host. 
Therefore, in this stage promastigote requires an array of strategies to evade the 
host immune system. The surface-bound display or secretion of virulence factors 
are important for the parasite to enter the host cell undetected. Promastigotes 
secrete proteases such as glycoprotein 63 (GP63) and cysteine proteases to 
breakdown host extracellular matrix to facilitate internalization into host (de 
Menezes et al. 2016). GP63 is also pivotal for resisting complement lysis by 
cleaving the host C3b to an inactive form C3bi, thereby hindering the complement 
system (Yao et al. 2003; Laurenti et al. 2004). The complement system is part of 
the immune system that enhances the ability to clear pathogens by triggering 
phagocytosis, inflammation and attacking membranes of foreign cells (Kenneth et 
al. 2017).  
On the other hand, the intracellular amastigote stage is more resistant to the 
hostile environment when they are engulfed by phagocytes. After internalization 
into phagosomes, metacyclic promastigotes rapidly transform into amastigotes, 
shedding the promastigote LPG. LPG migrates to the surface of the infected 
macrophages and inhibited the respiratory burst occurs by phagocytosis (Awasthi 
et al. 2004). Once inside the phagolysosome of the host, amastigotes not only can 
survive the acidic pH, they also relies on the host cells for nutrients such as sugars, 
amino acids, lipids and phosphate (Burchmore & Barrett 2001). 
Leishmania are able to hijack the microbicidal function of macrophages, mainly 
by interfering with intracellular signalling initiated by IFN-γ and TLR. As TLR2 
induce immune responses, L. major recruit suppressors for the cytokines, namely 
SOCS-1 and SOCS-3 (Flandin et al. 2006). L. amazonensis subvert TLR2 signalling 
pathway by increasing the expression of IFN-β that increase superoxide dismutase 
1 (SOD1) levels. Consequently, this inhibit superoxide-dependent parasite killing 
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(Vivarini et al. 2011). Besides TLR2, Leishmania could also alter TLR4 signalling 
pathways to favour establishment of infection. For example, L. mexicana 
capitalizes on TLR4 signalling to inhibit the production of IL-12 by infected 
macrophages and thereby promotes infection (Shweash et al. 2011). One of the 
main signalling molecules involve is Src-homology 2 domain containing 
phosphatase-1 (SHP1) (Shio et al. 2012). SHP1 has a central role in the regulation 
of iNOS and NO by inactivating JAK2 and Erk1/Erk2. Studies with SHP1-deficient 
infected macrophages confirmed the role of this phosphatase in the regulation of 
Erk1/2 signalling (Blanchette et al. 2009). Interestingly, L. mexicana amastigote 
block LPS induced IL-12 production by degrading the Erk1/2 and Jun N-terminal 
kinase (JNK) using their cysteine proteinases (Cameron et al. 2004). Next, protein 
kinase C (PKC) signalling is important to drive the expression of NO and oxidative 
burst (Shio et al. 2012). However, Leishmania LPG can block PKC activity by 
binding to the regulatory domain of PKC (Turco & Descoteaux 1992). JAK 
activation plays an important role in apoptosis and immune activation through the 
activation of STAT1 and transcription factors (TFs) (Rawlings et al. 2004). More 
importantly, the gene promoter on iNOS has binding sites for several TFs including 
STAT1. Leishmania has developed several strategies to interfere with these TFs 
including NF-κB, STAT-1α and AP-1 (Shio et al. 2012). One study reported that 
cysteine proteinases of L. mexicana degrade NF-κB and resulted in failure to bind 
to its DNA consensus on iNOS gene (Cameron et al. 2004). In addition, GP63 is 
responsible to degrade AP-1 subunits and block its downstream functions such as 
NO production (Contreras et al. 2010).  
Collectively, it is very clear that Leishmania have the ability to evade host immune 
responses as well as modulating most of the key immune regulator molecules and 
signalling pathways produced by the host. Therefore, critical macrophage 
functions that were meant to threaten parasites were interfered, making them to 
persist in the host. 
1.4 Proteomics 
Recent advances in next-generation DNA sequencing and proteomics provide an 
unprecedented ability to survey mRNA and protein abundances. Such proteome-
wide surveys are illuminating the extent to which different aspects of gene 
expression help to regulate cellular protein abundances. Proteomics is an 
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emerging field of research facilitated by the advancements in protein separation, 
mass spectrometry, genome sequencing, and protein search databases. The most 
applied approaches to proteomics research can be generally classified as having 
one of two major objectives: (1) protein or peptide separation, and (2) 
identification and characterization of proteins or peptides. 
Proteins are essential players in all cellular processes, with numerous functions as 
enzymes and structure-forming or signal-transducing molecules. Their enormous 
characteristics enable a myriad of necessary tasks to ensure proper function of 
each cell. Changes in biological events such as disease, drug effect, or 
physiological activity will be reflected in abundancies or processing of the 
proteins. Therefore, proteins have always been, and presumably will always be, 
the target of all types of studies in biological sciences. 
Unlike the genome, the proteome is dynamic, responding to any change in genetic 
and environmental factors. Furthermore, the proteome is more complex than a 
genome due to post-translational modification events. Moreover, the dynamic 
range of the protein abundance makes protein studies even more difficult. In order 
to decipher the constituents of a proteome, the dynamics and complexity of 
proteins could be analysed quantitatively. Gel-based proteomics have always used 
by many scientists. However, limitations such as reduced reproducibility and time-
consuming make scientists to seek for other alternatives. Thus, methods such as 
in-solution digestions, liquid chromatography, and Multidimensional Protein 
Identification Technology (MudPIT), which are gel-free, are favoured when dealing 
with complex proteins samples. 
1.4.1 Gel-based protein separation and detection 
Currently, there are three preferred methods for separation of complex protein 
samples: SDS-PAGE, 2-DE, and DiGE. Each of these has its own merits and 
drawbacks.  
First reported by Laemmli in 1970, sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) is a very common method for separating proteins by 
electrophoresis using a discontinuous polyacrylamide gel as a support medium and 
sodium dodecyl sulphate (SDS) to denature the proteins. Proteins were separated 
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according to size. Although SDS-PAGE is relatively easy to use and have low cost, 
it has low resolution, low accuracy and samples of high complexity are unable to 
be separated.  
As an alternative, researchers moved to 2-dimensional gel electrophoresis (2-DE). 
2-DE was pioneered by O’Farrell (1975). This technique separate proteins from 
complex samples based on their isoelectric points and molecular weights. In the 
first dimension, proteins are separated by their isoelectric point (isoelectric 
focusing; IEF) and in the second dimension by their molecular weight. After 
separation, proteins can be visualized, cut out of the gel, and identified by mass 
spectrometry. For comparative purposes, samples are loaded on separate gels and 
protein spot patterns are compared visually using 2D gel analysis software. Despite 
its powerful resolving capabilities, 2-DE technique lack reproducibility and 
laborious (Delahunty & Yates 2005). Additionally, there are several challenges for 
automatic software-based analysis such as incompletely separated (overlapping) 
spots, weak spots/ noise, running differences between gels (e.g., protein migrates 
to different positions on different gels) as well as unmatched or undetected spots. 
Nevertheless, many researchers employ 2-DE coupled with mass spectrometry (MS) 
as a standard protocol of proteomics, where automated in-gel digestion of protein 
spots will be subjected to subsequent identification of the proteins by MS.  
In a variation of 2-DE technique, difference gel electrophoresis (DiGE), proteins 
from up to three different samples are labelled with different size-matched, 
charge-matched spectrally resolvable fluorescent dyes (e.g. Cy3, Cy5, Cy2) and 
then mixed, making it possible to directly compare different samples on a single 
gel. Interesting spots with differential fluorescent intensity between the dyes are 
removed from the preparative gel after post-staining with Coomassie Blue in order 
to allow proteins identification by MS analysis. Limitations of this method include 
time-consuming technique, and limited sensitivity, which, as a consequence, 
proteins with a low concentration may be failed to be selected (Unlu et al. 1997). 
Another method that combines gel-based separation with MS is called OFFGEL. 
This separation is based on immobilized pH gradient (IPG) strips to separate 
peptides and proteins according to their isoelectric point (pI), that will be 
captured in solution, thus making recovery for LCMS much easier than traditional 
gels (Chenau et al. 2008). 
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The first comparative proteomic analyses utilising 2-DE on Leishmania spp. were 
done by El Fakhry et al. (2002), Bente et al. (2003), and Nugent et al. (2004). 
These studies were done on promastigotes and axenic amastigotes of L. infantum, 
L. donovani and L. mexicana where 2000 protein spots were detected. Of these 
spots, 3-5% were differentially expressed including proteins involved in 
carbohydrate metabolism, proteolysis, and response to stress. 
1.4.2 Gel-free proteomics 
The greatest step forward in the last decade has been the application of the 
physical sciences to cell biology. The behaviour of a cell emerges from the 
collective property of the millions of molecules in a cell could be elucidated.  
However, knowledge of molecules does not tell us how a cell is organized.  Thus, 
the physical sciences provide us with the tools and techniques to answer such 
problems.  Hence, MS-based proteomics approaches are essential in this regard.  
One of the example of gel-free proteomics is the use of multi-dimensional 
capillary liquid chromatography coupled to tandem mass spectrometry to separate 
and identify the peptides obtained from the enzymatic digest of an entire protein 
extract. Proteins are cleaved into peptides using proteolytic enzymes and, 
subsequently separated and subjected to tandem mass spectrometric analysis. 
Mass spectrometric identification of these peptides allows the determination of 
the protein content of the initial sample. Since peptides can be more easily 
separated by liquid chromatography than proteins, a peptide based proteomic 
analysis can be performed much faster than a complete gel-based analysis.  
In a typical shotgun proteomics experiment using MS, a complex protein sample is 
enzymatically digested into peptides which are then separated by HPLC, 
introduced into a mass spectrometer, fragmented, sequenced and used to identify 
the parent protein via database searching (Matallana-Surget et al. 2010). MS is 
currently the driving force to generate massive amount of proteomics data due to 
the ability to detect and identify proteins in large scale. Another benefit of this 
technique is its sensitivity. Most importantly, the ground-breaking development 
of specific ionization techniques (particularly ESI and MALDI) awarded with the 
Nobel Prize in 2002, ultimately rendered biological molecules amenable to MS and 
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made instruments to become widespread in research laboratories (Cox & Mann 
2011).  
In ESI, high voltage is applied to a flowing solution containing the analyte as it 
passes through a narrow needle. As the solution of charged molecules evaporates, 
the emitted droplets shrink into smaller droplets and shortly thereafter enter the 
gas phase (Thelen 2007). ESI produces multiple charge ions compared to singly 
charged ions as produced in MALDI. MS-MS spectra reveal fragmentation patterns. 
In MALDI, a laser is fired at a stainless-steel plate under vacuum. The analyte will 
be dried on the plate, co-crystallized with “matrix”, which is a small organic 
molecule that absorbs the pulsed UV laser light. The laser light pulsed on the co-
crystallized matrix-analyte layer resulting in the vaporization of matrix and the 
associated analyte. Spectra indicate masses of the peptide ions and protein 
identification is achieved by peptide mass fingerprinting. Although MALDI-MS has 
high sensitivity, quick and not expensive, some of the disadvantages of MALDI 
include low reproducibility and repeatability of single shot spectra. 
Nevertheless, MS-based proteomics are costly and requires highly-skill person. At 
present, MS-based proteomics has become the method of preference to study 
differences in global protein compositions, for detection of post-translational 
modifications (PTMs) and protein-protein interactions (PPIs) as well as for protein 
biomarker discovery (Cox & Mann 2011). 
1.5 Quantitative approaches in MS-based Proteomics 
LC-MS/MS is one of the most powerful techniques in proteomics allowing high 
throughput identifications of proteins out of complex protein mixtures. MS has 
both qualitative and quantitative uses. Quantitative proteomic experiments 
usually aim at detecting differentially regulated proteins between different 
sample groups, e.g., tumour tissue samples versus healthy control samples. In MS 
approach, quantification of proteins is based on the peak height or area of the 
proteolytic peptide peaks in the mass spectrum and/or chromatogram. However, 
peak intensity differences of the same analyte within one LC-MS run often cannot 
be distinguished. One way to distinguish the same analyte from different sample 
sources within one LC-MS experiment is by using labelling technique. Coupled with 
labelling techniques (chemical and metabolic labelling), the relative amounts of 
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proteins can be measured at any given time and therefore provide more insight 
into the dynamics of biological system.  
There are two types of quantification: relative quantification and absolute 
quantification. In relative quantification, samples are differentially labelled with 
stable isotopes, combined, and subjected to quantitative MS. Peak intensity ratio 
between unlabelled and labelled peptides is measured to learn relative change in 
protein abundance (Kito & Ito 2008). These approaches are often used in discovery 
proteomics, where many proteins are identified across a broad dynamic range 
using different-sized labels. In MS-based absolute quantification, a known amount 
of isotope-labelled authentic standard is spiked with the analyte before 
introducing the mixture into mass spectrometer. The absolute amount of the 
analyte is calculated from the ratio of ion intensity between the analyte and its 
standard (Kito & Ito 2008). Absolute quantitation is performed in targeted 
proteomic experiments and increases the sensitivity of detection for a limited 
number of target analytes.  
LC-MS protein quantification strategies fall into two broad categories: label free 
and protein/peptide labelling (also known as differential mass tagging or isotopic 
labelling). Label-free quantification is the simplest and most economical 
approach. Label-free quantitation methods involve comparison of peptide ion 
currents between samples or the comparison of spectral counts for peptide ions 
from particular proteins across the samples. This approach is suitable to any kind 
of samples including samples that cannot be directly metabolically labelled (Cox 
et al. 2014). In contrast, labelling strategies allow the mixing of samples prior to 
LC-MS, thereby reducing error. Thus, multiple samples can be run simultaneously 
with the same peptides (or proteins) being identically separated and co-eluted 
into the mass spectrometer with ion intensities being directly compared in the 
same MS or MS/MS scans. 
Many MS-based approaches that utilize stable isotopes have been explored and 
implemented for the routine quantitation of proteins (Figure 1.10) (Ong & Mann 
2005). Till date, several approaches have been developed for comprehensively 
assessing proteomes. They include Isotope-coded affinity tags (ICAT), Isotope tags 
for relative and absolute quantification (iTRAQ), stable isotope dimethyl labelling 
(DiMe) and stable isotope labelling with amino acids in cell culture (SILAC) 
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(Bantscheff et al. 2007). Owing to the natural occurrence of certain stable heavy 
isotopes (e.g., 13C, 15N, 18O, 2H) each peptide/protein contains a certain 
proportion of these; the isotope pattern seen in the mass spectrometer thus 
reflects the natural abundances of these heavy isotopes within the peptide. 
Artificial incorporation of heavy isotopes produces a mass shift of the peptide’s 
peaks in the mass spectrum. Thus, intensity ratios of peaks corresponding to 
different isotopic compositions of the same molecular species reflect 
quantitatively the isotopic abundance ratios. Due to the different mass introduced 
during labelling process, peptides derived from the various samples can be directly 
compared and this reflects the relative quantities of the particular peptide and 
proteins.  
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Figure 1.10: An overview of mass spectrometry-based quantitative proteomics.  
Mass spectrometry (MS)-based quantification can be achieved either by relative or absolute 
quantification (AQUA). Both relative and AQUA can be further classified into labelled and label-free 
quantification, each of which can be performed by several approaches. Abbreviations: MRM - 
Multiple-reaction monitoring, TMT - Tandem mass tags, APEX - Absolute Protein Expression (Lill 
2003; Mirza 2012). 
 
Despite the phenomenal impact of MS and peptide separation techniques on 
proteomics, the identification and quantification of all the proteins in a biological 
system is still an unmet technical challenge (Figure 1.11). Several factors affect 
quantitative capabilities of MS including factors related to instrument as well as 
sample-related (Urban 2016). As the quality and reproducibility of sample 
preparation significantly impact results from MS instruments, proper sample 
preparation is critical for MS analysis. 
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Figure 1.11: Quantification bias.  
Schematic representation of the fraction of a proteome that can by identified or quantified by mass-
spectrometry-based proteomics. Cellular proteins span a wide range of expression and current mass 
spectrometric technologies typically sample only a fraction of all the proteins present in a sample. 
Due to limited data quality, only a fraction of all identified proteins can also be reliably quantified 
(Bantscheff et al. 2007). 
 
In the Leishmania research field, proteomic studies have provided valuable 
insights into the identification of molecules and pathways involved in the parasite 
(El Fakhry et al. 2002; Bente et al. 2003; Biyani & Madhubala 2012). However, only 
very few studies used proteomics to identify proteins expressed by the host cell 
in response to Leishmania. MS-based proteomic was used to identify markers of 
resistance and susceptibility in CBA mouse macrophages during L. major and L. 
amazonensis infection in vitro (Menezes et al. 2013). A total of 1352 proteins were 
found expressed in both infected and uninfected CBA macrophages. Of these, only 
62 proteins were predominantly expressed in infected macrophages. Most of these 
proteins were involved in cell metabolism, cell signalling, cellular detoxification 
and cell immune response. Interesting, only 10 out of the 62 proteins were 
exclusively identified in L. major infection: ribosomal protein S13, glutamate 
receptor ionotropic, guanine nucleotide binding protein (G protein, γ8 subunit), 
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myosin, proteasome β3 subunit, ras homolog gene family member B, cytochrome 
c-1, N-acetylglucosamine kinase, TNF receptor-associated protein 1 (TRAP1), and 
translin. By contrast, the unique protein found expressed in L. amazonensis 
infection was succinate dehydrogenase which is an enzyme involved in cell 
metabolism (Menezes et al. 2013). 
Another study that evaluated the host cell response to Leishmania infection using 
proteomics was done by Singh et al. (2015). In this study, the authors employed 
iTRAQ and LC-MS/MS to compare the expression profiles of non-infected and L. 
donovani-infected THP-1 cells. They found that proteins involved in major 
metabolic pathways, including glycolysis and fatty acid oxidation, are highly 
expressed following L. donovani infection, suggesting a parasite-induced global 
reprogramming of cell metabolism. Furthermore, proteins involved in gene 
transcription, RNA splicing (heterogeneous nuclear ribonucleoproteins (hnRNPs)), 
histones, DNA repair and replication was also found to be increased in response to 
infection.  
1.5.1 Stable isotope labelling technique 
Stable isotope labelled analogues of substances have been used as standards for 
quantitative measurements with MS for a long time. Several methods have been 
developed to quantify proteins by MS. Stable isotope labelling is by far the most 
accurate type of quantitative proteomics (Ong & Mann 2005). As mentioned 
before, these approaches exploited the identical physicochemical properties of 
labelled and native peptides (e.g., in stable isotope labelling with amino acids in 
cell culture, SILAC) or of peptides labelled with physicochemically identical 
reagents (e.g., in iTRAQ) for relative comparison of intensities of mass-shifted 
peaks within the same mass spectrum (Kito & Ito 2008; Urban 2016). Stable 
isotopes can be introduced at the protein or peptide level either chemically (e.g. 
ICAT, iTRAQ, DiMe), enzymatically (18O) or metabolically (SILAC) (Ong & Mann 
2005).  
The chemical labelling approaches make use of tags with the same (isobaric 
labelling) or different masses (isotopic labelling). Isobaric labelling (e.g., iTRAQ, 
TMT) consists of peptide tags which generate specific fragment ions by MS/MS 
whereby relative quantitation is performed by comparison of intensities of the 
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‘reporter’ fragments in the MS/MS spectra. In contrast, isotopic labelling methods 
(e.g., ICATs or proteolytic 18O labelling) generate pairs (or more) of peptides with 
a mass difference introduced by the label. Chemical labelling is essentially based 
on similar mechanisms as metabolic labelling, except that the label is introduced 
into proteins or peptides by a chemical reaction, e.g., with sulfhydryl groups or 
amine groups, or through acetylation or esterification of amino acid residues 
(Chahrour et al. 2015). In general, the advantage of chemical labelling over 
metabolic labelling is the possibility to label a wide range of different sample 
types, since incorporation of the label is performed only after harvesting cells and 
subsequent purification of proteins.  
When using any labelling approach for LC-MS, the labels are best introduced at 
the earliest point in the workflow to minimise differences introduced into the 
samples between LC-MS runs. This could be achieved by metabolic labelling during 
cell growth and division. Metabolic labelling involves the in vivo incorporation of 
stable isotopes into the protein sequence, supplied through the growth medium 
during protein biosynthesis. Historically, this been done with unstable isotopes of 
amino acids of which the radioactive decay could be measured in time. Figure 
1.12 depicted some of the type of stable isotope labelling for quantitative 
proteomics. Of all these approaches, SILAC is the mode popular and has enormous 
potential (Ong & Mann 2005).  
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Figure 1.12: Stable-isotope tagging techniques on in vivo and in vitro labelling for differential 
proteomic.  
Abbreviations: CDIT - Culture-derived isotope tags, SILAC - Stable isotope labelling with amino acids 
in cell culture, ICAT - Isotope-coded affinity tags, MeCAT -  Metal-coded affinity tag, QUEST -  
Amidination-quantitation using enhanced signal tags, iTRAQ - Isotope tags for relative and absolute 
quantification, GIST - Global internal standard technology (Lill 2003; Chakraborty & Regnier 2002; 
Rauniyar & Yates 2014). 
 
SILAC was originally developed in the lab of Matthias Mann in 2002. Typical SILAC 
experiment involves the growth of cells in culture medium supplemented with 
heavy stable isotope versions of essential amino acids (Ong & Mann 2006). SILAC 
replaces natural amino acids with a stable isotope-labelled version. For example, 
it might substitute C-13 for C-12 in particular amino acids, normally 13C6-arginine 
and 13C6-lysine. Other isotopes widely used include 15N2, D3-leucine, and D10-
leucine. The labelled amino acids are added to the growth medium, taken up by 
the cells during cell divisions, and subsequently incorporated into newly 
synthesized proteins. The two versions of the proteins (labelled and not labelled) 
can be processed together (mixed, digest) and differentiate on MS (Mann 2014). 
This implies that errors introduced by the aforementioned sample preparation 
steps are overcome. As trypsin predominantly cleaves proteins at the carboxyl side 
(or ‘C-terminal side’) of the amino acids lysine and arginine, all tryptic cleavage 
products of a protein (except for the very C-terminal peptide) carry at least one 
labelled amino acid resulting in a constant mass increment over the non-labelled 
counterpart. Depending on the label used in SILAC, light and heavy peptide peaks 
differ in mass from at least four up to ten Dalton. This allows researchers to look 
at the relative quantity of proteins in two different samples. 
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The application of SILAC is enormous. SILAC has been successfully used in studying 
differential protein expression to identify disease biomarkers. Gronborg (2005) 
have used this strategy to do differential secretome proteomics in case of 
pancreatic cancer. Similar approach has been undertaken by Hoedt et al. (2014) 
to do differential proteomics on proteins associated with antitumoral activities in 
breast cancer cells. SILAC has also been used for cells signalling dynamics studies. 
For example, Olsen et al. (2006) employed SILAC to study temporal dynamics of 
signalling pathways by exploiting phosphorylation based enrichment methods 
coupled to MS. SILAC was used in Trypanosoma brucei to compare the proteome 
of two different life cycle stages to better understand the sophisticated life cycle 
of this parasite (Butter et al. 2013). The application of SILAC in PTMs studies has 
been widely used (Pimienta et al. 2009; Zhang & Neubert 2009; Zanivan et al. 
2013; Ibarrola et al. 2003). In the past few years, the applicability of SILAC has 
been revolutionized to label entire organisms such as mouse and bacteria (e.g., 
Zanivan et al. 2012; Soufi et al. 2010). Application of SILAC to whole organisms is 
valuable when in vivo experiments are performed that analyse whole tissues 
rather than cultured cells. As an alternative to the classical SILAC approach, 
heavy-labelled samples can be used as an internal standard for quantification. 
This approach is termed as Spike-in SILAC (Geiger et al. 2011). Use of SILAC-
labelled cells as a ‘spike-in’ standard overcomes the labelling problem as the 
quantification of each of the tissue samples can be performed relative to a 
standard. Furthermore, when the samples of interest are diverse, several SILAC-
labelled cell lines that together serve as the spike-in standard can be mixed, 
creating a super-set of SILAC labelled cells, termed ‘super-SILAC’ mix (Geiger et 
al. 2011; Geiger et al. 2012). 
While SILAC is very powerful, however, since steady-state protein levels reflect 
the net outcome of antagonizing protein synthesis and protein degradation 
processes, the typical SILAC method was not useful to explicitly measure 
differences in protein translation. Hence, different variants of SILAC such as pulse-
chase SILAC (pcSILAC) were invented that enable quantification of different 
aspects of proteome dynamics on a global scale (Bunner & Williamson 2009). In 
pcSILAC, differentially treated cell populations are simultaneously transferred to 
culture medium supplemented with different versions of stable-isotope labelled 
amino acids after certain time. After extraction, digestion, and identification of 
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proteins by tandem MS, the heavy/light ratios determined for peptides provide 
the level of label incorporation during the time frame considered. This is 
advantageous over the classic SILAC strategy as MS-based relative quantification 
is exclusively based on the newly synthesized protein amounts. This enables the 
specific detection of differences in protein translation resulting from the 
differential treatment. pcSILAC is powerful enough to be use on its own (Fierro-
Monti et al. 2013; Bunner & Williamson 2009; Kristensen et al. 2012; Schmidt et 
al. 2010). However, some researchers employed pcSILAC along with pulsed AHA 
labelling to try to enrich the number of newly synthesized proteins they could 
capture (Debarba et al. 2015).  
1.6 Protein dynamics 
For any cell or tissue, protein balance reflects the net protein synthesis and 
protein degradation that differ significantly among tissues and organs and 
between cell compartments (Poortmans et al. 2012). Thus, protein turnover is the 
balance between protein synthesis and protein degradation (Figure 1.13). When 
older proteins are broken down in the body, they must be replaced. Whereas, 
protein synthesis occurs during the process of translation on ribosomes. Protein 
turnover has a substantial metabolic demand due to high energy needs for both 
biosynthesis and degradation of proteins. For example, in the young rat, the rate 
of synthesis of liver proteins is about 50% per day, and in the young mouse, it may 
be as high as 100% per day (Claydon & Beynon 2012). A primary function of this 
energetically expensive constant turnover is to alter the levels of specific proteins 
in response to physiological changes, hormonal status, or diet (Claydon & Beynon 
2012). How rapid the proteins being replaced correspond to its turnover rate. 
Different types of proteins have different turnover rates (Pratt et al. 2002; Beynon 
2005). For a protein with high turnover rates, the change in abundance can be 
rapid. Changes in the abundance of proteins in response to different stimuli or 
environment is control by the rate of turnover. A protein that has a high rate of 
turnover can be increased in abundance, or removed from the protein pool, very 
rapidly. 
  37 
 
 
Figure 1.13: States of protein turnover.  
During steady state, protein synthesis equal to degradation with neither the related transcriptome nor 
the metabolome affected. When protein pool expands, there is increased synthesis or decreased 
degradation with the related transcriptome or metabolome being modulated, respectively. During 
protein pool contraction, there is decreased synthesis (transcriptome changed) or increased 
degradation (metabolome changed). Adapted from (Chou et al. 2012). 
 
In steady-state systems, where the concentration of all proteins is assumed to be 
constant, incorporation ratios allow to measure protein turnover and half-life. Our 
scientific heritage in the study of protein metabolism started with Black (1756) 
and Rutherford (1772) who observed the release of CO2 and NH3 in animal tissues. 
Since then, the metabolic changes produced by an intake of protein have been 
widely studied. Before the advent of proteomic MS, protein turnover was studied 
using radiolabel pulse-chase experiments that are similar to the modern MS-based 
turnover studies. MS-based pulse-chase labelling was later used for targeted 
analyses to measure the flux of ribosomal proteins in nucleoli (Lam et al. 2007; 
Bunner & Williamson 2009) and to determine turnover for bacteria (Pförtner et al. 
2013; Schmidt et al. 2010), yeast (Christiano et al. 2014; Helbig et al. 2011a; Belle 
et al. 2006; Martin-Perez & Villén 2015), as well as several human cell lines 
(Kristensen et al. 2012; Eichelbaum & Krijgsveld 2014). Although most turnover 
studies relied on isotope labelling and MS, GFP-tagging and other classical 
biochemical approaches have also been used to determine turnover (Bojkowska et 
al. 2011; Lam et al. 2007). However, SILAC based strategies are nevertheless 
preferred for the large-scale analysis of protein levels and protein turnover.  
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To determine the rate of protein synthesis using mass spectrometry, the 
incorporation of a stable isotope-labelled tracer into newly synthesized proteins 
can be monitored. Similarly, to assess rates of degradation, loss of the tracer is 
followed (Claydon & Beynon 2012). 
Direct measurement of protein synthesis can provide relevant information 
regarding the metabolic state of individual tissues. Protein turnover is an 
important aspect of the regulation of cellular processes for organisms when 
responding to developmental or environmental cues. Notably, the measurement 
of protein turnover in mammalian cells, in contrast to that of rapidly growing 
unicellular organismal cultures, is more complicated by the high degree of amino 
acid recycling. Therefore, the data analysis part will be very critical to translate 
them into meaningful inferences related to the biology of organisms.  
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1.7 Aims 
There were two important motivations that drive this research. First, Leishmania 
cause life-threatening diseases that significantly affect global health and present 
an economic burden. New treatments against these infections are urgently needed 
since the current treatments are limited by emerging drug resistance, poor 
efficacy, and insufferable side effects. In addition, the development of effective 
vaccines has remained elusive. Second, the intricate relationship between 
Leishmania and host that could unravel potential candidates for 
chemotherapeutic development. As Leishmania have evolved unique strategies to 
successfully co-exist with their hosts, it is important to understand the responses 
of host towards this parasite. Therefore, the aims of this project are to: 
1.  Employ discovery and quantitative proteomics approaches on human host 
macrophages infected with parasite L. mexicana. 
2. Establish the method of pulse-chase stable isotope labelling with amino 
acids in cell culture on human host macrophages infected with L. mexicana 
for 24 hours. 
3. Extend the approach of pulse-chase stable isotope labelling with amino 
acids in cell culture to investigate the proteome dynamic in terms of 
synthesis, degradation, half-lives and turnover upon 24 and 48 hours 
infection. 
As proteome dynamics is an essential aspect of biological processes, understanding 
the differences of protein expressions in Leishmania-infected macrophages could 
give insights into host metabolic processes, immune responses, and signalling 
pathways.  
 
 Chapter 2 
 
2 Materials and Methods 
2.1 Parasites and cell lines used 
The parasite used in this work is Leishmania mexicana strain MNYC/BZ/62/M379. 
For infection experiments, THP-1 (ATCC TIB-202TM), which is a human monocytic 
cell line derived from an acute monocytic leukaemia patient was used.  
2.2 Tissue culture 
2.2.1 L. mexicana 
Promastigotes of L. mexicana were cultivated in complete haemoflagellate 
minimal essential medium (HOMEM) (Life Technologies) supplemented with 10% 
(vol/vol) heat-inactivated foetal calf serum (HI-FCS) (Life Technologies) and 100 
U/ml penicillin-streptomycin (Life Technologies) and incubated at 27°C. 
Promastigotes were transformed into axenic amastigotes by cultivation in 
Schneider’s Drosophilla Medium (SDM) (Life Technologies) (pH 5.5) supplemented 
with 20% (vol/vol) HI-FCS (Life Technologies) and Hemin (2.5 mg/ ml in 50 mM 
NaOH) (Sigma Aldrich) and incubated at 32°C with 5% CO2 (Bates et al., 1992). A 
typical starting density of 105 cells per ml was used and counted with Neubauer 
haemocytometer. Growth curve was made using Microsoft Excel and doubling time 
was calculated using the formula below: 
𝑇 (𝑑) = (𝑡3 − 𝑡1)× [log(2) ÷ log(𝑄3 ÷ 𝑄1)] 
 
T3-t1 = two time intervals in log phase, 
Q3 = No. of cells at T3, 
Q1 = No. of cells at T1, 
Log (2) = 0.30103 
 
2.2.2 THP-1 
The THP-1 cell line, an acute monocytic leukemia-derived human cell line (ATCC 
TIB-202TM), was cultured at a density of 0.5-8 x 105 cells/ml in RPMI 1640 (Thermo 
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Scientific) supplemented with 10% HI-FCS, 2 mM L-glutamine, 10 mM HEPES and 
100 U/ml penicillin-streptomycin. The number of cells per ml should not be higher 
than 106 and were seeded every 3 days. The cultures were maintained at 37°C in 
a humidified atmosphere (95% air/5% CO2) and assessments with trypan blue 
exclusion were done regularly to check viability. To assess the cells viability, cells 
were mix with 0.4% trypan blue solution (in PBS) in 1:1 ratio and incubated at 
room temperature for several min. After that, cells were counted. The viable cells 
will exclude trypan blue whereas dead cells will be stained blue. Growth curve 
was made and doubling time was calculated using the formula below: 
𝑇 (𝑑) = (𝑡3 − 𝑡1)× [log(2) ÷ log(𝑄3 ÷ 𝑄1)] 
 
T3-t1 = two time intervals in log phase, 
Q3 = No. of cells at T3, 
Q1 = No. of cells at T1, 
Log (2) = 0.30103 
 
 
2.3 Sample collection for stabilates and storage 
To make stabilates, cell cultures were centrifuged at 1000 x g for 10 min. 
Supernatant was discarded but a total of 5 ml of supernatant were left to 
resuspend. 500 µl of cultures were transferred into a cryovial and added with 500 
µl of cryoprotectant (in 1:1 ratio). The tubes were vortex, wrapped in cotton wool 
and frozen at -80°C before storing them in the liquid nitrogen tank. A 
cryoprotectant for parasites consists of 70% of HI-FCS and 30% glycerol whereas 
for THP-1 it was consisted of 95% Hi-FCS and 5% DMSO (Sigma Aldrich) or glycerol. 
THP-1 was grown to a confluent of 106 cells/ml. 
To recover stabilates, they were thawed by warming them using hand and then 
poured into new media and incubated. 
2.4 Generation of proteomics samples 
2.4.1 Proteomics samples from promastigotes and amastigotes 
Cells were cultivated to a log phase (5x108 cells/ml) and harvested by centrifuge 
at 1000 x g for 10 min. Pellets were rinsed 3 times with PBS before lysis. Cells 
were then lysed in SDT lysis buffer (4% SDS, 100mM Tris/HCl pH 7.6, 0.1 M DTT, 
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and protease inhibitor cocktails (100 µg/ml of Leupeptin, 500 µg/ml of Pefabloc, 
2 mM of 1,10-Phenanthroline, 5 µg/ml of Pepstatin A and 50 µg/ml of E-64) (Sigma 
Aldrich), pH 7.4). Protease inhibitors were prepared according to the 
manufacturer protocol (Sigma Aldrich). DTT and protease inhibitors were added 
fresh to the buffer. Apart from SDT lysis buffer, we also tried using a different 
lysis buffer (TTG lysis buffer) consisting of 500 mM Tris-HCl pH 8, 0.25% Triton X-
100, 20% glycerol and protease inhibitors cocktail. The compositions in extraction 
buffers used in this work were described in Table 2.1. Samples were heated at 
95°C for 5 min. Samples were briefly sonicated (3 sec, repeated 3x with 1 min 
interval in between) with Soniprep 150 (MSE) before doing acetone precipitation. 
(Probe sonication times were optimised in this work). Four volumes of 100% cold 
acetone was added to each sample and left overnight in -20°C. Samples were 
centrifuged at 14, 000 x g for 15 min and supernatants containing protein lysates 
were collected for proteomics analysis. Subsequently, the protein pellet was 
washed once with 80% cold acetone and dried briefly. Subsequently, the protein 
pellet was resuspended in lysis buffer containing the protease inhibitor cocktails. 
Lysates can be stored at -80°C.The protein concentration was assayed in triplicate 
for each sample by the Bradford assay (Biorad). 
Table 2.1: Compositions of Extraction Buffers.  
Two types of extraction buffers were used to extract proteins from L. mexicana and THP-1. 
Extraction buffers Chaotrope/detergent Reductant 
SDT 4% SDS, 100mM Tris/HCl pH 7.6 0.1 M DTT 
TTG 500 mM Tris-HCl pH 8, 0.25% Triton X-100, 
20% glycerol 
0.1 M DTT 
 
Following whole cell extraction, 50-100 µg of lysates were digested with 
sequencing grade trypsin (Promega) using the Filter Aided Sample Preparation 1 
(FASP 1) method (as described in 2.4.1.2.). Peptides were then dried using the 
speed vacuum Concentrator 5301 (Eppendorf) for 30 min at room temperature. If 
there were salts present in the peptide mixtures, solid phase extraction clean-up 
(desalting) using SepPak C18 cartridges (Sigma Aldrich) should be carried out 
followed by drying the samples and resuspended in 10% (v/v) acetonitrile for LC-
MS/ MS analysis. 
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2.4.1.1 Optimisation of protein extraction with different protease inhibitors 
Cells harvested from growth medium were rinsed 3 times with PBS before lysis. 
Cells were then lysed in lysis buffer (as described in Table 2.1) supplemented with 
protease inhibitors. Different protease inhibitors (as listed below) were used and 
assessed to get better result. The optimisations were assessed by 1D-SDS-PAGE. 
1. cOmplete™, Mini, EDTA-free protease inhibitors cocktail tablet (Roche, 
UK).  
2. 100 µg/ml of Leupeptin, 500 µg/ml of Pefabloc, 1 mM of 1,10-
Phenanthroline, 5 µg/ml of Pepstatin A (Sigma Aldrich) and 1 mM EDTA 
(Nugent et al. 2004). 
3. 100 µg/ml of Leupeptin, 500 µg/ml of Pefabloc, 2 mM of 1,10-
Phenanthroline, 5 µg/ml of Pepstatin A (Sigma Aldrich) and 1 mM EDTA.  
4. 100 µg/ml of Leupeptin, 500 µg/ml of Pefabloc, 2 mM of 1,10-
Phenanthroline, 5 µg/ml of Pepstatin A and 25 µg/ml of E-64 (Sigma Aldrich) 
5. 100 µg/ml of Leupeptin, 500 µg/ml of Pefabloc, 2 mM of 1,10-
Phenanthroline, 10 µg/ml of Pepstatin A and 50 µg/ml of E-64 (Sigma 
Aldrich) 
As described in 2.4.1, samples were briefly sonicated before doing acetone 
precipitation. Subsequently, the protein pellet was resolubilized in lysis buffer 
containing the protease inhibitor cocktails. The protein concentration was assayed 
by the Bradford assay (Biorad). 
2.4.1.2 SDS-PAGE 
Mini-PROTEAN precast polyacrylamide gels TGX 4 – 20% (Biorad or Invitrogen) was 
used in this work. Before placing the gel cassettes into the electrode assembly, 
the comb and tape on the gel was removed. The assembly was done according to 
the manual by Biorad or Invitrogen. The electrophoresis module was placed into 
the tank and filled up with 1x running buffer (25 mM Tris, 192 mM glycine, 0.1% 
SDS). Samples with approximately 10 μg of concentration was diluted with 2x 
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sample buffer (62.5 mM Tris-HCl, pH 6.8, 2% SDS, 25% (v/v) glycerol, 0.01% 
bromophenol blue) with added reducing agent (5% β-mercaptoethanol, freshly 
added). The diluted samples along with Protein Marker Broad range (New England 
Biolab) were vortex and heated at 95°C for 5 min before loading the samples into 
the gel well. The proteins were allowed to separate using the running conditions 
suggested by the manufacturer which is 1 hour at 200 V. After that, the gel was 
removed, fixed with fixing solution (40% methanol, 10% acetic acid) for 30 min, 
stained with stain solution (0.025% (w/v) Coomassie Blue G-250, 50% methanol, 
10% acetic acid) for 2 – 4 hour and destained with destaining solution (40% 
methanol, 10% acetic acid) overnight. The gel was then documented using GelDoc 
instrument (BioRad).  
2.4.1.3 Filter aided sample filtration (FASP) 
Protein lysates were subjected to proteolysis by FASP 1 (Wisniewski et al. 2009) 
(Figure 3.11) to generate peptides for mass spectrometry. In this protocol, protein 
lysates were mix with 200 μl of 8M urea in 0.1 M Tris/HCl pH 8.5 (freshly prepared) 
and transfer into Microcon YM-30 (Millipore) filter unit for centrifugation at 14, 
000 x g for 40 min. This process was repeated twice and the flow through was 
discarded, followed by the addition of 100 μl of 0.05 M iodoacetamide in urea 
buffer (freshly prepared). Samples were mix at 600 rpm in a thermomixer for 1 
min before further incubation without mixing for 10 min. The filter units were 
centrifuged at 14, 000 x g for 30 min. 100 μl of urea buffer was added to the filter 
unit and centrifuge at 14, 000 x g for 15 min. This step was repeated twice. Then, 
a total of 100 μl of 0.05M ammonium bicarbonate was added to the filter units 
and centrifuge at 14, 000 x g for 10 min. Again, this step was repeated twice. 40 
μl of ammonium bicarbonate with trypsin was added and mix at 600 rpm in 
thermomixer for 1 min before incubating the units in a wet chamber at 37°C for 
4 - 18 h. After incubation, the filter units that contains the digested peptides were 
transferred to new collection tubes and spin at 14, 000 x g for 10 min. Finally, 40 
μl of ammonium bicarbonate was added and centrifuge at 14, 000 x g for 10 min, 
acidify with Trifluoroacetic acid (TFA) and proceed with desalting process.  
This original protocol was modified and optimised to suit our samples and to get 
better resolution on mass spectrometry. We have tried using both trypsin and 
endoproteinase Lys-C enzyme (Promega) for proteolysis. The ratios of 
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enzyme:protein were also optimised from 1:100 to 1:50. Furthermore, instead of 
using ammonium bicarbonate for completing elution, 10% acetonitrile was used to 
avoid performing desalting process. 
2.4.1.4 Desalting 
This protocol involves placing 3 ml EMPORE SPE Extraction disk cartridges (C18-
SD) (Sigma Aldrich) in 15 ml tubes, adding 1 ml of methanol and centrifuge at 
1,500 x g for 1 min, followed with addition of 0.5 ml of 70% of acetonitrile in 
water, 0.1% of TFA and centrifuge at 1,500 x g for 1 min. Next, 0.5 ml of 0.1% TFA 
in water was added and centrifuge at 1,500 x g for 1 min. The filtrates collected 
after FASP were added to the SPE cartridges and centrifuge at 150 x g for 3 min. 
After this, 0.5 ml of 0.1% TFA was added and centrifuge at 150 x g for 3 min. 
Lastly, the eluates were washed with 0.5 ml of 70% acetonitrile and centrifuge at 
150 x g for 3 min in new tubes. Different volumes of conditioning or washing buffer 
may be applied based on the size of C18 cartridge used in the experiments. 
Samples were dried in a speedVac before subjecting to mass spectrometry.  
2.4.2 Proteomics samples from THP-1 
For THP-1 proteolysis, a modified FASP-1 adapted from Zanivan et al. (2012) was 
used. According to this protocol, 100 µg of lysate was mix with 200 µl of 8M Urea 
buffer on a Microcon 10 kDa filter followed by centrifugation at 14, 000 x g for 15 
min. This step was repeated before adding 100 µl of alkylation buffer containing 
iodoacetamide, mix at 600 rpm in thermomixer and incubation for 20 min at room 
temperature in the dark. Filter units were then centrifuged at 14, 000 x g for 15 
min. 100 µl of 8M Urea buffer was added, centrifuged at 14, 000 x g for 15 min 
and repeated 3 times. Flow-through was removed after this step. Next, 100 µl of 
50 mM ammonium bicarbonate was added, centrifuged at 14, 000 x g for 15 min 
and repeated 3 times. However, after this step the flow-through was kept in the 
collection tubes to retain humidity. 40 µl of 50 mM ammonium bicarbonate with 
Trypsin (1 mg every 50 mg of lysate) was added, mix for 1 min at 600 rpm in 
thermo-mixer and incubate overnight at 37°C in a wet chamber. The digested 
peptides were collected by centrifugation at 14, 000 x g for 10 min in a new 
collection tubes. Finally, the elution was completed by adding 50 µl of 10% 
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acetonitrile and centrifuge before acidifying the peptides with 10% TFA to stop 
digestion and samples drying in Concentrator 5301. 
2.5 Protein concentration determination 
To determine protein concentration in samples, the Bio-Rad protein assay was 
used. It is based on the colour change of Coomassie brilliant blue G-250 dye in 
response to various concentrations of protein. The dye binds to primarily basic 
(especially arginine) and aromatic amino acid residues. This assay is useful for 
measuring proteins and polypeptides with molecular weights >3,000–5,000.  
A diluted Protein Assay Dye-reagent (BioRad) was prepared by diluting it with 
water in 1:5 ratios. BSA standards with concentration of 0.1 mg/ml, 0.2 mg/ml, 
0.3 mg/ml, 0.4 mg/ml and 0.5 mg/ml were prepared in order to make a standard 
curve. 10 μl of the same buffer as in the samples was used as blank whereas 
samples were diluted 10-fold and pipetted onto microplate well. A total of 200 µl 
of diluted dye-reagent were added to each well. The plate was incubated for 5 
min on a shaker before reading the absorbance at 595 nm. The concentration of 
the samples was determined by plotting a standard curve on Excel.  
2.6 Labelling for quantitation 
In this work, stable isotope dimethyl labelling method was used to label different 
growth stages of L. mexicana which are promastigotes and amastigotes whereas 
SILAC was performed on THP-1. Label free quantitation was also done on 
promastigotes and amastigotes.  
2.6.1 Stable Isotope Dimethyl labelling (DiMe) 
DiMe was employed to promastigotes and axenic amastigotes following FASP and 
desalting (Figure 3.2). In this work, two different DiMe protocols were chosen to 
get better result. The first protocol (Hsu et al. 2003) started with the 
reconstitution of peptides in 90 µl of 100 mM sodium acetate to all samples. Next, 
10 µl of 4% H2 formaldehyde (Sigma Aldrich) was added to the ‘light’ samples (or 
in this case, promastigotes) while 10 µl of 4% D2 formaldehyde (Sigma Aldrich) was 
added to the ‘heavy’ (or amastigotes) samples. After this, 10 µl of 1M sodium 
cyanoborohydride was added to all samples, vortex and incubated for 5 min. A 
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total of 10 µl of 4% ammonium hydroxide was added to all samples to stop the 
labelling reaction. Finally, both promastigotes and amastigotes samples were mix 
together and desalting protocol was repeated. The labelled peptides were then 
dried in Concentrator 5301.  
Another protocol for DiMe chosen was adapted from Boersema et al. (2009). The 
dried peptides were reconstituted in 100 µl of 100 mM Triethyl Ammonium 
Bicarbonate (TeAB). 4ul of 4% CH2O or CD2O (Formaldehyde) were added to 
samples accordingly. Samples were mix and pulse centrifuged. Then, 4 μl of 
freshly prepared 0.6 M Sodium cyanoborohydride was added to the samples and 
mix in fume hood for 1 h at room temperature. Labelling reaction was quenched 
by adding 16 μl of 1% ammonia hydroxide. Samples were mix and pulsed 
centrifuged, followed by addition of 8 μl of 5% formic acid in water to acidify 
samples. This step needs to be done on ice. Finally, the differentially labelled 
samples were mix thoroughly and dried in Concentrator 5301 at room temperature 
and analysed on mass spectrometry.   
2.6.2 SILAC 
Before starting SILAC experiment, growth rate of THP-1 in dialyzed serum was 
tested to ensure it does not affect the cells. Specially formulated media for SILAC 
were from Dundee Cell Products Ltd (Dundee). RPMI 1640 medium with heavy L-
[13C6] Arg and L-[13C6] Lys isotopes (R6K6) supplemented with 10% (v/v) dialyzed 
FCS (Invitrogen) and 100 U/ml penicillin-streptomycin was used alongside RPMI 
1640 with naturally occurring isotopes (R0K0). 2 mM of L-glutamine (Life 
Technologies) and 25 mM of HEPES (Life Technologies) were also added to make 
it identical to the normal media used for culturing THP-1. They were grown for at 
least 8 cell doublings to ensure complete incorporation of the isotopes into 
proteins (Ong et al. 2002). In order to check the labelling efficiency, small amount 
of protein lysates from the THP-1 grown in SILAC medium were run on SDS PAGE 
and several random bands were excised from the gel. The gel pieces were then 
subjected to tryptic digestion and mass spectrometry. R script was used to 
generate a density plot of the heavy to light ratio of the peptides. The labelling 
efficiency was calculated using the formula: 
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{1 − (1 ÷ 𝑟𝑎𝑡𝑖𝑜
𝐻
𝐿
)} ×100% 
where ‘ratio H/L’ = median of the ratio H/L (log2 normalized) of the quantified 
peptides in the ‘peptide.txt’ output file of MaxQuant, after removal of reverse 
and contaminant peptides. 
2.6.2.1 Pulse-chase SILAC 
The work-flow of a pcSILAC experiment is depicted in Figure 4.1. In the pcSILAC 
labelling scheme, unstimulated THP-1 was cultured in R6K6 (13C-Arg, 13C-Lys) 
medium until the level of heavy isotopes incorporation achieved more than 95%. 
There are four groups of samples in this experiment which are uninfected THP-1 
(control), 24 hour infected THP-1, 48 hour uninfected THP-1 and 48 hour infected 
THP-1. The mock-infected cells were grown in parallel with the perturbed cells. 
Each group were performed in at least triplicate. NUNC flasks (Thermo Scientific) 
were used for large scale experiment. Cells were then allowed to undergo 
differentiation with PMA (explain in 2.8.1). The cells adhere to the surface of the 
flask when they have differentiated into macrophage-like cells. Medium was 
removed and rinsed with warm RPMI by gently rocking the flask. The heavy 
medium was exchanged to R0K0 (12C-Arg, 12C-Lys) medium before infection. To 
harvest the cells upon infection, cells were rinsed with warm media, cold PBS was 
pipetted into the flask and incubate at 4°C for 15 min. After that, the cells were 
scraped gently using a cell scraper and collected in a tube before centrifuge at 
1000 x g for 10 min and proceeds to protein extraction (as described in 2.4.2), 
FASP and mass spectrometry. 
2.6.3 Label free 
Promastigotes and axenic amastigotes were cultivated in their normal respective 
media. Cells were harvested followed by protein extraction (as described in 2.4.1) 
and Bradford assay (as described in 2.5). Equal concentrations of lysates were 
digested individually by FASP (as described in 2.5.1.2) and subjected to individual 
LC-MS/MS analysis on MaxQuant. Quantification is based on the comparison of 
peak intensity of the same peptide or the spectral count of the same protein. 
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2.7 Infections 
2.7.1 THP-1 differentiation 
The desired amount of monocytes (1.0x106 cells/ml) was collected by 
centrifugation at 700 x g for 10 min and supernatant was discarded. Activation of 
monocytic THP-1 cell line was obtained by incubation with fresh RPMI 1640 
medium containing phorbol 12-myristate 13-acetate (PMA) (Sigma Aldrich) 
dissolved in DMSO (Sigma Aldrich). Several methods have been tried and optimised 
in terms of the concentration of PMA and period of incubation: 
1. PMA concentration of 300 ng/ml (0.5 μM), incubate for 24 h. 
2. PMA concentration of 60 ng/ml (0.1 μM), incubate for 24 h. 
3. PMA concentration of 60 ng/ml (0.1 μM), incubate for 48 h. 
At this point, some of the cells were plated on LabTek 16-well chamber slides 
(Thermo Scientific) at a density of 0.15x106 cells/ml to assess the rate of 
infection, while the remaining cells were left in the pre-treated flask (NUNC) for 
large scale experiment (Table 2.2). Cells were incubated at 37°C, 5% CO2. Cell 
adhesion and spreading, which are the hallmarks of macrophages, were then 
examined under a microscope. The unattached cells were centrifuged, 
resuspended in 200 μl of media, and counted in order to determine the adherence 
percentages. Cells were rinsed with warm media to remove excess PMA and 
infection experiments were carried out. 
Table 2.2: Number of cells needed to be plated in tissue culture dishes.  
THP-1 cells were counted as depicted in this table for infection studies. 
Plate Volume per well Cells/well 
6 well 3 ml 1 X 106  
24 well 1 ml 0.4 X 106   
96 well 200 μl 0.15 X 106  
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2.7.2 Determination of infectivity rates 
After PMA stimulation, cells were rinsed with warm RPMI 1640 media and changed 
with the same volume of fresh media. THP-1 cells were incubated with 
promastigotes, metaclyclic promastigotes and axenic amastigotes, respectively, 
at 32°C, 5% CO2, after which they were washed to remove extracellular parasites. 
Different ratios of macrophage to parasites and several incubation times were 
used to get the best result: 
Macrophage: parasites Incubation period 
1:5 6 hour 
1:8 24 hour 
1:10 48 hour 
 
Cells on the chamber slides were stained with Giemsa and DAPI (Vector 
Laboratories, USA). The percentage of infected macrophages and number of 
amastigotes per infected macrophage were determined by examination of 100 
macrophages per well under confocal microscope and fluorescence microscopy 
using a Zeiss Axioskop 2 mot plus (Zeiss Ltd, Cambridge, UK). To harvest the cells 
upon infection, cells were rinsed with warm media, cold PBS was pipetted into 
the flask and incubate at 4°C for 15 min. After that, the cells were scraped gently 
using a cell scraper and collected in a tube before centrifuge at 1000 x g for 10 
min. 
2.7.3 Isolation of metacyclic promastigotes 
Metacyclic promastigotes were isolated by using a Ficoll PM 400 (Sigma Aldrich) 
based on density gradient (Serafim et al. 2012). 20% Ficoll PM 400 was prepared 
in Milli-Q water and heated at 60°C to dissolve it then filter sterilized. 
Approximately 10 ml of early stationary phase L. mexicana grown in HOMEM was 
centrifuged at 1000 x g for 10 min. Pellet was washed twice with PBS. 2 ml of 10% 
Ficoll solution in PBS was added slowly at the bottom of the tube and centrifuged 
at 107 x g with slow acceleration and deceleration for 15 min. Supernatant 
containing metacyclics was collected in a new tube and washed with PBS to 
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remove Ficoll. Morphology and motility of the metacyclics was assessed under 
microscope. 
2.8 Microscopy 
Cells on the chamber slides were stained with Giemsa and DAPI (Vector 
Laboratories, USA). The percentage of infected macrophages and number of 
amastigotes per infected macrophage were determined by examination of 100 
macrophages per well under confocal microscope and fluorescence microscopy 
using a Zeiss Axioskop 2 mot plus (Zeiss Ltd, Cambridge, UK). 
For differential counting of THP-1 cells nuclei and parasite nuclei, ImageJ 
(http://rsb.info.nih.gov/ij/download.html) was used. Cell counter was found in 
Analyse option in plugin of the Software. The image was initialized and cell 
counter type 1 was selected for THP-1 cell nuclei and cell counter type 2 was 
selected for parasite nuclei.   
2.8.1 Giemsa staining 
Cells were fixed with methanol for 1 min followed and air dried. This followed by 
staining the slide with 10% Giemsa (filtered) for 20 min and lastly, washed with 
water.  
2.8.2 DAPI (4’,6’ diamino-2-phenylindole-2HCl) staining 
Cells on the slide were washed once with 100 μl of filtered PBS. Then, it was fixed 
with 2% formaldehyde in PBS for 10 to 20 min at 4°C. 10 μl of 1% Triton X-100 in 
PBS was added to the slide to permeabilize the cells. Cells were washed twice 
with PBS and air dried. A few drops of Vectashield-DAPI were laid on top of the 
cells and cover with coverslip before sealing it with nail varnish on the edge to 
prevent from drying.  
2.9 Mass spectrometry 
Mass spectrometry was conducted by MS Technologist, Dr Stefan Weidt, Dr Cristina 
Naula and Suzanne Edie from Glasgow Polyomics Facility.  
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Peptides were routinely run through Amazon Speed ion trap MS/MS (Bruker 
Daltonics) for quality control before using the higher resolution mass 
spectrometer. For this step, peptides were solubilized in 0.5 % formic acid and 
fractionated on a nanoflow uHPLC system (Thermo RSLCnano) before online 
analysis by electrospray ionisation (ESI) mass spectrometry on an Amazon Speed 
ion trap MS/MS. Peptide separation was performed on a Pepmap C18 reversed 
phase column (LC Packings), using a 5 - 85% (v/v) acetonitrile gradient (in 0.5% 
formic acid) run over 45 min at a flow rate of 0.2 μl/min. Mass spectrometric (MS) 
analysis was performed using a continuous duty cycle of survey MS scan followed 
by up to ten MS/MS analyses of the most abundant peptides, choosing the most 
intense multiply charged ions with dynamic exclusion for 120s. 
2.9.1 High-Resolution 1D-LC-MS/MS and 2D-LC-MS/MS 
For 1D-LC-MS/MS, peptide samples were analysed by LC-MS using an Orbitrap Elite 
MS (Thermo Scientific), using the same gradient as previously stated. The Orbitrap 
Elite acquires a continuous duty cycle of a high-resolution precursor scan at 60,000 
RP (at 400 m/z), while simultaneously acquiring the top 20 precursors subjected 
to CID fragmentation in the linear ion trap. Singly charged ions are excluded from 
selection, while selected precursors are added to a dynamic exclusion list for 120s.  
Peptides were solubilized in 2% acetonitrile with 0.1% TFA and fractionated on a 
nanoflow uHPLC system (Thermo Scientific RSLCnano) before online analysis by 
electrospray ionisation (ESI) mass spectrometry on an Amazon Speed ion trap 
MS/MS for quality control. Peptide separations were performed on a Pepmap C18 
reversed phase column (Thermo Scientific). Peptides are desalted and 
concentrated for 4 min on trap column followed by an acetonitrile gradient (in 
0.1% v/v formic acid) (3.2 - 32% v/v 4 - 27 min, 32% to 80% v/v 27 - 36 min, held 
at 80% v/v 36- 41 min and re-equilibrium at 3.2%) for a total time of 45 min. A 
fixed solvent flow rate of 0.3 μl/min is used for the analytical column.  The trap 
column solvent flows at a fixed at 25 μl/min using 2% acetonitrile with 0.1% (v/v) 
TFA. Mass spectrometric (MS) analysis were performed using a continuous duty 
cycle of survey MS scan followed by up to ten MS/MS analyses of the most abundant 
peptides, choosing the most intense multiply charged ions with dynamic exclusion 
for 120s. 
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For 2D-LC-MS/MS, the desired peptide digest was loaded onto the cation exchange 
(SCX) column and the column was eluted using as series of salt steps ranging from 
0 to 2000 mM natrium chloride, pH 3.5 containing 10% acetonitrile (ACN).  
The effluent of the SCX column in each case was directed onto the reversed phase 
(RP) column through the automated valve. The valve was programmed to direct 
liquid flow from the pumps through a flow split (1:1000) to the RP column. 
Following a 2-min pulse at the desired salt concentration at flow rate of 
approximately 600 nL/min, the SCX column was washed for 10 min with buffer. 
0.02% TFA was added to load the eluted sample onto the RP column in an 
automatic fashion. The RP column was eluted with a linear acetonitrile gradient 
elution from buffer A (H2O + 0.02% TFA) to 50% buffer A + 50% buffer B (ACN+ 
0.02% TFA) in 100 min using the Voyager pumps at a flow rate of approximately 
400 nL/min. Nanospray ionization was accomplished through an 8-µm fused silica 
tip with a spray voltage of 1.65 kV and heated capillary temperature of 230 °C. 
Data dependent MS scans were performed and the four strongest ions in each MS 
spectrum (with threshold intensity set at 1 × 105) were subjected to MS/MS analysis 
with collision energy set at 35%. 
2.10 Bioinformatics analysis 
This work has generated proteomics data from DiMe-labelled-L. mexicana 
promastigotes and axenic amastigotes, label-free L. mexicana promastigotes and 
axenic amastigotes and THP-1-pcSILAC experiments. Proteomics data from the 
parasite were mainly analysed on Mascot Distiller whereas data from THP-1 were 
analysed on different tools including MaxQuant and Perseus. 
2.10.1 Mascot Distiller and Daemon 
The yep/buf files generated by the Amazon ion Speed and/or Xcalibur files 
generated by Orbitrap Velos were processed with Mascot Distiller, Data Analysis 
software (Bruker) and the automated Matrix Science Mascot Daemon server 
(v2.4.1). The default processing options were applied for MS data processing 
according to the type of instrument. Protein identifications were assigned using 
the Mascot search engine to interrogate protein sequences in the NCBI Genebank 
database (taxanomy: Leishmania/Homo sapiens), allowing a mass tolerance of 10 
  54 
 
ppm for both MS and MS/MS analyses. Peptide tolerance was set to 0.3 Da and 
peptide charge was 2+, 3+, 4+. Search settings allowed two missed cleavages with 
trypsin, one fixed modifications (carbamidomethylation of cysteine) and one 
variable modification (oxidation of methionine). A quantification setting was set 
as Dimethylation for DiMe-labelled peptides and 13C-K(6) + 13C-R(6) for SILAC-
labelled peptides with a coefficient of 1.0. Signal to noise ratio (S/N) was set using 
the default setting which is 2. Protein significance was calculated by Mascot 
Distiller via the following comparison equation: 
|𝑥 −  𝜇|  ≤ 𝑡 ∗
𝑠
√𝑁
 
where N = number of peptide ratios,  
s = standard deviation,  
x = mean of the peptide ratios (s and x calculated in log space),  
μ = ratio with a true value of 0 in log space,  
t = Student’s t test for N-1 degrees of freedom and a two-sided confidence level 
of 95%.  
Significantly modulated are the proteins that are different from unit which is 1.  
 
Statistical confidence limits of 95% were applied for protein identification. Where 
matches were obtained to predicted proteins annotated as hypothetical and 
unspecified product, the protein ID was manually validated on 
http://tritrypdb.org/tritrypdb/ (for Leishmania) and http://www.uniprot.org 
(for human THP-1). The database was also used to get information on gene 
ontology and metabolic pathway by uploading the gene ID into the database.  
To predict potentially secreted proteins, sequences were analysed with SignalP 
4.1 Server (http://www.cbs.dtu.dk/services/SignalP/) with default parameters. 
Transmembrane domains were predicted with TMHMM 2.0 
(http://www.cbs.dtu.dk/services/TMHMM/).  
2.10.2 MaxQuant and Perseus 
MaxQuant and Perseus are available to download on 
http://www.coxdocs.org/doku.php?id=maxquant:start and 
http://www.coxdocs.org/doku.php?id=perseus:start, respectively. To run 
MaxQuant, several programs were installed on the local computer including .NET 
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framework 4.5 as well as the MSFileReader for Thermo data. Local storage was 
used for all raw files belonging to a project, and about half of this size were 
needed for intermediate results. The raw files were stored in the same directory 
to avoid crashes. 
The raw files generated by the LTQ-Orbitrap were processed and analysed using 
MaxQuant (Cox et al. 2009; Tyanova et al. 2016), Version 1.5.2.8 and 1.5.5.1 using 
the UniProt (www.uniprot.org/) protein FASTA database (2015, April version; 
2016, Aug version), including commonly observed contaminants. The following 
settings were applied: cysteine carbamidomethylation was selected as fixed 
modification; methionine oxidation and protein N-terminal acetylation were set 
as variable modification; and enzyme specificity was set to trypsin. Up to two 
missed cleavages of trypsin were allowed. Precursor ion mass tolerances were 7 
ppm, and fragment ion mass tolerance was 10 ppm for MS/MS spectra. If the 
identified peptide sequences from one protein were equal to or contained within 
another protein’s peptide set, then the proteins were grouped together and 
reported as one protein group. Protein and peptide identifications were filtered 
at 1% false discovery rate (FDR) established by MaxQuant against a database of 
reversed sequences and a minimum length of seven amino acids was used for 
peptides identification. MaxQuant used a posterior error probability (PEP) based 
on the peptide P-score distribution to set the cutoff of FDR (Cox & Mann 2008). A 
threshold PEP of 1 was applied. Quantification was performed using median 
normalized log2 L/H ratio. Protein ratio was calculated on unique and razor 
peptides (Occam’s razor principle). Minimum ratio count for SILAC quantification 
was set to two. Computation times vary with sample complexity, richness of 
spectra and LC gradient length. Typical values for 72 LC/MS runs are 10 – 72 h. 
The MaxQuant output was further analysed for quantification on Perseus Version 
1.5.1.6 by first uploading the ‘ProteinGroups.txt’ file generated by MaxQuant. 
Common contaminants, reversed sequences and sequence only identified by site 
were omitted. All data was inverted to L/H ratio, log2 transformed and median 
normalized before further analysed.  
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2.10.3 Functional analyses 
Several tools were used for further functional analysis including Gene Ontology 
Enrichment, subcellular localisation, functional domains and motifs, pathways, 
and protein-protein interactions. Among the tools used in this work are The 
Database for Annotation, Visualization and Integrated Discovery, DAVID 
(https://david.ncifcrf.gov) (Huang et al. 2009), Kyoto Encyclopaedia of Genes and 
Genomes, KEGG (http://www.genome.jp/kegg/), and functional protein 
association networks, STRING10 (http://string-db.org).  
2.10.4 Identification of newly synthesized proteins and protein 
synthesis rate calculation 
Evidence tab delimited (txt) file generated as output from MaxQuant were used 
to identify newly synthesized proteins following THP-1 infection based on the L 
intensity of the proteins. The L and H spectra were validated using SeeMS and 
Skyline. The criteria for assessing relative isotope abundance (RIA) are: 1) RIA was 
calculated at each time point and in triplicate, 2) Minimum peptide is 7, 3) 
Minimum individual peptide is 2.  
A script written in R (https://www.r-project.org) was used to determine rate of 
protein synthesis. Non-normalized data of control_24h, 24hpi, control_48h and 
48hpi THP-1 (pcSILAC data) was used for this purpose to avoid introducing a 
transformative distortion. Calculation of protein synthesis rates were based on 
abundance ratios of new (partly labelled) to old proteins (fully labelled). RIA was 
calculated using formula (Pratt et al. 2002): 
𝑅𝐼𝐴 (𝑠𝑦𝑛)  =
𝑛𝑒𝑤𝑃𝑟𝑜𝑡𝑒𝑖𝑛
𝑜𝑙𝑑𝑃𝑟𝑜𝑡𝑒𝑖𝑛 + 𝑛𝑒𝑤𝑃𝑟𝑜𝑡𝑒𝑖𝑛
 =  
𝐿
𝐻 + 𝐿
 
2.10.5 Skyline 
Raw data were imported into Skyline 
(https://skyline.ms/project/home/begin.view?).  The monoisotopic peak of each 
precursor ion extracted using the software's defined settings for MS1 
quantification, peak picking manually checked and correlated in terms of 
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retention time with the identifications from Andromeda generated from MaxQuant 
(Schilling et al. 2012).  
2.10.6 Protein degradation rate and half-life calculation 
A script written in R (https://www.r-project.org) was used to determine rate of 
protein degradation. Non-normalized data of control_24h, 24hpi, control_48h and 
48hpi THP-1 (pcSILAC data) was used for this purpose. Relative isotope abundance 
(RIA) was calculated using formula (Pratt et al. 2002): 
𝑅𝐼𝐴 (deg) =
𝑜𝑙𝑑𝑃𝑟𝑜𝑡𝑒𝑖𝑛
𝑜𝑙𝑑𝑃𝑟𝑜𝑡𝑒𝑖𝑛 + 𝑛𝑒𝑤𝑃𝑟𝑜𝑡𝑒𝑖𝑛
 =  
𝐻
𝐻 + 𝐿
 
The RIA data were fitted to a single exponential decay curve. The degradation 
rate constants (kdeg) was calculated using formula: 
𝑅𝐼𝐴 = ln(𝑘𝑑𝑒𝑔) × 𝑡 
ln(𝑘𝑑𝑒𝑔) =
𝑅𝐼𝐴
𝑡
 
True degradation rate constant was calculated by subtracting dilution rate (D) 
(0.006 h -1) derived from doubling time. 
Half-life of a proteins (t ½) (in h) were calculated by using formula (Helbig et al. 
2011): 
𝑡 1/2 =  
ln 2
𝑘𝑑𝑒𝑔
 
=  
0.693
𝑘𝑑𝑒𝑔
 
2.11 Protein Validation 
Two significant proteins found from pcSILAC data were validated via non-
quantitative Western blot. 
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2.11.1 Immunoblot Analysis 
Immunoblot analyses were performed using standard SDS-PAGE chemiluminescent 
procedures. Protein lysates from uninfected THP-1, 24 h infected THP-1 and 48 h 
infected THP-1 was separated on a RunBlue pre-cast polyacrylamide gel 4-20% 
(Expedeon, UK). 10 μg of protein lysates were solubilized in 4 x sample loading 
buffer (Expedeon) and boiled at 95°C for 10 min, together with RunBlue 
prestained tri-color marker (5 – 180 kDa) (Expedeon). Gels were subsequently 
transferred onto PVDF membranes (Thermo Fisher) in XCell II Blot Module 
(Invitrogen) filled with transfer buffer (Tris-SDS-Glycine and 20% methanol) at 30 
V for 1.5 h. Following transfer, membranes were stained with Ponceau S reagent 
for 5 min and then were destained with water. After that, the membranes were 
blocked overnight in 5% (w/v) milk in PBS-T (0.5% (v/v) Tween 20 in PBS) at 4°C. 
The membranes were washed with PBS-T for 5 min and repeated 3 times before 
incubation with primary antibody diluted in 5% (w/v) milk in PBS-T for 1 h at room 
temperature. Rabbit polyclonal anti-gelsolin (1 μg/ml or 500x dilutions) (Abcam, 
UK) and rabbit polyclonal anti-galectin-9 (500x dilutions) (Thermo Fisher) were 
used as primary antibodies in this work. Anti-alpha tubulin (rabbit) (Cell Signaling 
Technology) was used as loading control. Blots were washed with PBS-T for 5 min, 
repeated 3 times and incubated for 45 min with horseradish peroxidase-
conjugated goat anti-rabbit IgG (Thermo Fisher) diluted 1:1000 in blocking buffer. 
The membranes were washed as above, incubated with ECL Pico 
chemiluminescent substrate (Expedeon) for 1 min and exposed to X-ray film.  
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3 A quantitative proteomic approach to identify 
developmentally regulated proteins in L. 
mexicana 
3.1 Introduction 
In order to continue through their life cycle, Leishmania oscillate between the 
motile, extracellular promastigote that lives in sand fly vector and non-
flagellated, intracellular amastigote stages that proliferate inside the acidified 
phagolysosomes of host macrophages. Following transmission, promastigotes gain 
entry into mammalian cells when they are rapidly taken up by phagocytes where 
they transformed into amastigotes. This change in environment brings about 
dramatic morphological and molecular changes to the parasites. Both 
environments have different pH and temperature (Zilberstein & Shapira 1994) as 
well as different nutrient availability (Burchmore & Barrett 2001). In addition, 
they are being confronted by different types of hostile host defence mechanisms 
including cytotoxic activities. Leishmania respond to the challenging changes they 
encounter by differentiating into highly adapted forms that enable them to be 
transmitted, survive and proliferate. It has been reported by Bente et al. (2003) 
that Leishmania encounter three environmental shifts as they move between their 
hosts: they switch (i) from a poikilothermic to a homeothermic host; (ii) from an 
insect to a mammal; and (iii) from an extracellular to an intracellular lifestyle. 
These transformations are vital for the parasite’s transmission. Yet, the molecular 
basis underlying this transformation is poorly understood. The complex 
differentiation process involves different expression and regulation of numerous 
sets of proteins (Rochette et al. 2008). Proteins differentially expressed in both 
stages of the parasites are thought to be important to give insight on intracellular 
survival and subsequently pathogenicity.  
Although both promastigote and amastigote form can initiate infections, the 
infections are maintained by amastigotes. They reside within the acid 
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phagolysomal vacuole of the host macrophages and can persist in cells for many 
days. This is when clinical symptoms start to develop.  
Several reports have suggested that stage-specific gene expression is associated 
with and required for transformation, as well as for intracellular survival. For 
example, several proteins or protein families were reported to be promastigote- 
or amastigote-specific in L. donovani including LdARL-3A and GP63 which are 
promastigote-specific (Bente et al. 2003). LdARL-3A is a G-protein involved in 
flagellum biosynthesis (Cuvillier et al. 2000) while GP63 is a virulence factor that 
plays a major role in protection against complement-mediated lysis and is needed 
by promastigotes prior to entry into the mammalian host cell (Joshi et al. 1998). 
Stage specific differences in protein abundance were also detected in L. 
panamensis, where 75 proteins were found upregulated in axenic amastigotes and 
45 were solely detected in promastigotes (Walker et al. 2006). 2-DE and gel-free 
analysis of L. mexicana promastigotes and lesion-derived amastigotes revealed a 
set of proteins identified solely in amastigotes including HSPs, β-tubulin, and the 
EF-1α subunit (Paape et al. 2008; Zilberstein & Shapira 1994; Paape et al. 2010; 
Brotherton et al. 2010).  
In contrast to higher eukaryotes, trypanosomatid genomes are constitutively 
expressed and they regulate their protein expression and abundance post-
transcriptionally (Papadopoulou et al. 2003). Therefore, proteomics is the method 
of choice to investigate gene expression patterns in different stages of 
Leishmania. 
L. mexicana is an excellent model of Leishmania species. The genome has been 
sequenced and annotated (Leishmania mexicana Genome Project, 
http://www.sanger.ac.uk/sequencing/Leishmania/mexicana/). Both major life 
cycle stages, the promastigote and the amastigote, can be cultivated and 
differentiated in vitro (Bates 1994; Antoine et al. 2004; Gossage et al. 2010). In 
vitro induced axenic amastigotes closely resemble animal-derived amastigotes 
(Bates 1993; Saar et al. 1998; Gupta et al. 2001; Burchmore & Landfear 1998).  
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3.1.1 Promastigotes 
The promastigote form occurs in the alimentary tract of the insect vector. They 
are very well adapted to survive and multiply within the intestine of the sand fly 
before being transmitted to the mammalian host. Promastigotes are able to break 
down the peritrophic matrix during blood feeding and protect themselves from 
proteolytic enzymes secreted by the midgut of the sand fly. Quantitative 
transcriptomic analysis of midgut tissues from the sand fly P. perniciosus, infected 
with L. infantum showed a slight decrease in the abundance of the tryptic 
protease that is induced by blood feeding, suggesting the parasites were able to 
modulate the expression of the vector’s proteases (Dostálová et al. 2011). Another 
factor that aids in promastigote transmission is the glycoconjugate 
Lipophosphoglycan (LPG). LPG is a surface coat composed of 
glycosylphosphatidylinositol (GPI)-anchored phosphoglycosylated glycans that are 
found on parasite’s membrane. They form a highly hydrophobic barrier that acts 
to protect against host immune responses (Forestier et al. 2014). LPG helps 
parasites to bind to the midgut epithelium of the sand fly. This attachment 
prevents the parasites from being excreted. Furthermore, this binding is stage-
dependent as it is only a property of nectomonad and leptomonad forms 
(Dostálová et al. 2011). The LPG-enriched glycocalyx of Leishmania also 
constitutes the primary encounter when parasites inoculated into mammalian host 
by the sand fly vector (Forestier et al. 2014). Furthermore, promastigotes secrete 
chitinase that can damage the stomodaeal valve which controls the junction 
between midgut and foregut, allowing them to pass through this barrier (Rogers 
et al. 2008). Promastigotes proliferate optimally at ambient temperatures (around 
25°C) in a mildly basic environment (pH > 8), reflecting conditions within the sand 
fly gut. 
Several proteomic studies have been undertaken to elucidate the proteins and 
metabolic pathways involved when procyclic promastigotes differentiate to 
metacyclic promastigotes. In L. mexicana, cysteine proteinase b and 
trypanoredoxin were upregulated during the differentiation (Nugent et al. 2004). 
During metacyclogenesis, expression of promastigote virulence factors increases 
significantly. These include major surface protease GP63 and gp46 (also called 
promastigote surface antigen protein 2) (Yao et al. 2010). In addition, metabolic 
enzymes were reported to be decreased in L. chagasi (Yao et al. 2010). 
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3.1.2 Amastigotes 
Amastigotes are the intracellular lifecycle stage of Leishmania in a mammalian 
host. They are normally found in mononuclear phagocytes. All Leishmania have an 
amastigote stage of their lifecycle. Amastigotes are oval and smaller than 
promastigotes, with 3-6 µm in length and 1–3 µm in breadth. The flagellum is very 
short, so it does not emerge from the flagellar pocket and does not confer motility 
on the parasite. The kinetoplast and basal body situated towards the anterior end.  
During the differentiation from metacyclic promastigotes to amastigotes, a series 
of changes on the morphology, cell surface properties and metabolism occur. The 
promastigote LPG coat is lost during the transformation while amastin surface 
proteins are upregulated (Wu et al. 2000). Importantly, a change in metabolism 
allows amastigotes to increase β-oxidation of fatty acids and catabolism of amino 
acids to replace glucose and proline as their main carbon sources (Opperdoes & 
Coombs 2007; McConville & Naderer 2011). In L. donovani, L. mexicana and L. 
infantum, differentiation from promastigotes to amastigotes were accompanied 
by reduced glycolytic pathway, increased fatty acid oxidation, increased 
gluconeogenesis, and increased mitochondrial respiration (Bente et al. 2003; 
Nugent et al. 2004; Rosenzweig et al. 2008; Brotherton et al. 2010; Paape et al. 
2010). Several virulence factors have been reported to be expressed in amastigote 
forms including superoxide dismutase (SOD) (Paramchuk et al. 1997), the major 
surface protease GP63 (leishmanolysin) (Isnard et al. 2012), cysteine peptidases 
(Mottram et al. 2004), the iron transporter LIT1 (Huynh et al. 2006), and A2 
proteins (Zhang & Matlashewski 2001). Early research on L. mexicana found that 
cysteine protease activity was considerably greater in the amastigote form than 
the promastigote forms, suggesting that the cysteine proteases might be 
important for survival of the parasite in the mammalian host (North & Coombs 
1982). 
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Figure 3.1: Changes in cell shape during the Leishmania life-cycle.  
(a) Scanning electron microscope images of the main Leishmania major life-cycle stages, the 
procyclic and metacyclic promastigotes were grown in culture, the amastigote was isolated from an 
infected mouse macrophage. (b) Schematic representation of the main intracellular organelles from 
Leishmania promastigote (left) or amastigote (right) forms. The flagellar pocket marks the anterior 
end of the cell (adapted from Besteiro et al. 2007). 
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3.1.3 Host-free in vitro differentiation (axenic system) 
To study the biology of amastigotes, parasites have been isolated from infected 
animals or in vitro infected macrophages or alternatively, generated from 
promastigotes in host-free medium. These cells are called “axenic amastigote”. 
Amastigotes that are differentiated from promastigotes in vitro are an attractive 
model for biochemical analyses, including proteomics, because axenic culture 
avoids the inclusion of heterologous biological material. Although axenic 
amastigotes generated in vitro may not precisely represent the phenotype of 
intracellular amastigotes, it is not possible to obtain these cells without disrupting 
the niche to which they are adapted and triggering a phenotypic response. 
Furthermore, for similar reasons, analysis of promastigotes is focused on a similar 
axenic culture system. In vitro cultivation offers an indefinite source of viable, 
homogenous amastigotes and promastigotes that can be compared by quantitative 
proteomic approaches.  
Several laboratories have succeeded in axenic culture of Leishmania amastigotes 
by combining both acidic pH and elevated temperature. Axenic amastigotes have 
been considered to mimic animal-derived amastigotes based on their morphology, 
molecular and biochemical characteristics (Bates et al. 1992; Pral et al. 1993; Saar 
et al. 1998; Gupta et al. 2001; Burchmore & Landfear 1998). Transmission electron 
microscopy of axenic amastigotes showed that the cells have amastigotes-specific 
features including the shape, flagellum and megasomes (Bates et al. 1992; Pral et 
al. 1993). Although they are grown without a host, they are virulent as they can 
infect hamsters and macrophage cell lines (Jain et al. 2012; Pescher et al. 2011). 
However, a study from Pescher et al. (2011) argues that the virulence of L. 
infantum axenic amastigotes were attenuated compared to splenic amastigotes. 
Thus, the advantages of using axenic amastigotes are the ability to get higher 
number of cells as opposed from purification of amastigotes from macrophages 
and the cells are free from contaminating host cell material. Nevertheless, the 
extent to which axenically-generated Leishmania promastigotes or amastigotes 
recapitulate the phenotype of these stages in their natural niche.   
In this work, we employed differential peptide labelling, together with mass 
spectrometry, to compare the proteomes of axenically-maintained promastigotes 
and amastigotes of L. mexicana. This study will be extremely useful for additional 
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biological, biochemical and molecular studies of the developmental stages in 
Leishmania in the aid of identifying suitable novel target proteins for therapeutic 
development. 
3.1.4 Stable isotope dimethyl labelling (DiMe) 
Stable isotope dimethyl labelling (DiMe) using reductive amination for MS-based 
quantitative proteomics was first reported in 2003 by Hsu et al. (2003). DiMe is a 
method used to quantify protein abundance by introducing “light” or “heavy” 
isotopic tags (normally formaldehyde) to generate chemically similar peptides 
that will be separated by a known m/z shift in subsequent LC-MS analysis. The 
relative ion intensity of each isotopic peak provides an estimate of the relative 
abundance of the peptide in the two samples (Hsu et al. 2003). Labelling is 
achieved through the α- and ε-amino group of lysine residues via reductive 
amination (Hsu et al. 2003). Formaldehyde forms Schiff base with the N-terminus 
or ϵ-amino group of Lys residue of a peptide/protein; the aldimine intermediate 
is then reduced by sodium cyanoborohydride (NaBH3CN) to form a secondary 
amine. This secondary amine is more nucleophilic than the primary amine. The 
secondary amine immediately reacts with another formaldehyde molecule to form 
dimethylamino group. Reductive amination is a global labelling method for all 
peptides with one labelling site for peptides without Lys residue or 1 + N labelling 
sites for peptides with N Lys residues. All amino groups are dimethylated except 
the N-termini of Pro residue, which is a secondary amino group and is 
monomethylated by the reaction (Hsu et al. 2016). In MS/MS analysis, this labelling 
strategy provides a signal enhancement for the a1 and yn-1 ions, which are not 
detectable from most of the non-derivatized fragments (Hsu et al. 2003). Because 
formaldehyde (CH2O) is small and water-soluble, the labelling reaction is quick, 
specific and complete (Hsu et al. 2016). A multiplex labelling strategy using 
isotopic reagents of formaldehyde (H12CHO, D13CDO) and cyanoborohydride 
(NaBH3CN, NaBD3CN) may be also applied for comparison of up to four samples 
(Boersema et al. 2009). This method is convenient, robust and relatively cheap 
compared with other labelling techniques.  It has been widely used in quantitative 
proteomics for global expression profiling, post-translational modifications (PTMs) 
and protein interaction (reviewed in Hsu et al. (2016). 
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In this work, two DiMe protocols were employed in order to get higher protein 
recovery. Figure 3.2 illustrate the workflow of DiMe in this study. 
 
Figure 3.2: Schematic illustration of stable isotope dimethyl labelling for relative quantitation 
of protein.  
Reductive N-dimethylation of aliphatic amines in a peptide is carried out by using H12CHO (light) or 
D13CDO (heavy) and sodium cyanoborohydride. The isotopic mass shift between the light and heavy 
labelled peptides is Δ = 4 Da. Labelled peptides were combined and processed through sample 
clean-up, drying and MS. 
 
Originally we followed the protocol from Hsu et al. (2003) as described in section 
2.6.1. We then tried the protocol adapted from Boersema et al. (2009) to 
circumvent the desalting step as this seemed to result in significant protein loss. 
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3.2 Aims 
In this chapter, the various optimisations for proteomics and labelling will be 
explored and discussed. There are several important aims in this chapter, which 
were to: 
❖ Optimise protein extraction method from promastigotes and amastigotes 
❖ Enhance proteolysis of the samples to increase proteome coverage on MS 
❖ Employ stable isotope dimethyl labelling method to differentially label 
promastigote and amastigote 
❖ Assess label-free approach on promastigotes and amastigotes. 
Ultimately, we used a comparative proteomic approach based on a stable isotope 
dimethyl labelling method to identify proteins that were differentially expressed 
in different stages of the parasite L. mexicana.   
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3.3 Results 
3.3.1 Growth and differentiation 
L. mexicana promastigote was maintained in HOMEM supplemented with 10% FCS 
and 1% penicillin/streptomycin. A typical growth curve was done by counting the 
cells every day for 7 consecutive days and shown in Figure 3.3. Doubling time for 
promastigotes during the peak of log phase is 7.5 h.  
 
Figure 3.3: Growth curve of L. mexicana promastigote in HOMEM.  
A culture was initiated at 1 x 105 cells/ml and samples taken on 7 consecutive days for cell counting. 
Cells were fixed in 2% formaldehyde/PBS and counted on Neubauer haemocytometer. Doubling time 
taken at the peak of log phase for promastigote is 7.5 h. 
 
Amastigote was transformed from stationary phase promastigotes in Schneider’s 
Drosophila Media supplemented with 20% FCS and 1% penicillin/ streptomycin at 
a lower pH (pH 5.5) and higher temperature (32ºC). Promastigotes were 
transformed into amastigote morphology after about 5 days. Cultures were 
subpassaged every 6-7 days by passing them through a syringe needle gauge (22G) 
as the cells tend to clump with each other. After transformation, cells were 
counted every day for 5 consecutive days to determine the doubling time which is 
10.68 h (Figure 3.4). Following this, all experiments subsequently described in this 
thesis were performed on promastigotes and amastigotes which had been in 
culture for no more than 10 subpassages.  
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Figure 3.4: Growth curve of L. mexicana axenic amastigote in Schneider’s Drosophila Media.  
After first passage, cells were passed through a needle gauge, fixed in 2% formaldehyde/PBS and 
counted on Neubauer haemocytometer. Cells were taken for 5 consecutive days and the number of 
cells was plotted against time. Doubling time for axenic amastigotes was 10.68 h. 
 
Promastigote and amastigote cells were stained with DAPI and observed on a Zeiss 
Axioskop microscope, as shown in Figure 3.5. 
 
Figure 3.5: DAPI-stained of L. mexicana promastigotes in exponential growth.  
It was observed that all cells contained one kinetoplast (K) and one nucleus (N). 
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3.3.2 Protein concentration determination 
Following protein extraction, lysates were subjected to Bradford assay to 
determine the concentration. Firstly, a standard curve with a known 
concentration of BSA was plotted in order to determine the concentration of 
unknown samples. In this work, BSA with concentration of 0.1, 0.2, 0.3, 0.4 and 
0.5 mg/ml were measured by spectrometer at 595 nm wavelength. They were 
plotted on Microsoft Excel (Figure 3.6) and the concentration of an unknown 
protein samples were determined using formula 𝑦 = 𝑚𝑥 + 𝑐. Standard curve assay 
was plotted every time Bradford assay was done to ensure accuracy. The 
concentrations obtained will be used for SDS PAGE and FASP. 
 
Figure 3.6: Standard curve assay to determine protein concentration.  
BSA with different concentrations was used to make a standard curve for protein concentration 
determination. 
 
3.3.3 Sample preparation optimisations 
3.3.3.1 Protein extraction 
Several optimisations for protein extraction method were considered in this 
research, prior to finalising the method as described in section 2.4.1. The 
variables that were tested include the constituent of the lysis buffer, the type of 
protease inhibitors, the probe sonication time and heating the samples at 95°C. 
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Two types of lysis buffer were tested on promastigotes and amastigotes to improve 
protein extraction (Table 2.1). The lysis buffers tested were: 
1. SDT buffer (4% SDS, 100mM Tris-HCl pH 7.6, 0.1 M DTT)  
2. TTG buffer (500 mM Tris-HCl pH 8, 0.25% Triton X-100, 20% glycerol).  
Protein lysates were run on a 1D sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) to get a general overview of the protein distribution. 
Both lysis buffers were tested and evaluated on SDS-PAGE (Figure 3.7 and 3.8, 
respectively). 
In addition, different cocktails of protease inhibitors were also optimised. 
Originally, cOmplete™, Mini, EDTA-free protease inhibitors cocktail tablet from 
Roche was routinely added fresh to lysis buffer (Figure 3.7 and 3.8). The figures 
clearly showed that the protein separation was not good as no distinct bands could 
be seen. Since it is known that amastigotes have more proteases activity (North & 
Coombs 1982), we decided to try different protease inhibitors in order to get more 
proteins in the lysates. We started with mixture of 100 µg/ml of Leupeptin, 500 
µg/ml of Pefabloc, 1 mM of 1,10-Phenanthroline, 5 µg/ml of Pepstatin A and 1 mM 
EDTA (Figure 3.9).  
Several techniques in the original protocol were modified too. Initially, the 
samples were not heated at 95°C prior to sonication. Figure 3.7 showed protein 
lysates that were extracted without and with prior heating. When the samples 
were heated at 95°C, there seems to be more protein bands on the gel (b).  
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Figure 3.7: SDS PAGE profile of promastigotes and amastigotes lysates with and without heat 
treatment.  
(a) All samples were sonicated for 1 min without prior heating at 95°C. 10 µg of lysates was analysed 
on SDS PAGE. Lane M: Broad range marker (NEB); lane 1: amastigote in SDT lysis buffer with 
cOmplete™, Mini, EDTA-free protease inhibitors cocktail tablet; lane 2-3: promastigote in SDT lysis 
buffer with cOmplete™, Mini, EDTA-free protease inhibitors cocktail tablet. (b) All samples were 
heated at 95°C followed by 1 min on sonicator. 10 µg of lysates was analysed on SDS PAGE. Lane 
M: Prestained marker (Expedeon); lane 1: promastigote in SDT lysis buffer with cOmplete™, Mini, 
EDTA-free protease inhibitors cocktail tablet; lane 2: promastigote in SDT lysis buffer with 
cOmplete™, Mini, EDTA-free protease inhibitors cocktail tablet; lane 3: amastigote in SDT lysis 
buffer with cOmplete™, Mini, EDTA-free protease inhibitors cocktail tablet. 
 
 
73 
 
 
Figure 3.8: SDS PAGE profile of promastigotes and amastigotes lysates showing the effect of 
TTG lysis buffer.  
All samples were sonicated for 1 min without prior heating at 95°C. 10 µg of lysates was analysed 
on SDS PAGE. Lane M: Prestained marker (Expedeon); lane 1: promastigotes in TTG lysis buffer 
with cOmplete™, Mini, EDTA-free protease inhibitors cocktail tablet; lane 2: promastigotes in TTG 
lysis buffer with 100 µg/ml of Leupeptin, 500 µg/ml of Pefabloc, 2 mM of 1,10-Phenanthroline, 5 µg/ml 
of Pepstatin A and 1 mM EDTA; lane 3: amastigote in TTG lysis buffer with cOmplete™, Mini, EDTA-
free protease inhibitors cocktail tablet; lane 4: amastigote in TTG lysis buffer with 100 µg/ml of 
Leupeptin, 500 µg/ml of Pefabloc, 2 mM of 1,10-Phenanthroline, 5 µg/ml of Pepstatin A and 1 mM 
EDTA. 
 
However, when the protein lysates were trypsin digested and subjected to mass 
spectrometry, the number of peptides identified was only 200. As long sonic burst 
may cause proteins to overheat and denature we experimented with multiple 
short sonic bursts. Daneshvar et al. (2012) suggested modifying the probe 
sonication timing from 1 min on the probe to only 3 secs, repeated 3 times with 1 
min interval in between. The process was done on ice to minimize heating. As 
shown in Figure 3.9 and 3.10, the protein lysates that were obtained with heating 
at 95°C followed by shorter bursts of sonication have better proteins separation. 
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Figure 3.9: SDS PAGE profile of promastigotes and amastigotes lysates showing the effects 
of protease inhibitors.  
All samples were heated at 95°C for 5 min and sonicated for 3 sec, repeated 3x. 10 µg of lysates 
was analysed on SDS PAGE. Lane M: Broad range marker (NEB); lane 1-3: promastigote in SDT 
lysis buffer with 100 µg/ml of Leupeptin, 500 µg/ml of Pefabloc, 2 mM of 1,10-Phenanthroline, 5 µg/ml 
of Pepstatin A and 1 mM EDTA; lane 4-5: amastigote in SDT lysis buffer with 100 µg/ml of Leupeptin, 
500 µg/ml of Pefabloc, 2 mM of 1,10-Phenanthroline, 5 µg/ml of Pepstatin A and 1 mM EDTA; lane 
6: promastigote in TTG lysis buffer with 100 µg/ml of Leupeptin, 500 µg/ml of Pefabloc, 2 mM of 1,10-
Phenanthroline, 5 µg/ml of Pepstatin A and 1 mM EDTA;  lane 7: amastigote in TTG buffer with 100 
µg/ml of Leupeptin, 500 µg/ml of Pefabloc, 2 mM of 1,10-Phenanthroline, 5 µg/ml of Pepstatin A and 
1 mM EDTA.  
 
Since we still could not get good MS data, different concentrations of protease 
inhibitors were tested (as described in 2.4.1.1) to improve peptides identification 
with LCMS. After several repeats, it was observed that increasing the 
concentration of Pepstatin A and E-64 gave more bands on SDS PAGE (Figure 3.10). 
Extraction in SDT buffer with 100 µg/ml of Leupeptin, 500 µg/ml of Pefabloc, 2 
mM of 1,10-Phenanthroline, 10 µg/ml of Pepstatin A and 50 µg/ml of E-64 showed 
high extraction and solubilisation efficiency across a broad MW range. 
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Figure 3.10: SDS PAGE profile of promastigotes and amastigotes lysates showing the effects 
of increased Pepstatin A and E-64 concentrations.  
All samples were heated at 95°C and sonicated for 3 secs, repeated 3 times. 10 µg of lysates was 
analysed on SDS PAGE. Lane M: Broad range marker (NEB) (marker was not clear on this gel); lane 
1: promastigote in SDT lysis buffer with 100 µg/ml of Leupeptin, 500 µg/ml of Pefabloc, 2 mM of 1,10-
Phenanthroline, 10 µg/ml of Pepstatin A and 50 µg/ml of E-64; lane 2: amastigote in SDT lysis buffer 
with 100 µg/ml of Leupeptin, 500 µg/ml of Pefabloc, 2 mM of 1,10-Phenanthroline, 10 µg/ml of 
Pepstatin A and 50 µg/ml of E-64.  
 
There were also small but rather critical adjustments made such as using freshly 
prepared DTT and protease inhibitors, keeping the buffer in -20°C and keeping 
the samples on ice all the time to prevent protein degradation.  
3.3.3.2 Proteolysis and labelling 
Digestion of proteins is a critical step in proteomic workflows, especially for 
quantitative experiments. It is also the most time-consuming step in the sample 
preparation workflow. The protocol adapted from Wisniewski et al. (2009) was 
employed for protein digestion prior to LC-MS/MS. In general, the workflow of 
FASP is depicted in Figure 3.11. The filter acts like a proteomic reactor where 
protein lysates were reduced, alkylated and digested. L. mexicana promastigote 
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and amastigote whole cell protein lysates were digested with trypsin before 
labelled with DiMe and separated by LCMS. In this study, several optimisations 
were done on proteolysis and all digests were examined through Amazon Speed 
ion trap MS/MS.  
 
Figure 3.11: General workflow of FASP.  
Samples that were prepared in 4% SDS were diluted with 8 M urea to dissociate SDS from proteins. 
Diluted samples were then applied to Microcon filters for buffer exchanges, eliminating SDS and 
contaminants. Proteins are reduced and alkylated followed by successive buffer exchanges. Proteins 
were digested in the column overnight before centrifuge and elution in the collection tube. Peptides 
could be processed through sample clean-up, for fractionation or directly analysis by LC–MS. 
 
We initially employed the protocol from Wisniewski et al. (2009) starting with as 
little as 10 µg lysates and 1:100 enzyme to protein ratio. The elution buffer chosen 
was NaCl and desalting with SPE cartridges was required for sample clean-up. 
However, when the digested peptides were analysed on 1D- LC-MS/MS on Amazon 
Speed ion trap MS/MS less than 100 proteins were identified. Upon further 
investigation, it emerged that the starting concentration of protein lysates used 
for FASP was very low and that significant proportions of peptides were being lost 
during the workflow. Processing small quantities of sample led to proportionally 
larger losses. Lysate concentration was increased up to 100 µg to increase peptide 
recovery following FASP. We also tried different ratios of digestion enzyme to 
protein’s concentration as the recommended 1:100 enzymes to protein ratio was 
not found satisfactory. Furthermore, proteolysis using endoproteinase LysC 
together with trypsin did not give higher protein identification in our experiments. 
This might be due to increased competition for trypsin cleavage sites. 
Additionally, it was observed that desalting process greatly reduced peptide 
identification, leading to lower peptide ion abundances thereby reducing signal 
intensity from the peptides. Therefore, we modified the original FASP protocol to 
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replace the salt elution step with elution with 50% acetonitrile. Adding ACN has 
been shown to improve sequence coverage and enhance solubility of tryptic 
peptides (Hervey IV et al. 2007). Without desalting, we manage to increase 
peptide yield by 30%. Table 3.1 describe the different parameters that were 
optimised on FASP in order to give higher peptide yield. 
 
Table 3.1: Analysis of promastigotes and amastigotes lysate processed by FASP with 
different parameters.  
Lysates (n=1) were prepared using SDT buffer with 100 µg/ml of Leupeptin, 500 µg/ml of Pefabloc, 
2 mM of 1,10-Phenanthroline, 10 µg/ml of Pepstatin A and 50 µg/ml of E-64. Then, the lysates were 
subjected to FASP for protein digestion. Peptides were run on Amazon Speed ion trap MS/MS. 
Digestion enzyme 
Enzyme:Protein 
ratio 
Elution 
buffer 
Lysates 
quantity 
(µg) 
Clean-up 
method 
Proteins 
identified 
Trypsin 1:100 NaCl 10 *Desalt  39 
Trypsin 1:100 NaCl 25 *Desalt 77 
Trypsin 1:100 NaCl 50 *Desalt 207 
Trypsin 1:100 NaCl 100 *Desalt 522 
Trypsin and LysC 1:100 NaCl 50 *Desalt 195 
Trypsin 1:100 ACN 50 None 464 
Trypsin 1:100 ACN 100 None 769 
Trypsin 1:50 ACN 100 None 1119 
*Desalting was done on SPE cartridge 
Following proteolytic digestion, peptides were chemically labelled with DiMe. 
Preliminary protocol that was employed was adapted from Hsu et al. (2003) where 
peptides were reconstituted in sodium acetate followed by labelling with 
formaldehyde, quenching with sodium cyanoborohydride and the reaction was 
stop with ammonium hydroxide. Then, we tried another protocol for DiMe from 
Boersema et al. (2009). In this method, TeAB was used for peptides reconstitution 
before they were labelled with L and H formaldehyde.  Peptides were incubated 
with sodium cyanoborohydride before quenching with ammonium hydroxide and 
acidifying with formic acid.  
3.3.4 Proteome analysis and quantification of stage-regulated 
proteins 
To perform a global quantitative proteome analysis of stage-regulated proteins, 
we subjected the same amount of digested peptides from promastigotes and 
amastigotes to stable isotope DiMe followed by analysis on 1D high performance 
liquid chromatography (HPLC) using Amazon Speed ion trap MS/MS. The 
promastigotes were light labelled whereas amastigotes were heavy labelled. In 
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this work, several bioinformatics tools were used for peptide identification (Figure 
3.12).  
 
Figure 3.12: A schematic overview of bioinformatic tools used for analysing Leishmania 
proteomic data.  
Amazon Ion Speed Mass spectrometer gives mzML data format as output which can be process with 
Mascot Distiller for peptide quantification and Mascot Daemon for protein identification. After that, 
various tools can be used for functional analysis and statistical analysis including Kinetoplastid 
Genomics Resource TriTrypDB, Kyoto Encyclopaedia of Genes and Genomes (KEGG), R and 
Functional Protein Associations Network (STRING). On the other hand, mzmL format needs to be 
converted to mgf format using ProteoWizard and process with PeptideShaker for protein 
identification and quantification.  
 
The Mascot search showed that virtually all peptides were DiMe-labelled with 99% 
labelling efficiency (Figure 3.13). A minimum of 2 matched peptides and Mascot 
report parameter set as maximum number of hits: AUTO which means only 
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statistically significant (p<0.05) proteins were reported. To ensure the quality of 
our quantitation result, a default S/N ratio cut-off for all peptide peaks was set 
at 2. With Mascot search, total protein identified in all combined replicates was 
1411. Out of this, the functions of 710 proteins are known while the remaining 678 
proteins were hypothetical proteins with unknown functions and 23 unspecified 
products. Hypothetical proteins and unspecified products were manually validated 
on TriTrypDB and UniProt databases. Hypothetical proteins are predicted by 
bioinformatical genome analysis but with no known homologs. Whereas, unspecific 
products are predicted and proven to exist experimentally but are not 
characterized. Of the 1411 total proteins identified, 203 proteins were predicted 
by SignalP to have a signal peptide which could potentially target a protein for 
translocation across the membrane. 190 proteins predicted to have at least one 
transmembrane domain. 94 of the hypothetical proteins were predicted to have 
transmembrane while 109 have signal peptide. 
Among the 710 genes which encode proteins with putative function, 91 proteins 
were membrane related proteins containing transmembrane region, of which the 
important proteins being amastin-like surface protein, amino acid transporter, 
cathepsin, cysteine peptidases, GP63 and 3-ketoacyl-CoA reductase. In addition, 
94 proteins with putative function were predicted to have signal peptide. These 
includes amastin-like surface protein, GP63, cathepsin, cysteine peptidases, 3-
ketoacyl-CoA reductase, ABC transporter, adenylate kinase and cyclophilin. 
Cathepsin and cysteine peptidases are involved in proteolysis which may assist in 
evading the host immune system (Mottram et al. 2004; Vermelho et al. 2010). The 
Leishmania surface proteinase leishmanolysin GP63 has been postulated to be a 
virulence factor involved in the promastigote and host receptor interaction (Isnard 
et al. 2015; Joshi et al. 1998). Interestingly, there was one protein involve in 
pathogenesis (based on GO) which is flagellum targeting protein kharon1. This 
novel protein has been reported to be important for the flagellar trafficking of a 
glucose transporter (Tran et al. 2013). Kh1 null mutants were shown to attenuate 
amastigotes growth within host macrophages, suggesting it may be important for 
pathogenesis (Tran et al. 2013). 
The application of Mascot Distiller enabled relative quantitation of matched 
peptides. The presence of L and H pair spectra were analysed using SeeMS tool 
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that is included in ProteoWizard 3.0.9 package (Figure 3.14).  Of the identified 
proteins, only 38% of them were quantified, equivalent to 542 proteins.    
 
Figure 3.13: Partial peptide summary of unspecified product (L. mexicana) identified as 
protein hit #1 in promastigote sample.  
The peptide sequences showed the modifications occurred, in this case, labelling with heavy 
dimethyl, indicating efficient DiMe labelling into the peptides. 
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Figure 3.14: MS/MS spectra of tryptic peptides showing DiMe pair of heavy and light.  
(a) An example of protein quantification using Mascot Distiller (Matrix Science). (b) mgf data 
generated by Amazon Speed ion trap MS/MS was analysed by SeeMS tool (included in 
ProteoWizard 3.0.9 package) to verify spectra that has been labelled with heavy and light 
formaldehyde. 
 
The high abundance proteins spotted in every biological replicate (n=6) included 
actin, tubulin, heat shock proteins, ribosomal proteins (40S and 60S), enolase, ABC 
transporter, protein kinases, elongation factor proteins, and several types of 
peptidases. Gene ID of all 1411 proteins identified were uploaded on TriTrypDB 
for functional analysis. Leishmania mexicana MHOM/GT/2001/U1103 strain was 
used as reference. Gene Ontology (GO) Enrichment tool was chosen with p-value 
cutoff 0.05. Figure 3.15 show GO with molecular function of the proteins. Notably, 
60% of the proteome involves in metabolic processes such as carbohydrate, lipid, 
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and nucleic acid metabolism, followed by biosynthetic process and cellular 
process. These includes fumarate hydratase, ribonuclease mar1 and long-chain-
fatty-acid-CoA ligase. Biosynthetic process is the chemical reactions and pathways 
resulting in the formation of substances. From our data, proteins involves in this 
process include alanine aminotransferase, adenylosuccinate synthetase and myo-
inositol-1-phosphate synthase. For instance, alanine aminotransferase catalyzes 
the reversible transamination between alanine and 2-oxoglutarate to form 
pyruvate and glutamate in gluconeogenesis pathway. Most hypothetical proteins 
predicted on TriTrypDB in our data involves in cellular processes such as cell cycle, 
autophagy, endocytosis and DNA repair.  
Figure 3.16 shows the significant pathways in L. mexicana. Most altered pathways 
involves within the parasite are glycolysis and gluconeogenesis for energy 
production. Example of proteins that we found in our data involves in this pathway 
are glucose-6-phosphate isomerase, enolase, glycosomal malate dehydrogenase, 
phosphoglycerate kinase C and 6-phospho-1-fructokinase.  
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Figure 3.15: Clustering of Gene Ontology based on biological processes (GOBP) of all proteins detected in L. mexicana.  
The total number of proteins identified in L. mexicana was analysed on TriTrypDB based on molecular function they involve in.
  
 
Figure 3.16: Pathway analysis on KEGG showing most enriched pathways in L. mexicana.  
The total number of proteins identified in L. mexicana was analysed on TriTrypDB with links to KEGG 
in order to identify the pathways they are involved in.  
 
Comparative analysis of ESI-LC-MS/MS of L. mexicana promastigotes and 
amastigotes revealed several (542 proteins) differentially expressed proteins. The 
values of L/H ratio give information about stage-regulated proteins. In this case, 
L/H>1 indicates that a protein is upregulated in promastigotes, compared with 
amastigotes. Likewise, L/H<1 suggests that the protein is upregulated in 
amastigotes. 542 proteins were identified as both L and H labelled pairs, enabling 
this ratio to be calculated. Of these, 317 proteins showed a L/H ratio greater than 
1, while 225 proteins showed a ratio less than 1 (Figure 3.18). Supplementary table 
8.1 and 8.2 (in Appendix) lists proteins modulation in promastigote and amastigote 
respectively. Distribution of the quantified proteins based on L/H ratio obtained 
85 
 
by Distiller showed most L/H ratios were in range of 2-10 for promastigote life 
stage and 0.1-0.5 for amastigote life stage (Figure 3.17). 
 
Figure 3.17: Distribution of the significantly modulated proteins in L. mexicana based on L/H 
ratio.  
Peptide quantifications were performed in Mascot Distiller where DiMe-labelled pair will be given an 
L/H ratio. These ratios were grouped within certain range to see the overall distributions. Most 
peptides were in the range of 2-10 and 0.1-0.5.  
 
 
Figure 3.18: Differential protein expressions in promastigote and amastigote.  
Protein quantification was performed using Mascot Distiller to give rise of L/H ratios (total of 542).  
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We found several well-documented promastigote stage specific proteins including 
kinetoplastid membrane protein-11 (KMP-11) (Stebeck et al. 1995; Bhaumik et al. 
2009), SNF2/RAD54 related DNA helicase putative (Alcolea et al. 2016), elongation 
factor 1-alpha (Brotherton et al. 2010), heat shock protein (Brotherton et al. 
2010), β-tubulin (Leifso et al. 2007) and paraflagellar rod proteins (Moore et al. 
1996; Brotherton et al. 2010). The most strongly modulated protein was KMP-11 
with L/H ratio of 55 and Mascot score of 53. The 317 promastigote specific proteins 
detected were divided into the following putative functional classification 
categories based on GO annotations: metabolic process, oxidoreductase, 
transportation, translation, catalytic activities, cellular process and microtubule 
based movement (Figure 3.19). Examples of proteins from our data that involves 
in metabolic process are glyceraldehyde 3-phosphate dehydrogenase with L/H 
ratio of 16.81, glycosomal phosphoenolpyruvate carboxykinase with L/H ratio of 
16.68 and 6-phosphogluconate dehydrogenase with L/H ratio of 15.03. 
Fascinatingly, there were 66 hypothetical proteins and 10 unspecific products in 
our data with L/H>1. Pathway analysis showed glycolysis, gluconeogenesis, amino 
acid metabolism, sugar metabolism, tricarboxylic acid (TCA) cycle, fatty acid 
degradation and many more were modulated between promastigotes and 
amastigotes (Figure 3.20).  
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Figure 3.19: Clustering of Gene Ontology based on biological process (GOBP) of proteins 
detected in L. mexicana promastigote stage.  
The proteins that were considerably upregulated in promastigote stage was analysed on TriTrypDB 
based on the biological processes they are involved in. 
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Figure 3.20: Pathway analysis on KEGG showing most altered pathways in L. mexicana 
promastigote stage.  
The proteins that were considerably upregulated in promastigote stage was analysed on TriTrypDB 
with links to KEGG to identify the pathways they are involved in. 
 
 
Upregulated amastigote proteins included ribosomal proteins, calpain-like 
cysteine peptidase, GP63/leishmanolysin, aminopeptidase putative, histone, 
cathepsin L-like protease putative and carboxypeptidase. Notably, peptidases 
were found more in amastigote compared to promastigote. Of the 225 proteins, 
64 were predicted to be hypothetical proteins while 4 predicted as unspecific 
product. The proteins that were detected in amastigote stage were grouped into 
classification categories based on GO annotation: metabolic process, proteolysis, 
translation, oxidation-reduction process, biosynthetic process, cellular process 
and microtubule-based process (Figure 3.21). The majority of the proteins that 
were observed to be upregulated in amastigotes were implicated in amino acid 
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metabolism, fatty acid metabolism and vitamin metabolism (Figure 3.22). Several 
differentially expressed proteins in amino acid metabolism were upregulated in 
amastigote such as aldehyde dehydrogenase, arginase, ribose-phosphate 
pyrophosphokinase and dihydrolipoamide dehydrogenase.  
 
Figure 3.21: Clustering of Gene Ontology based on biological process (GOBP) of proteins 
detected in L. mexicana amastigote stage.  
The proteins that were considerably upregulated in amastigote stage was analysed on TriTrypDB 
based on biological processes they involve in. 
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Figure 3.22: Pathway analysis on KEGG showing most altered pathways in L. mexicana 
amastigote stage.  
The proteins that were considerably upregulated in amastigote stage was analysed on TriTrypDB 
with links to KEGG to identify the pathways they are involved in. 
 
Further analysis on the presence of signal peptide revealed a total of 28 proteins 
predicted to have signal peptides were upregulated in amastigote stage (Table 
3.2). Most mitochondrial proteins are synthesized as cytosolic precursors 
containing uptake peptide signals and post-translationally targeted to the 
mitochondria (Lithgow 2000). Some of the proteins listed in Table 3.2 have a 
mitochondrial role including aldehyde dehydrogenase, cytochrome c oxidase and 
malate dehydrogenase.  
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Table 3.2: Proteins upregulated in amastigote stage with predicted signal peptide.  
The protein sequence of amastigote proteins was analysed on SignalP for detection of predictive 
signal peptide.  
Accession ID L/H Protein name 
LmxM.23.0690 0.26 3-ketoacyl-CoA thiolase-like protein 
LmxM.19.0995 0.63 4-coumarate:coa ligase-like protein 
LmxM.15.1203 0.99 60S acidic ribosomal protein P2  
LmxM.29.2900 0.47 aldehyde dehydrogenase, putative   
LmxM.21.0895 0.4 aspartyl-tRNA synthetase, putative  
LmxM.08.1070 0.54 cathepsin L-like protease, putative  
LmxM.19.1420 0.18 cysteine peptidase A (CBA)  
LmxM.26.1710 0.96 cytochrome c oxidase subunit V, putative 
LmxM.21.0550 0.27 dihydrolipoamide acetyltransferase precursor like protein  
LmxM.07.0600 0.11 electron transfer flavoprotein-ubiquinone oxidoreductase, 
putative 
LmxM.10.0610 0.06 endonuclease G, putative 
LmxM.10.0390 0.03 GP63, leishmanolysin 
LmxM.16.0670 0.64 hypothetical protein, conserved 
LmxM.17.0910 0.59 hypothetical protein, conserved 
LmxM.03.0530 0.41 hypothetical protein, conserved 
LmxM.02.0470 0.85 hypothetical protein, unknown function 
LmxM.27.0930 0.5 isovaleryl-coA dehydrogenase, putative  
LmxM.09.0800 0.01 kinetoplast-associated protein-like protein 
LmxM.33.0140 0.34 malate dehydrogenase  
LmxM.13.0870 0.77 mitochondrial processing peptidase alpha subunit, 
putative,metallo-peptidase, Clan ME, Family M16 
LmxM.13.1060 0.95 NADH-cytochrome b5 reductase, putative 
LmxM.28.1240 0.59 p450 reductase, putative  
LmxM.26.1610 0.74 proline oxidase, mitochondrial precursor-like protein  
LmxM.06.1050 0.63 protein disulfide isomerase  
LmxM.15.0275 0.77 ribonucleoprotein p18, mitochondrial precursor, putative  
LmxM.34.1120 0.02 Selenoprotein T, putative 
LmxM.08.1030a 0.41 unspecified product  
 
Figure 3.23 shows differences in how many promastigote and amastigote proteins 
are involve in each pathway. It is apparent from the figure that more proteins 
upregulated in promastigote have been associated with metabolic pathway, 
carbon metabolism, biosynthesis of secondary metabolites, TCA cycle and amino 
acid metabolism. On the other hand, more ribosomal proteins are upregulated in 
the amastigote, compared to the promastigote stage.  
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Figure 3.23: Pathway analysis on KEGG showing most altered pathways in L. mexicana 
promastigote and amastigote stage.  
Both promastigote and amastigote proteins stage were analysed on StringDB with links to KEGG to 
identify the pathways they involve in. The chart shows pathway differences in both stages. 
 
We analysed the proteins enriched in promastigote (Figure 3.24) and amastigote 
(Figure 3.25) on StringDB to know the protein-protein interactions highlighting 
proteins involved in metabolic pathway. There were several ATPase synthases 
found in promastigotes. Arginase was found in amastigotes and it has been 
reported to be critical for parasite replication (Kropf et al. 2005).  
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Figure 3.24: Protein network between identified proteins in promastigote.  
Protein ID of proteins identified in promastigote were uploaded on STRING database to show the 
complex protein network and protein-protein interactions.  
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Figure 3.25: Protein network between identified proteins in amastigote.  
Protein ID of proteins identified in amastigote were uploaded on STRING database to show the 
complex protein network and protein-protein interactions.  
 
Label-free proteomics was attempted to analyse total proteins found in L. 
mexicana with the hope of getting higher number of identified proteins and higher 
coverage. Analysis was performed using MaxQuant with LFQ intensity. There were 
6 biological replicates for promastigote and amastigote. Applying the default 
setting on MaxQuant we only managed to discover 117 proteins. Multiscatter plot 
analysis was performed on all replicates with Pearson correlation close to 1 
suggesting good reproducibility (Figure 3.26). Comparing with DiMe-labelled 
proteins, 7 proteins found exclusively in label-free sample: carboxypeptidase B2, 
Complement C3 precursor, Heat shock protein 83, Cysteine proteinase B, Probable 
quinone oxidoreductase, Triosephosphate isomerase and Multidrug resistance 
protein 1. We could not detect these 7 proteins using DiMe probably due to 
incomplete labelling or the low intensity of H or L isotope which prevented the 
detection of one of the isotopes by MS. Figure 3.27 showed analysis of label-free 
proteins performed on Perseus. Histogram below showed the distribution in 
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triplicates of promastigote and amastigote with the red colour indicates proteins 
involved in glycolytic process (Figure 3.27 b). Promastigote appeared to have 
greater number of glycolytic enzymes, in accordance with previous results from 
DiMe-labelled proteins described earlier. However, we note that this experiment 
was done once and was not optimised. The number of proteins detected using 
label-free approach was too low compared to DiMe. This could be due to sample 
preparation problem. Hence, the results were preliminary.  
 
Figure 3.26: Label-free proteomics of replicates of promastigote and amastigote.  
6 biological replicates of each promastigote and amastigote were subjected to FASP and 1D-
LCMS/MS on Orbitrap Velos. Multiscatter plot with Pearson correlation close to 1 showed good 
reproducibility between each replicate. 
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Figure 3.27: Label-free proteins distribution in L. mexicana.  
Protein lysates from both promastigote and amastigote were subjected to FASP and 1D-LCMS/MS 
on Orbitrap Velos (biological replicates, n=3). The raw data was analysed on MaxQuant and Perseus. 
(a) Venn diagram showed total proteins identified by DiMe and label-free (b) Histogram showed the 
distribution of fold changes of label-free peptides between promastigote and amastigote, red colour 
indicates proteins involves in glycolytic process.  
 
3.4 Discussion  
Many investigations on stage-regulated proteins in Leishmania have been done 
over the years (Lynn et al. 2013; Leifso et al. 2007; Pescher et al. 2011; Walker 
et al. 2006; Bente et al. 2003; El Fakhry et al. 2002; Nugent et al. 2004; Zilberstein 
& Shapira 1994; Paape et al. 2010; Zilberstein 2015). Since the Leishmania genome 
is, in general, constitutively expressed with regulation occurring via post-
transcriptional mechanisms (Leifso et al. 2007), proteomic studies that are 
focused on profiling global differences in life-stage specific expression have 
enhanced value, compared with systems where transcriptional regulation is 
significant (Lynn et al. 2013). Previous studies utilised 2D gel techniques as well 
as MS-based proteomics. In the present studies, we exploited stable isotope 
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labelling as means of comparative quantitation of the proteins in the main L. 
mexicana life stages: promastigote and amastigote. 
The reliability of quantitative proteomic experiments depends on the consistency 
and the robustness of the protein extraction and digestion methods utilized. With 
this in mind, we employed a relatively new method for proteomic sample 
proteolysis, namely filter-aided sample preparation (FASP) that was invented by 
Wisniewski et al. (2009). FASP has been shown to be able to circumvent many of 
the challenges associated with other proteomic sample preparation methods, 
particularly elimination of contaminants that will affect downstream processes. 
This is achieved using a filter unit. In a single filter, a total of 0.2-200 µg of total 
protein can be processed at a time. However, despite the advantages, one major 
drawback of FASP is it causes a significant sample loss. 
Sample preparation factors influencing proteomic results, aside from enzymatic 
digestion, include protein concentration, detergents used and the efficiency of 
the clean-up process. Protein extraction was initially found to be a problem during 
the preparation of protein samples especially on amastigote lysates. This could 
possibly due to the large amount of proteolysis enzymes presence in amastigote 
stage (Mottram et al. 2004). To overcome this problem, lysates were routinely 
prepared in the presence of an extensive inhibitor cocktail of protease inhibitors. 
This cocktail dramatically improved the number of gel bands when analysed on 
SDS-PAGE. In accordance with a report by Nugent et al. (2004), we also found that 
when testing the inhibitors individually, leupeptin was revealed to be the most 
effective component, nonetheless the entire cocktail was necessary to avoid 
detectable proteolysis. Furthermore, omitting elution with salt, thus obviating the 
need for subsequent desalting, improved protein coverage by 30%.  
The total number of proteins identified in L. mexicana was 1411 with 50.3% 
proteins with known function, while the remaining were hypothetical proteins 
with no known homologs and unspecified products that are not yet characterized. 
The set of the regulated proteins reported here includes characterized L. 
mexicana proteins such as KHARON1 (KH1) which is the first protein identified in 
kinetoplastid protozoa that functions to selectively target an integral membrane 
protein to the flagellar compartment (Tran et al. 2013). KH1 mediates flagellar 
targeting of a glucose transporter in L. mexicana and is critical for viability of 
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infectious intracellular amastigotes (Tran et al. 2013). Also included are amastin-
like surface protein and lypophosphoglycan (LPG).  Amastin is a surface 
glycoprotein and highly expressed in the intracellular amastigote stages of 
Trypanosoma cruzi and Leishmania spp (de Paiva et al. 2015). To date, the 
function of amastin is still unknown. However, work by de Paiva et al. (2015) 
documented that amastin knockdown parasites had growth attenuation after in 
vitro infection of mouse macrophages and completely failed to produce infection 
when inoculated in BALB/c mice. This implied that amastin has significant role in 
pathogenesis. LPG is the most abundant major surface glycoconjugate that 
present in all Leishmania species. LPG help promastigote to attach on the lining 
of sand fly gut as well as protecting them from degradation by proteolytic enzymes 
(Diniz Atayde et al. 2016). Furthermore, Argueta-donohué et al. (2015) reported 
that LPG impairs nuclear translocation of NF-κB in monocytes with the subsequent 
decrease in IL-12 production, thereby advancing the progression of infection in 
host. 
Of the proteins identified, 118 proteins were predicted to have multiple putative 
transmembrane domains which could be associated with membrane. These include 
protein kinase, protein tyrosine phosphatase, protein disulphide isomerase, Qc-
SNARE protein, ABC transporter, cathepsin L-like protease, hsp-90, GP63, NADH-
cytochrome b5 reductase, fatty acid elongase, cysteine peptidase A, and 3-
ketoacyl-CoA reductase. Most studies involving Leishmania membrane-bound or 
secreted molecules have been done with the promastigote where they are known 
to synthesize and traffic most surface molecules such as LPG, GP63 and acid 
phosphatases (Mcconville et al. 2002). Analysis of these proteins on SignalP 
confirmed the presence of signal peptides. LPG and GP63 were postulated to be 
transported out to flagellar pocket in large translucent vacuoles for adaptations 
to parasitic lifestyles (Mullin et al. 2001; Mcconville et al. 2002). Phosphatases 
have been identified as virulence factors in many pathogenic microorganisms such 
as virus, fungi and parasites by deregulating the signalling pathways of the host 
cell (Shibata et al. 1994; Escalona-Montaño et al. 2016). Phosphatases are 
enzymes that remove phosphate groups from molecules such as amino acid 
residues of proteins. Escalona-Montaño et al. (2016) has shown that L. mexicana 
promastigotes and amastigotes secrete proteins with phosphatase activity to the 
culture medium. They also showed that phosphatases were located in the flagellar 
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pocket. We found several phosphatases in our data such as phosphatase 2C. 
However, only one (vacuolar-type proton translocating pyrophosphatase 1) had a 
predicted signal peptide. As secreted proteins could be potential vaccine 
candidates, we believe this data offer a useful resource even though signal peptide 
independent secretory pathways exist in Leishmania. It is known that the vast 
majority of the characterized Leishmania secreted proteins have no secretion 
signal sequence which suggests the existence of important non-classical pathways 
of secretion (Mcconville et al. 2002). 
To define the molecular mechanism of leishmanial differentiation, we used the 
DiMe to identify and quantify the proteins preferentially expressed in 
promastigotes and amastigotes of L. mexicana. Similar quantities of protein lysate 
from promastigote and amastigote were mixed and subjected to LC-MS analysis. 
When promastigote transforms to amastigote, Leishmania undergo significant 
changes in metabolism, cell morphology, motility, cell division and infectivity for 
adaptation to different microenvironment. These changes are reflected in the 
proteome differences between promastigote and amastigote. Thus, we observed 
many identified putative proteins that were differentially regulated covered a 
diversity of functions, mainly metabolism, redox process, proteolysis and protein 
synthesis. Proteins that have yet to be assigned a function are also important as 
they could give more insight on the molecular adaptation of Leishmania.  
We observed that many metabolic enzymes were upregulated in promastigotes, 
compared to amastigotes. This is consistent with an increased growth rate and  
motility in the promastigote stage (Holzer et al. 2006), and also with the stringent 
response that is reportedly induced in amastigotes. Additionally, increased 
expression in the promastigote of proteins involved in carbon metabolism, TCA 
cycle, amino acid metabolism, glycolysis and gluconeogenesis, are consistent with 
a higher energy requirement by the promastigote. Promastigotes expressed higher 
levels of mitochondrial proteins such as pyruvate dehydrogenase E1. This enzyme 
generates acetyl-CoA that enters TCA cycle. This is in corroboration with our 
findings where glycolytic pathway and TCA pathway were elevated in 
promastigote. Other mitochondria proteins upregulated in promastigotes include 
isocitrate dehydrogenase (NADP), ATP synthase and aldehyde dehydrogenase. 
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Fewer mitochondrial proteins were upregulated in amastigotes, including proline 
oxidase, trifunctional enzyme alpha subunit and DNA topoisomerase II.  
The promastigotes can import sugar from the extracellular environment when 
available, and they are able to synthesize sugar de novo, via gluconeogenesis, 
under sugar starvation (Burchmore & Landfear 1998; Rodriguez-Contreras & 
Hamilton 2014). Our data support the hypothesis that promastigotes can utilize 
glucose and amino acids such as lysine as energy source. The catabolism of these 
substrates involves glycolysis and the TCA cycle. There is also evidence that other 
sugars could be used by promastigotes. These include fructose and mannose. 
Glycerol kinase (GK), phosphoenolpyruvate carboxykinase (PEPCK), and pyruvate 
phosphate dikinase (PPDK) play important role in gluconeogenesis (Rodriguez-
Contreras & Hamilton 2014). As illustrated in figure 3.20, promastigotes 
upregulate expression of sugar metabolism proteins. This is important as 
promastigotes living in the midgut of the primarily phytophagous sand fly will 
encounter abundant plant sugars (Cameron et al. 1995). From our data, PEPCK 
and PPDK were found to be upregulated in promastigotes. PEPCK catalyses the 
conversion of oxaloacetate into phosphoenolpyruvate (PEP) while PPDK catalyses 
the conversion of pyruvate into PEP. GK, which catalyses the conversion of 
glycerol into glycerol 3-phosphate, was not found in our data. As L. mexicana is 
able to use glycerol, aspartate, and alanine to synthesize their storage 
carbohydrate mannogen, glycerol enters the gluconeogenesis pathway through 
GK, whereas aspartate and alanine enter through PEPCK and PPDK, respectively 
(Rodriguez-Contreras & Hamilton 2014). Furthermore, Rodriguez-Contreras & 
Hamilton (2014) showed that PEPCK was constitutively expressed in 
promastigotes, suggesting the importance of this enzyme in promastigote stage. 
Compared with promastigotes, amastigotes have been previously shown to 
increase fatty acid β-oxidation and reduce glycolysis. This notion is in agreement 
with a previous report showing that amastigotes exhibit low rates of glucose 
uptake (Burchmore & Hart 1995). These metabolic adaptations are also in good 
agreement with previous reports (Opperdoes & Coombs 2007; Paape et al. 2008; 
Rosenzweig et al. 2008; McConville & Naderer 2011; Saunders et al. 2014; 
McConville et al. 2015). Fatty acid β-oxidation enzymes are reported to be highly 
expressed in amastigotes (Saunders et al. 2014). The increased of fatty acid 
101 
 
metabolism in amastigote suggest more efficient utilization of fatty acids as 
alternative carbon source. Contrary to promastigote, amastigote stage in the 
phagosome most probably feeds on fatty acids and amino acids as there are limited 
availability of glucose and other sugars in the phagosome (McConville et al. 2007). 
Additionally, our data showed amino acids metabolism was decreased in 
amastigote, which could affect protein and lipid biosynthesis. It is well established 
that Leishmania species are auxotrophic for several amino acids, thereby 
necessitating them to scavenge amino acids from the phagolysosome (McConville 
et al. 2007; Opperdoes & Coombs 2007). This could suggest the increase of amino 
acids degradation in amastigote. Recently, Saunders et al. (2014) reported that 
lesion-derived amastigotes have a similar metabolic profile to axenic amastigotes, 
thus indicating that the differences between axenic amastigotes and 
promastigotes should also reflect the parasite in their natural environment. 
Specifically, promastigotes exhibited high metabolic activity, with high rates of 
glucose and amino acid consumption and secretion of metabolic end-products, 
while amastigotes exhibited lower levels of catabolism of glucose and other 
potential carbon sources such as amino acid uptake as well as increased 
catabolism of fatty acids (Figure 3.28). This switch to a more economical 
metabolism in amastigotes has been termed the stringent response (Saunders et 
al. 2014; McConville et al. 2015). 
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Figure 3.28: Intracellular amastigotes exhibit a stringent metabolic response.  
The differentiation of Leishmania promastigotes to amastigotes is accompanied with major changes 
in central carbon metabolism. Promastigotes exhibit high rates of glucose and (non-essential) amino 
acid uptake as well as uptake of fatty acids (downward arrow). Amastigotes also preferentially use 
glucose as a carbon source. However, they exhibit much lower rates of sugar and amino acid uptake. 
Although amastigotes continue to take up essential amino acids but these amino acids were used 
mainly for protein synthesis. Amastigotes also actively catabolize fatty acids in the tricarboxylic acid 
(TCA) cycle, because of reduced glucose uptake. The downregulation of hexose/ amino acid uptake 
in amastigotes (stringent response) is due to differentiation and is associated with a reduced growth 
rate (adapted from McConville et al. 2015). 
 
The pathway of glycolysis/ gluconeogenesis in figure 3.29 displayed a conspicuous 
presence of proteins identified in our data (bright green box).  Figure 3.29 showed 
the glycolytic proteins that were upregulated in promastigote and amastigote 
stage. 
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Figure 3.29: Diagram of glycolysis and gluconeogenesis pathway in L. mexicana.  
The total proteins identified by Mascot were uploaded on TriTrypDB for functional analysis. The gene 
ID were transformed to pathways given an output of the list of pathways involve in L. mexicana. The 
diagram showed pathway of glycolysis/ gluconeogenesis involving starch and sucrose metabolism, 
pentose phosphate pathway, carbon fixation in photosynthetic organisms, TCA cycle, pyruvate 
metabolism and propanoate metabolism. The boxes with bright green colour represent proteins 
identified in our data. The red circles indicated proteins upregulated in promastigote, whereas the 
purple circles represented proteins upregulated in amastigote. Abbreviations: 5.1.3.3 – aldose 1-
epimerase, 5.3.1.1 – triose-phosphate isomerase, 2.3.1.12 – dihydrolipoyllysine-residue 
acetyltransferase, 1.8.1.4 – dihydrolipoyldehydrogenase, 1.2.1.3 – aldehyde dehydrogenase, 2.7.1.1 
– hexokinase, 2.7.1.11 – 6-phosphofructokinase, 4.1.1.13 – fructose-bisphosphate aldolase, 
1.2.1.12 – glyceraldehyde-3-phosphate dehydrogenase, 2.7.2.3 – phosphoglycerate kinase, 4.2.1.11 
– phosphopyruvate hydratase, 2.7.1.40 – pyruvate kinase, 4.1.1.49 – phosphoenolpyruvate 
carboxykinase, 1.2.4.1 – pyruvate dehydrogenase, 1.1.1.1 – alcohol dehydrogenase. 
 
Figure 3.30 illustrated purine metabolism in Leishmania (KEGG) with proteins 
found in this study (bright green boxes). Specifically, we found proteins involved 
in alanine, aspartate, glutamate metabolism, histidine metabolism, riboflavin 
metabolism, arginine and proline metabolism and folate biosynthesis.  
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Figure 3.30: Diagram of purine metabolism pathway in L. mexicana.  
The proteins identified by Mascot were uploaded on TriTrypDB for functional analysis. The gene ID 
were transformed to pathways given an output of the list of pathways involve in L. mexicana. The 
diagram showed pathway of purine metabolism. The boxes with bright green color represent proteins 
found in our data. 
 
We also identified several proteins correlated with oxidative phosphorylation in 
promastigote including 2,4-dienoyl-coa reductase fadh1, 2-hydroxy-3-
oxopropionate reductase, 6-phosphogluconate dehydrogenase and aldehyde 
dehydrogenase. In this pathway, cells use enzymes to oxidize nutrients in the 
mitochondria, thereby releasing energy which is used to reform ATP.  
Several of the promastigote-enriched proteins in this study may have a role in 
flagellar function. Among the proteins are paraflagellar rod protein (PFR), dynein 
heavy chain protein, dynein light chain, beta-tubulin, centrin, kinesin, flagella 
connector protein, flagellar pocket cytoskeletal protein Bilbo 1 and flagellum 
targeting protein KHARON 1. The promastigote flagellum is important for motility 
and attachment within the sand fly gut (Cuvillier et al. 2003). Although many 
literatures reported that amastigotes are aflagellate, in fact they retain a short 
flagellum that extends to the neck of the flagellar pocket (Gluenz et al. 2010). 
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Various reports documented that Leishmania contain high abundance of cysteine 
proteases of the papain family (C1) and that the cysteine proteases show a high 
level of stage-regulated expression (Brooks et al. 2000; Alves et al. 2001; Denise 
et al. 2006). In L. mexicana, it was found that cysteine protease activity was 
considerably greater in the mammalian amastigote form than the promastigote 
forms that live in the sand fly vector (North & Coombs 1982). Several other 
proteins involved in proteolysis were also detected in our data including 
aminopeptidase and cathepsin L-like protease. The fact that amastigotes express 
more proteolytic proteins suggests that they might be important for survival of 
the parasite in the mammalian host. 
3.5 Summary 
Comparative analysis of proteins across L. mexicana promastigote and amastigote 
forms revealed that 542 are differentially expressed between promastigotes and 
axenic amastigotes. There were variations in the function of stage-regulated 
proteins that could reflect the differing challenges that they face in their habitat 
(Figure 3.31). The promastigote relies mostly on glycolysis and amino acid 
metabolism for energy production. A large proportion of proteins that were 
downregulated during differentiation to amastigotes were associated with 
glycolysis, gluconeogenesis and amino acid biosynthesis. Instead, amastigote use 
fatty acid β-oxidation metabolism as carbon source, and this is reflected in our 
data. Proteins related to a motile flagellum are also down-regulated in 
amastigote. In contrast, proteins that were upregulated in amastigotes included 
cell surface proteins, peptidases, amino acids degradation proteins, and many 
uncharacterized genes. This study could complement present information on the 
differences of protein expression in different life cycle stage of L. mexicana.  
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Figure 3.31: Summary of differentially regulated proteins between promastigote and 
amastigote.  
Diagram showed the differences in proteins regulation between promastigote and amastigote. 
 
 
 Chapter 4 
 
4 A quantitative proteome dynamic analysis of the 
macrophage in response to L. mexicana: 
Determination of newly synthesized proteins 
4.1 Introduction 
Infectious diseases such as leishmaniasis are one of the principal challenges in the 
world. The limitations with current treatments and the lack of vaccines mean that 
new treatments for leishmaniasis are urgently needed. However, the development 
of new chemotherapies requires a thorough understanding of the pathophysiology 
of infectious diseases, especially of the intricate interplay between the pathogen 
and the host during the progression of disease. Leishmania has developed a 
complex relationship with its host, where it exploits and subverts the host immune 
system to ensure its survival. The parasites are able to seek refuge in the host 
macrophages, utilizing available resources from the host and hiding from the host 
immune system for an indefinite period of time.  
4.1.1 SILAC  
In this post-genomic era, rapid developments in proteomics technologies have 
empowered researchers to obtain a wealth of information that relates the 
genomic blueprint to specific phenotypes. Moreover, the development of 
quantitative methods makes it possible to acquire information about differences 
between samples and to monitor temporal changes in the proteome by mass 
spectrometry. In this regard, SILAC is considered as a gold standard of quantitative 
proteomics. Cells are differentially labelled by cultivating them in the presence 
of normal or heavy isotope-substituted amino acids. As labelling does not affect 
chromatographic characteristics, co-eluting pairs of chemically equivalent 
peptides emerge in the same mass spectrum but can still be distinguished from 
each other due to the constant mass increment conferred by heavy isotopes. 
Hence, the ratio of intensities for such peptide pairs accurately reflects the 
108 
 
abundance ratio for the corresponding proteins (Mann 2014), particularly in 
steady-state protein levels (Figure 4.1 a).  
4.1.2 Pulse-chase SILAC (pcSILAC) measures changes in protein 
production 
Although standard quantitative proteomics techniques are essential to identify 
and measure variations in protein abundances, they are not adapted to determine 
if such variations are due to changes in synthesis rates, decay rates, or a 
combination of both. Nor are these techniques able to quantitate other properties 
such as turnover, which may give an indication of the intrinsic stability and half-
life of proteins (Fierro-Monti et al. 2013). Pulse-chase SILAC (pcSILAC), a variant 
of the standard SILAC workflow, involves cultivating cells in media with either 
light or heavy-labelled amino acids, prior to perturbation accompanied by medium 
exchange (Figure 4.1 b). This can provide information on how proteins that are 
expressed under specific conditions affect the phenotype on a global scale. The 
advantage of pcSILAC over standard SILAC is that the quantitation is exclusively 
based on the newly synthesized protein amounts in a given time and consequently, 
in this project, allows delineation of a subset of proteins that show modulated 
expression upon infection. Understanding the changes in host macrophage protein 
expression that accompany Leishmania infection could shed light on the 
interactions between host and parasite and will present an additional research 
tool to investigate the pathways that determine the outcome of infection. 
Dynamic proteome analysis has been pioneered by the Beynon group (Pratt et al. 
2002; Beynon 2005; Doherty et al. 2005). The technique that they used consists of 
exchanging specific amino acid sources in media at a particular time point from 
light to heavy (or vice versa). As the cells grow in labelled medium, the original 
pool of unlabelled amino acids is diluted. Several doubling times (6-8) ensures that 
all proteins have been turned-over intracellularly and labelled. From the point of 
media exchange, all exogenously-acquired amino acids will be distinguishable 
from those acquired prior to media exchange. Providing the biological system 
under study is auxotrophic for the labelled amino acids employed, newly 
synthesized proteins will be distinct from those that were expressed prior to media 
exchange. Therefore, in principle, it is straightforward to determine protein 
turnover by looking at the changes of the precursor relative isotope abundance 
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(RIA) in the mass spectra over time, as all ‘heavy’ will gradually transition to all 
‘light’ as  protein turnover progresses (Claydon & Beynon 2012).  
Protein biosynthesis consumes a high amount of energy during cellular 
proliferation. Translation by ribosomes is estimated to account for ~50% of the 
energy consumption of a rapidly growing bacterial cell, and ~30% of that for a 
differentiating mammalian cell (Russell & Cook 1995). The huge cost associated 
with protein synthesis makes it a key step for regulating diverse cellular functions 
(Li et al. 2015). Hence, understanding and determining how a cell allocates its 
synthesis capacity for each protein offers foundational information for systems 
biology. Methods to monitor protein synthesis rates at the global level have mainly 
relied on pulsed metabolic labelling followed by two-dimensional gel 
electrophoresis, or more recently by mass spectrometry (Schwanhäusser et al. 
2009; Schwanhäusser et al. 2008). 
SILAC has been extensively used in mammalian cells including the human 
monocytic leukaemia cell line THP-1 (Klegeris et al. 2008), human lymph node 
carcinoma of prostate LNCaP cell line (Piechura et al. 2012; Geiger et al. 2012), 
cervical carcinoma HeLa cells (Thiede et al. 2013; Geiger et al. 2012), embryonic 
kidney cells HEK293 (Geiger et al. 2012) and so on. On the other hand, pcSILAC 
labelling scheme has been applied in HeLa cells (Andersen et al. 2005), Jurkat T-
lymphocytes (Fierro-Monti et al. 2013), bacteria Staphylococcus aureus (Schmidt 
et al. 2010) and human adenocarcinoma A549 cells (Doherty et al. 2009) for 
protein dynamic studies. In this work, we have applied pcSILAC strategy on THP-
1. To date, there is no application of pcSILAC to investigate host responses towards 
Leishmania infection. Therefore, this is a very novel research. However, because 
of the large amount of data involved, interpretation of results is still a limiting 
factor. These includes the processing power to analyse the huge datasets that are 
generated using relevant bioinformatic tools, time acquired to analyse the data, 
and the requirement for skills in specific bioinformatic tools and approaches.  
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Figure 4.1: Workflow of standard SILAC and pulse-chase SILAC.  
(a) Cells are grown in culture media that are identical with exception of certain amino acids. The 
“light” culture (L) contains all the amino acids in unlabelled form and the “heavy” culture (H) contains 
one or two amino acids in labelled form only. Cells from both cultures are mixed in a 1:1 ratio. The 
proteins of interest are extracted and digested with trypsin or LysC. The proteolytic cleavage creates 
pairs of peptides deriving from protein synthesised during culture in “light” and “heavy” media, 
differing by a molecular weight of 6 Da. The ratio of the amount of light and heavy peptides is 
determined by mass spectrometry. (b) In the pcSILAC method, cells are first cultivated in standard 
growth medium with “heavy” (H) amino acids. Concomitantly with differential treatment, cells are 
transferred to culture medium containing “light” (L) isotope-coded amino acids. Therefore, cells are 
'chased' with L amino acids, thus all newly synthesized proteins will incorporate the L amino acids. 
Two cell populations are further processed separately and analysed by MS.  
 
Substantial effort has focused on elucidating host gene expression profiling using 
different (murine and/or human) cell types and different species of Leishmania 
(Rodriguez et al. 2004; Menezes et al. 2013; Paape & Aebischer 2011; Li et al. 
2012; Singh et al. 2015). This information provides key insights into an extensive 
modulation of protein function and contributes to a better understanding of the 
dynamics of protein expression following infection. It has been noted that 
transcriptome-based analysis has major limitations as it does not represent the 
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true effectors of cellular functions. In the present study, we have adopted a 
quantitative proteomics-based approach to gain insight into the reprogramming of 
the THP-1 cell line, an acute monocytic leukaemia-derived human cell line, 
infected with L. mexicana for 24 hours.  
Several considerations have been undertaken for pcSILAC to determine protein 
turnover (Hinkson & Elias 2011): 
1) Cells are auxotrophic for the amino acid used. This would minimise any 
dilution of the label by de novo synthesis. 
2) The amino acids are highly abundant 
3) The mass difference between the heavy and light labels must be at least 4 
Da for optimal distinction between isotopic envelopes. 
4) Minimal amino acid recycling. We ensure this by using dialyzed serum in the 
media and considered the dilution rates through cell growth. 
5) Use compatible proteases for amino acid pair. For example, lysine and 
arginine pair are most suited to use trypsin, while lysine is compatible with 
endoproteinase Lys-C. 
While chapter 3 elaborated on the differential stage-regulated proteomes of the 
parasite Leishmania, this chapter focuses on the establishment of pcSILAC as a 
tool to monitor protein expression with time, and to reveal host proteome changes 
in response to infection with Leishmania. 
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4.2 Aims 
This study has produced a large volume of data. Therefore, we will divide the 
study into two chapters (chapter 4 and 5). The first part of the chapter describes 
the establishment of pcSILAC, a modified version of the classic SILAC approach, to 
investigate changes in protein expression in a macrophage cell line upon infection 
with L. mexicana as well as to derive protein synthesis rate. The workflow was 
developed by comparing protein expression in uninfected macrophages with 
expression in macrophages 24 h after Leishmania infection. Following this, mock-
infected, 24 h infection data and 48 h infection data were used to analyse newly 
synthesized proteins. Another chapter (Chapter 5) extends this study to 
investigate protein degradation and turnover in response to Leishmania infection. 
The aims of this study were to:  
❖ Isolate metacyclic promastigotes for THP-1 infection 
❖ Optimise THP-1 differentiation 
❖ Enhance proteolysis of the samples in order to increase proteome coverage 
on MS. 
❖ Establish pulse-chased SILAC approach as a new quantitative technique to 
investigate the proteome changes of THP-1 when infected with L. mexicana 
for 24 h, comparing with mock-infected THP-1. 
❖ Extend the application of pulse-chase SILAC to investigate the proteome 
changes in the THP-1 macrophage cell line when infected with L. mexicana 
with additional time-course infection of 48 h. 
❖ Undertake a statistical analysis of the protein modulations observed. 
❖ Investigate newly synthesized proteins and calculate relative protein 
synthesis rate. 
Investigation of this parasite’s interaction with the host macrophage may lead to 
a better understanding of how the macrophage proteome changes in response to 
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Leishmania infection, thus, assisting in the development of new chemotherapeutic 
strategies against leishmaniasis.  
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4.3 Results 
4.3.1 THP-1 differentiation and infection assays 
The human monocytic cell line, THP-1, has been used as a model host macrophage 
for Leishmania for over two decades (Gebre-Hiwot et al. 1992; Tsuchiya et al. 
1982). In vitro cultured THP-1 monocytes must be induced into adherent 
macrophage-like cells with chemical agents such as PMA, 1,25-dihydroxyvitamin 
D3, retinoic acid or DMSO (Tsuchiya et al. 1982; Daigneault et al. 2010).  
PMA has been used at concentrations of 10 – 400 ng/ml, regardless of whether this 
will affect the regulation of some genes (Daigneault et al. 2010). At the outset of 
this study, we tested various concentrations of PMA. We first tried using PMA at 
60 ng/ml (0.1 μM) and 300 ng/ml (0.5 μM) incubated for 24 h. However, cell 
attachment after 24 h incubation proved to be unstable as the cells were easily 
detached during washing. We then tried incubating the cells with PMA at the same 
concentration but for 48 h. Under these conditions, we observed approximately 
98% of THP-1 cells adhered strongly to tissue culture flask/dish even after 3 
washes with PBS, indicating complete differentiation, as illustrated in Figure 4.2. 
Cells attachment for each optimisation was determined by counting the 
unattached cells after washing (Figure 4.3). A lower concentration of PMA is 
preferable to limit the effect on gene regulation (Daigneault et al. 2010), so we 
selected 0.1 μM PMA for induction over a 48 h period. Cell viability was determined 
to be >97% by the Trypan blue dye exclusion method. For large scale experiments, 
we compared non-treated Corning flask and Nuclon Delta treated-surface flasks, 
determining that the latter was the best option (by observation), as it enhance 
cell attachment and differentiation. 
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Figure 4.2: Differentiation of THP-1 cells with PMA.  
THP-1 cells were cultured in media containing 60 ng/ml of PMA and incubated at 37°C for 48 hours. 
After that, cells were washed with PBS three times. At this point, 98% of the cells were differentiated 
and adhered to the flask. Picture without PMA (on the right) was taken from ATCC website. 
 
 
Figure 4.3: Optimisations of THP-1 activation by PMA.  
THP-1 cells were induced with PMA with different concentrations of PMA (60 and 300 ng/ml) and 
different incubation time (24 and 48 hour) to obtain better differentiation.  
 
Following differentiation, the cells stop dividing and adhere to the base of the 
tissue culture with a macrophage-like morphology. Induced-THP-1 were infected 
with L. mexicana and observed by microscopy. Figure 4.4 depicts a microscopic 
view of the THP-1 infected with L. mexicana.  Figure 4.5 shows an example of a 
fluorescent image of infected THP-1, counted using ImageJ software 
(http://rsb.info.nih.gov/ij/download.html). Infections were tested several times 
using both axenic amastigotes and metacyclic promastigotes. Several conditions 
(macrophage:parasites ratios and period of incubations) were tested to find the 
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optimal and most reproducible infection protocol. We tested 1:5, 1:8 and 1:10 
ratios incubated at 37°C for 6 h, 24 h and 48 h. Cells were washed several times 
to ensure complete removal of non-internalized parasites before staining the cells 
with DAPI or Giemsa. Both macrophage nuclei and intracellular Leishmania nuclei 
with kinetoplast DNA were observed under the fluorescent microscope. Uninfected 
THP-1 was used as a control. The ImageJ software was used to analyse these 
images.  
 
Figure 4.4: Microscopic view of PMA-differentiated THP-1 macrophages uninfected and 
infected with L. mexicana.  
Differentiated THP-1 were incubated with parasites at a ratio of 1:8 for 24 h and 48 h. Giemsa and 
DAPI staining were performed to determine the infectivity. Cells were imaged at 63×, scale bar shows 
20 µm. 
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Figure 4.5: Fluorescent (DAPI) image of a differentiated THP-1 cell infected in vitro with L. 
mexicana amastigotes.  
Differential counting of THP-1 cell nuclei and parasite nuclei was performed by ImageJ. Cell counter 
type 1 was selected for THP-1 cell nuclei and cell counter type 2 was selected for parasite nuclei. 
Differential counting was done for at least 200 THP-1 cell nuclei.  Cells were imaged at 63x. Legend: 
1 – THP-1 nuclei, 2 – parasite nuclei. 
 
 
Figure 4.6 shows the differential infectivity in THP-1 cells at different 
macrophage:parasites ratios and different period of incubations. Results were 
quantified as percentage of infected THP-1 cells and were mean of triplicates. We 
examined the effect of axenic amastigotes and metacyclic promastigotes, that 
were enriched from a mixed culture of procyclic and metacyclic promastigotes by 
Ficoll density gradient centrifugation. For both axenic amastigotes and metacyclic 
promastigotes, a ratio of 10:1 and incubation for 24 h yielded optimum and 
reproducible infection rate at approximately 90% (89.7% for axenic amastigotes 
and 91.7% for metacyclic promastigotes). The average number of amastigotes in 
each infected macrophage was 17±6 (on 100 macrophages). The infectivity rate 
for THP-1 infected with L. mexicana for 48 h was 93% (Figure 4.7). Based on these 
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results, subsequent experiments were done using metacyclic promastigotes 
instead of amastigotes, as we elected to investigate the response of the 
macrophage to infection by promastigotes. In addition, we observed infected THP-
1 cultures for 7 days. After 7 days, the parasite burden increased markedly and 
lysis of the host cells occurred progressively (by observation, result not shown).  
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Figure 4.6: Time kinetics of phorbol 12-myristate 7-acetate (PMA)-treated adherent THP-1 cell 
infection by L. mexicana.  
Differentiated THP-1 were incubated on LabTek slides with parasites at a ratio of 5:1, 8:1 and 10:1 
for 6 h and 24 h. Infected macrophages were counted for every 100 macrophages to obtain infection 
rate. (a) Infection with axenic amastigotes obtained from transformed promastigotes in Schneider 
Drosophilla medium. (b) Infection with metacyclic promastigotes obtained from stationary phase of 
parasites culture and separated through Ficoll gradient.  
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Figure 4.7: Time kinetics of PMA-treated adherent THP-1 cell infection by L. mexicana.  
Differentiated THP-1 were incubated on LabTek slides with parasites at a ratio of 1:8 for 6 h, 24 h 
and 48 h. Non-internalized parasites were washed away with PBS after 6 h. Cell were fixed and 
stained with Giemsa at each time point. The proportion of infected macrophages was assessed by 
microscopy. Error bar represented mean ± standard error from triplicates. 
 
Additionally, the method for releasing adhered and infected THP-1 cells into the 
medium was important for the integrity of the cells. Thus, we experimented with 
different approaches such as the use of syringe, cell scraper and the addition of 
EDTA. It was observed that the use of cell scraper after cells were kept in 4°C for 
15 min was the best approach to harvest high volume of cells.  
4.3.2 Establishment of pulse-chase SILAC for global assessment 
of infection-regulated proteins  
There are several prerequisites to a SILAC approach. First, the cells to be labelled 
must be auxotrophic for the labelled amino acids. In this case, we used arginine 
and lysine. Second, cells need to be able to grow in SILAC-compatible media, 
which must lack unlabelled sources of these amino acids. To ensure that cells only 
incorporate the labelled amino acids into their proteome, cells to be heavy 
labelled are grown with dialyzed serum (dFCS) since standard FCS contains 
unlabelled (light) amino acids. Some cell types require low molecular mass growth 
factors that are not present in dialyzed serum (Mann 2006). It is therefore 
imperative to do a preliminary test to monitor the growth of the cells in the SILAC 
media for certain amount of time. Figure 4.8, shows that THP-1 cells cultivated 
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in SILAC media grow at approximately the same rate as in normal RPMI media. 
Doubling time for THP-1 grown in RPMI 1640 media containing standard FCS is 19 
h whereas for THP-I grown with dFCS it is 20.4 h. 
 
 
Figure 4.8: Growth curve analysis of THP-1 grown in normal RPMI media and SILAC media.  
A culture was initiated at 1 x 105 cells/ml for all conditions and samples taken on 6 consecutive days 
for cell counting. Cells were fixed in 2% formaldehyde/PBS and counted on Neubauer 
haemocytometer. 
 
Third, the incorporation of isotopically labelled amino acids should approach 
100%, meaning that the isotopes are almost fully incorporated into the cells. This 
is to obtain clear discrimination of the signal originating from each sample. Thus, 
cultivating the cells in SILAC media for at least 6 doubling time (in our case, 8 
doubling times) is obligatory. The level of incorporation of stable isotope-labelled 
amino acids in the cells was assessed by fractionating using SDS–PAGE followed by 
tryptic digestion. Proteomic analyses were performed using LTQ-Velos Orbitrap 
mass spectrometer and the data were processed by MaxQuant. MS data showed 
that the level of incorporation of stable isotope labelled amino acids in the THP-
1 cells was high enough to proceed with SILAC experiments (Figure 4.9). We did 
not detect any significant arginine to proline transition in THP-1 cells. Labelling 
efficiency was calculated using formula given in 2.6.2 and it was over 99%. 
Moreover, we analysed the spectra by the SeeMS tool from ProteoWizard 3.0.9 
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package, to confirm presence of heavy and light-labelled SILAC pairs (example in 
Figure 4.10). 
 
Figure 4.9: Partial peptide summary of myosin heavy chain (Homo sapiens) identified as 
protein hit #3 and #6 in THP-1 uninfected sample.  
(a) The peptide sequences from samples that was cultivated in heavy SILAC medium for 1 cell 
doubling showed all peptides were still labelled with 12C-R and 12C-K. (b) After 8 cell doublings, cells 
were fractionated on SDS-PAGE, gel-digested and subjected to MS. The peptide sequences showed 
the modifications occurred, in this case, labelling with heavy 13C-R and 13C-K, indicating high heavy 
amino acids incorporation into the cells. (c) MaxQuant viewer output showing the MS/MS spectrum 
with labelling of K and R. 
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Figure 4.10: MS/MS spectra of tryptic peptides showing SILAC pair of heavy and light.  
Raw file generated by Orbitrap Velos MS was analysed by SeeMS tool (included in ProteoWizard 
3.0.9 package). Scan 3375 belonging to Erlin-2 showed SILAC pair containing light and heavy 
spectra. 
 
After maintenance in SILAC culture media for at least the period required to 
achieve better than 99% labelling, THP-1 were induced with PMA to become 
macrophage-like cells. At this stage, heavy SILAC medium was exchanged to light 
SILAC medium (RPMI 1640 containing 12C-Arg and 12C-Lys isotope) and the cells 
were infected with metacyclic promastigotes (1:8) for 24 h and 48 h. In parallel, 
mock-infected THP-1 were also treated the same way but without infection, to 
serve as a control. Sample preparation optimisations were also applied as 
described in chapter 3 (section 3.3.3). During this incubation phase, all newly-
synthesized proteins should incorporate light-labelled lysine and arginine. 
Subsequently, the uninfected and infected cells were harvested by scraping the 
adhered cells and cell lysis was performed followed by MS. This project produced 
72 LC/MS raw files from at least 6 SILAC experiments consisting of 2 sample groups 
(uninfected and 24 h-infected). Each experiment included 3 biological replicates. 
For quality control, the protein lysates were analysed on Amazon Speed ion trap 
1D-LCMS/MS. We tested different parameters for Filter-Assisted Sample 
Preparation (described in Table 4.1) and found that a trypsin to protein ratio of 
1:50 and elution with ACN without desalting gave the best protein identification. 
For 2-D LC/MS, each replicate has 12 fractions. These files were analysed 
separately and/or together by the MaxQuant software using the Andromeda search 
engine. 
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Table 4.1: Analysis of uninfected THP-1 lysate processed by FASP with different parameters.  
Lysates (n=1) were prepared using SDT buffer with 100 µg/ml of Leupeptin, 500 µg/ml of Pefabloc, 
2 mM of 1,10-Phenanthroline, 10 µg/ml of Pepstatin A and 50 µg/ml of E-64. Then, the lysates were 
subjected to FASP for protein digestion. Peptides were run on Amazon Speed ion trap MS/MS. 
 
Digestion enzyme 
Enzyme:Protein 
ratio 
Elution 
buffer 
Lysates 
quantity (μg) 
Clean-up 
method 
Proteins 
identified 
Trypsin 1:100 NaCl 50 *Desalt 240 
Trypsin 1:100 NaCl 100 *Desalt 595 
Trypsin and Lys-C 1:100 NaCl 50 *Desalt 203 
Trypsin 1:100 ACN 100 None 947 
Trypsin 1:50 ACN 100 None 1206 
*Desalting was done on SPE cartridge 
 
Three biological replicates for both uninfected and 24 hpi THP-1 were run on 1-D 
LC/MS and analysed together on MaxQuant before being evaluated in Perseus for 
quantification. As the range of the expression values can vary more than 10-fold, 
the expression values were Log transformed to facilitate the calculation of the 
protein expression fold change. The Log transformation of the expression values 
create a pool of “NaN” (Non-Assigned Number, non-quantified values) values, 
which correspond to expression values originally equal to zero, when one of the 
SILAC pairs were not detected by the mass spectrometer. Non-quantified values 
also arise when the SILAC pairs ratio does not met the minimum ratio for 
quantification threshold (in this case it is set at 2) or the peak intensities are 
below the instrument detection level. Figure 4.11 (a and b) shows a total of 732 
proteins that were identified in uninfected cells (in all three replicates) and 
different numbers of proteins were quantified (having L/H ratios) in each replicate 
(80 proteins in Control-1, 213 proteins in Control-2, 90 proteins in Control-3). Only 
47 proteins were quantified in all three replicates. Whereas, 695 proteins were 
identified in infected samples but only 7, 20 and 558 proteins were quantified in 
each biological replicate, respectively (Figure 4.11 d and e). Again, for this 
analysis, the median-normalized data of all quantified proteins were considered. 
We first inspected the reproducibility of the SILAC protein quantification between 
these replicates and found an average Pearson correlation coefficient of 0.76 for 
uninfected and 0.5 for 24 hpi THP-1. From these data, it is evident that 1-D LC/MS 
did not yield high reproducibility between replicates. Furthermore, the 
reproducibility of quantified protein in 24 hpi was low in two of the replicates. 
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This might be due to the low intensity of H or L label that could not be detected 
by MS. 
 
Figure 4.11: 1D-LCMS/MS data analysis from biological replicates of uninfected and 24 hpi 
THP-1.  
Digested peptides were run on the Orbitrap Velos instrument. Thermo raw files of uninfected and 24 
h infection (n=3, biological replicates) were analysed on MaxQuant and Perseus for quantitative 
analysis. (a) A total of 778 proteins were found in uninfected sample. (b) Venn Diagram shows that 
out of 778 proteins found in uninfected sample, 213 proteins were quantified in replicate_1, 80 in 
replicate_2 and 90 in replicate_3. (c) Pearson correlation of 3 biological replicates was 0.76, 
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indicating good reproducibility between replicates (close to 1). (d) A total of 724 proteins were found 
24 h infected sample. (e) Venn Diagram shows that out of 724 proteins found in 24 h infected sample, 
558 proteins were quantified in replicate_1, 20 in replicate_2 and 7 in replicate_3. (f) Pearson 
correlation of 3 biological replicates was 0.5, indicating the reproducibility between replicates was 
not good. 
 
Subsequently, we moved on to 2-D LC/MS in order to increase proteome coverage 
as this method enhances the identification of lower abundance proteins by 
increasing the separation of peptides. Combined analysis of the triplicates of 
uninfected THP-1 together, using a peptide and protein FDR of 1%, yielded 1472 
identified proteins and 650 proteins quantified in one of the replicates. The 
highest Andromeda score of identified proteins were 323, the average number of 
peptides per protein was 13 (the highest number of peptides per protein was 62, 
giving to 80% sequence coverage). Andromeda is a novel peptide search engine 
using a probabilistic scoring model of peptide−spectrum matches. This score 
measures how well an acquired spectrum matches the theoretical fragment 
masses. High Andromeda score cutoff of 100 indicates very high spectral quality 
(Cox et al. 2011). Depicted in Figure 4.12 are the proteins detected in each 
biological replicate of uninfected group (a) as well as scatter plot (b), heat map 
(c) and profile plot (d) analysis. Protein expression was comparable between 
replicates, as shown in the heat map and profile plot. A similar analysis on 24 hpi 
THP-1 was performed to assess the reproducibility of the replicates. Biological 
replicates of 24 hpi THP-1 were analysed together on MaxQuant. The total number 
of proteins detected was 1653 with 739 proteins quantified in one of them. In 
Figure 4.13, the Venn diagram depicts the number of proteins detected in each 
replicate (a), the multiscatter plot shows Pearson correlation coefficient for all 
replicates (b), and the heat map (c) and the profile plot (d) show that expression 
between replicates was similar. These two figures clearly show that the proteomic 
profiles of biological replicates of uninfected and 24 hpi THP-1 were quantitatively 
similar. More than 50% of the proteins were identified by 2D-LC/MS compared to 
1D-LC/MS. These data clearly showed that 2D-LC/MS gave better proteome 
coverage and yielded a higher number of identified and quantified proteins 
compared to 1-D LC/MS as it allows the separation and characterisation of 
peptides derived from less abundant proteins. 
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Figure 4.12: 2D-LCMS/MS profiles from biological replicates of uninfected THP-1.  
Digested peptides were subjected to SCX and RP separation on the Orbitrap Velos MS instrument. 
Thermo raw files of uninfected (n=3, biological replicates) were analysed on MaxQuant and Perseus 
for quantitative analysis. (a) Venn diagram showing the number of proteins detected in each 
replicate. (b) Multiscatter plot with Pearson correlation values (blue font) of near 1 indicates good 
correlation between replicates. (c) Heat map distribution of protein expressions in all replicates shows 
similar pattern. (d) Profile plot of protein expression with carbonic anhydrase (red) as example shows 
similar pattern. 
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Figure 4.13: 2-D LCMS/MS profiles from biological replicates of 24 hpi THP-1.  
Digested peptides were subjected to SCX and RP separation on the Orbitrap Velos MS instrument. 
Thermo raw files of uninfected (n=3, biological replicates) were analysed on MaxQuant and Perseus 
for quantitative analysis. (a) Venn diagram showing the number of proteins detected in each 
replicate. (b) Multiscatter plot with Pearson correlation values (blue font) of near 1 indicates good 
correlation between replicates. (c) Heat map distribution of protein expressions in all replicates shows 
similar pattern. (d) Profile plot of protein expression with gelsolin (red) as example shows similar 
pattern. 
  
 
After inspecting the reproducibility between replicates, we then combined raw 
data from uninfected and 24 hpi THP-1, each contain 12 fractions, and analysed 
them together on MaxQuant and Perseus for comparative analysis. This yielded 
2016 identified protein and 761 quantified proteins in at least one of the group 
(summarized in Figure 4.14 and in Table 4.4).  
129 
 
 
Figure 4.14: Strategy for analysing raw data using MaxQuant and Perseus.  
This diagram explains how we analyse raw data from Orbitrap Velos MS. For statistical purpose, we 
only use protein lysates from biological replicates that were prepared and processed on the same 
day. (a) Each uninfected and 24 hpi biological replicates (with 12 fractions each) were analysed 
separately on MaxQuant and Perseus. The number of proteins quantified were varies in all replicates. 
(b) 3 biological replicates of uninfected and 24 hpi were combined and analysed together on 
MaxQuant and Perseus. These generated 6 columns in Perseus: control_A, control_B, control_C, 
24 hpi_A, 24 hpi_B, 24 hpi_C. For 2 samples t-test analysis, control_A, _B and _C were grouped as 
control, whereas 24 hpi_A, _B and _C were grouped as 24 hpi. (c) Of the total proteins identified, 
they were filtered to proteins with quantification in all replicates. This subset of data was used for 
statistical analysis. Of these, the quantified proteins were narrowed down to fold-change (FC) greater 
than 1.2 to determine the modulations. Data for 48 hpi was analysed using the same strategy.                                                                        
 
After filtering missing values from the data (in Perseus), 521 proteins were 
quantified in all replicates. The proteins identified include neutrophil cytosol 
factor 1, galectin-9, galectin-1, actin, tubulin, Dynamin-1-like protein, 
Tripeptidyl-peptidase 1 and Thioredoxin-like protein. We predicted that the 
proteomes measured here are not complete and there is a likely bias toward 
proteins with high expression levels.  
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Functional analyses were performed on the proteins identified. Gene Ontology 
analysis based on biological process using DAVID showed that proteins involved in 
metabolic processes were most highly represented, followed by proteins involved 
in transport and apoptosis (Figure 4.15 a). Metabolic processes were then 
narrowed down to specific aspects of metabolism (Figure 4.15 b). Meanwhile, 
pathway analysis revealed that the majority proteins involve in metabolic, 
ribosome, oxidative phosphorylation, regulation of actin cytoskeleton and 
lysosome pathways (Figure 4.16). DAVID version 6.7 is designed around the "DAVID 
Gene Concept", a graph theory evidence-based method to agglomerate species-
specific gene/protein identifiers from a variety of public genomic resources 
including NCBI, PIR and Uniprot/SwissProt (Huang et al. 2009). We also analysed 
the proteins identified on Reactome (http://www.reactome.org) for curated 
human pathways as well as how they relate with each pathway (Figure 4.17). 
Reactome is an open source, expert-curated and peer-reviewed database of 
biological reactions and pathways with cross-references to major molecular 
databases. The basic information in the Reactome database is provided by either 
publications or sequence similarity-based inference (Matthews et al. 2009). The 
yellow line shows all proteins found in our data. For example, gelsolin was found 
in programmed cell death pathway. Furthermore, programmed cell death pathway 
seems to connect with cellular responses to stress. 
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Figure 4.15: Clustering of Gene Ontology based on biological process (GOBP) of all 
proteins detected after infection (24 hpi).  
The total number of proteins (UniProt identifiers) identified in uninfected and 24 hpi were analysed 
on DAVID based on biological processes they involve in. (a) GOBP of all proteins detected in 24 hpi 
THP-1. (b) GOBP partitions on metabolic processes.  
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Figure 4.16: Canonical pathway analysis on KEGG showing most altered pathways in 
uninfected and infected THP-1.  
The total number of proteins identified in uninfected and 24 hpi were analysed on DAVID with links 
to KEGG to identify the pathways they involve in (p ≤ 0.01; Fisher’s exact test). 
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Figure 4.17: Overview of Reactome pathways involve in this study.  
All proteins identified were analysed on Reactome to know the overview of biological pathways 
involve in our data. The yellow line represents proteins found in our data. The ‘Immune system’ 
pathway was highlighted in blue when we click on it.  
 
Data analysis using Mascot Distiller on the same data set revealed a total of 1642 
proteins identified with 135 proteins with no known function (proteins that are 
unclear to encode actual proteins) and 200 hypothetical proteins (proteins with 
no known homologs). Note that the reason of using Mascot Distiller in this regard 
was to identify hypothetical proteins as we did not detect these proteins using 
MaxQuant. We did not further analyse these data due to insignificant number of 
quantified proteins.  
We then analysed raw files of 48 h uninfected and infected samples alone to 
evaluate the reproducibility and to identify proteins that were only present at this 
time point. Three biological replicates were run on 2-D LC/MS and analysed 
together on MaxQuant generating 25,455 MS scans and 143,735 MS/MS scans 
equivalent to 1929 proteins identified in all replicates of uninfected group. 
Whereas, 9583 MS scans and 167,600 MS/MS scans corresponding to 1183 proteins 
were generated in 48 hpi groups (FDR of 1%, minimum ratio count of 2). Protein 
groups containing matches to proteins from the inverted database or contaminants 
were discarded. The number of quantified proteins with L/H ratios varies between 
replicates, ranging from 634 - 859 in uninfected and 454 - 484 in 48 hpi, as 
depicted in Venn diagram in Figure 4.18. Multiscatter plot analyses were applied 
to all replicates with Pearson correlation coefficient values ranges from 0.7 – 0.9. 
This indicated a good reproducibility across all replicates.  
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Figure 4.18: 2D-LCMS/MS data analysis from biological replicates of uninfected and 48 hpi 
THP-1.  
Digested peptides were run on the Orbitrap Velos instrument. Thermo raw files of control and 48 h 
infection (n=3, biological replicates) were analysed separately on MaxQuant and Perseus for 
quantitative analysis. (a) Venn Diagram shows that 859 proteins were quantified in Control_A, 634 
in Control_B and 795 in Control_C. (b) Multiscatter plot analysis were performed on all replicates of 
control. Blue font indicates a Pearson correlation value. Pearson correlation value near 1 showed 
high reproducibility (c) Venn Diagram shows that 454 proteins were quantified in 48 hpi_A, 484 in 48 
hpi_B and 483 in 48 hpi_C (d) Multiscatter plot analysis were performed on all replicates of 48 hpi. 
Blue font indicates a Pearson correlation value. Pearson correlation value near 1 showed high 
reproducibility. 
 
Expression profiles, displayed as a heat map between replicates for both 
uninfected and 48 hpi THP-1, showed similar patterns (Figure 4.19 a and c). Profile 
plots were performed on both uninfected and 48 hpi THP-1 using Perseus. Several 
proteins including SOD1, SOD2, GAPDH, PNP, prelamin A/C and galectin-9 were 
chosen as examples to show similar patterns across all replicates (Figure 4.19 b 
and d). 
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Figure 4.19: Expression profiles of uninfected and 48 hpi THP-1.  
Triplicates of uninfected and 48 hpi THP-1 were analysed separately on MaxQuant and Perseus. (a) 
Heat map distribution of protein expressions in all replicates of uninfected THP-1 showed similar 
patterns (b) Profile plot of protein expression in uninfected THP-1 with several proteins as example 
shows similar pattern (c) Heat map distribution of protein expressions in all replicates of 48 hpi THP-
1 shows similar pattern (d) Profile plot of protein expression 48 hpi THP-1 with several proteins as 
example shows similar pattern. 
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After examining the reproducibility between replicates, raw data from uninfected 
and 48 hpi THP-1 were combined (n = 3, each contain 12 SCX fractions) and 
analysed together on MaxQuant and Perseus for comparative analysis. Example of 
the strategy to analyse these data was illustrated in Figure 4.13. Using stringent 
parameters as described earlier, a total of 2280 proteins were detected in both 
groups (Figure 4.20). Each replicate of uninfected and 48 hpi were grouped 
together in Perseus for statistical analysis. For subsequent data analysis, we only 
considered protein with quantification in all 6 groups (Control_A, Control_B, 
Control_C, 48 hpi_A, 48 hpi_B and 48 hpi_C), leading to a total of 233 proteins 
(11%). Our 48 hpi datasets contains more proteins with NaN (missing values). This 
could be due to the greater reduction in the labelled protein that is expected over 
a longer chase period, resulting in the labelled population of certain proteins 
falling below the limit of detection. Furthermore, minimum ratio count for 
quantification was set to 2.  
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Figure 4.20: 2D-LCMS/MS data analysis of uninfected and 48 hpi THP-1.  
Digested peptides were run on the Orbitrap Velos instrument. Thermo raw files of uninfected and 48 
h infection (n=3, biological replicates) were analysed together on MaxQuant and Perseus for 
quantitative analysis. (a) Venn Diagram shows that 863 proteins were quantified in Control_A, 667 
in Control_B and 812 in Control_C. (b) Venn Diagram shows that 465 proteins were quantified in 48 
hpi_A, 505 in 48 hpi_B and 501 in 48 hpi_C (c) Histogram of uninfected and 48 hpi groups displayed 
a normal distribution (d) Multiscatter plot analysis were performed on all replicates of uninfected and 
48 hpi. Blue font indicates a Pearson correlation value. 
 
Protein ID (from Uniprot) for the proteins identified (2104 proteins) were uploaded 
to Database for Annotation, Visualization and Integrated Discovery (DAVID) as well 
as the Protein Analysis Through Evolutionary Relationships (PANTHER) 
classification system for global functional analysis. Gene Ontology analysis by 
biological process showed that metabolic processes were most highly represented, 
followed by localisation and response to stress/stimulus (Figure 4.21).  
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Figure 4.21: Clustering of Gene Ontology based on biological process (GOBP) of all proteins 
detected after infection (48 hpi).  
The total number of proteins (UniProt identifiers) identified in uninfected and 48 hpi were analysed 
on DAVID based on biological processes they involve in. Pie chart showed that most proteins 
involved in metabolic process, localisation and response to stress/stimulus. 
 
From DAVID, a link to KEGG pathways could also be retrieved. Pathway analysis 
on uninfected and 48 hpi THP-1 revealed that the top pathways associated with 
the proteins detected were ribosome, spliceosome, regulation of actin 
cytoskeleton, oxidative phosphorylation and lysosome (Figure 4.22).  
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Figure 4.22: Canonical pathway analysis on KEGG showing most altered pathways in 
uninfected and 48 hpi THP-1.  
The total number of proteins identified in uninfected and 48 hpi were analysed on DAVID with links 
to KEGG to identify the pathways they involve in (p ≤ 0.01; Fisher’s exact test). 
 
4.3.3 Determination of protein synthesis rate 
THP-1 cells were pre-labelled with heavy Arg and heavy Lys for approximately 160 
h, equivalent to 8 doubling times. After sufficient labelling had been achieved, 
light-labelled Arg and Lys were added in the medium-exchange process. Cells were 
exposed to metacyclic promastigote of L. mexicana at the start of the chase period 
and the cells were harvested at 24 and 48 h, and proteins were extracted. 
Uninfected cells were treated in the same way in parallel except without 
infection. During the chase period following infection, all newly synthesized 
proteins should only incorporate light-labelled Arg and Lys. The ratio of the H 
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versus the L intensity reflects the extent to which proteins have been turned over 
since the start of the chase and differences in this ratio reflect differences in the 
turnover of specific proteins between uninfected and infected macrophages. 
Protein populations that have persisted since before the chase remain in the H 
form, so the ratio of L:H reflects both the rate of synthesis and the rate of 
degradation. 
Replicates from both uninfected, 24 hpi and 48 hpi THP-1 (from MaxQuant and 
Perseus) were grouped and light (L) and heavy (H) intensities were averaged. To 
determine the synthesis rate, averaged intensities L/(L+H) were calculated 
(section 2.10.4) and plotted against time to monitor incorporation of heavy label. 
Only proteins with valid values with minimum individual peptides of 2 were 
considered for this purpose, leaving 400 proteins in total. Note that the doubling 
time for THP-1 in SILAC media was used to determine the dilution rate (kdil) over 
160 h of cultivation which is 0.006 h-1. Therefore, the dilution rate is negligible 
since over 99% of the arginine and leucine in the cells would be the stable isotope-
labelled form. Several of the proposed newly synthesized proteins were accessed 
on SeeMS and Skyline to look at the H and L spectra (Figure 4.23 and 4.24). 
 
Figure 4.23: Example of MS spectra and chromatogram in Skyline.  
Skyline was used to analyse the MS1 spectra by building a spectral library containing all spectra 
from raw files generated from Orbitrap Velos MS. Quantification of heavy Arg and Lys were applied 
on the setting. 
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Figure 4.24: Generation of labelled isotopologues of newly synthesized proteins.  
Mass spectra showing the appearance of the heavy isotopologue of polyadenylate-binding protein 
4, gelsolin and 14-3-3 protein zeta/delta at 24 h. After 48 h, the light isotopologues were incorporated 
into newly synthesized protein molecules, showing an increase of L intensity. 
 
A two-sample t-test was performed on the filtered data and gave rise to a subset 
of 51 proteins showed significant changes in synthesis rate for 24 hpi (Figure 4.25) 
and 84 proteins for 48 hpi (p-value < 0.05, FDR = 0.05). Table 4.2 and 4.3 list the 
significantly synthesized proteins in 24 hpi and 48 hpi, respectively.  
They were analysed in DAVID for functional annotation based on biological 
process, as shown in Figure 4.26. It is evident from the pie chart that these 
proteins are involved in various types of biological processes. However, in order 
to determine significant annotations between groups and to elucidate the common 
cluster of annotations in the group, we performed a Fisher Exact test (Benjamini-
Hochberg FDR < 0.02) for enrichment of proteins that showed significant 
modulation of expression (Subramanian et al. 2005). The most highly differentially 
expressed proteins were involved in metabolic process, translational processes, 
apoptosis, and RNA/mRNA processing. Also, we found multiple metabolic 
pathways, including fatty acid metabolism, amino acid metabolism and pyruvate 
metabolism. This demonstrates the diversity of energy production and 
biosynthetic pathways that are employed by the cells in response to infection.  
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Figure 4.25: Volcano plot showing proteins with different synthesis rate in uninfected and 24 
h infected THP-1 with FDR = 0.05.  
Conventional data were normalized and proteins with no quantification report were removed from all 
samples. t-test was performed on the remaining data to produce statistically significant proteins with 
p-value < 0.05 (above black line). The proteins were assigned with gene names. FDR of 0.05 was 
applied on the data producing 51 proteins with differential synthesis rate.  
 
Result from functional analyses also revealed that most of the proteins 
significantly synthesized in 24 hpi were involved in spliceosome, oxidative stress 
response, JAK/STAT signalling pathway, amino acids metabolism and translation 
(Figure 4.27).  
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Figure 4.26: Pie chart illustrating the types of biological processes involves in the 51 
significantly synthesized proteins in 24 hpi.  
RIA synthesis was determined for proteins identified in uninfected and 24 hpi. Proteins with no 
quantification report were removed from all samples. t-test was performed on the remaining data to 
produce 51 statistically significant proteins with p-value < 0.05. These proteins were assigned on 
Gene Ontology based on biological processes they involve in.  
 
 
Figure 4.27: Canonical pathway analysis on KEGG showing most altered pathways in the 51 
significantly synthesized proteins in 24 hpi THP-1.  
The highly synthesized proteins identified in uninfected and 24 hpi were analysed on DAVID with 
links to KEGG to identify the pathways they involve in (p ≤ 0.01; Fisher’s exact test). 
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Additionally, GO analysis on proteins significantly synthesized in 48 hpi showed 
that most proteins involved in metabolic process, response to stimulus, and 
nucleosome, chromatin, protein-DNA assembly (Figure 4.28). The group was also 
enriched in proteins involved in metabolic pathways and antigen processing and 
presentation (Figure 4.29). 
 
Figure 4.28: Pie chart illustrating the types of biological processes involves in the 84 
significantly synthesized proteins in 48 hpi.  
RIA synthesis was determined for proteins identified in uninfected and 48 hpi. Proteins with no 
quantification report were removed from all samples. t-test was performed on the remaining data to 
produce 84 statistically significant proteins with p-value < 0.05. These proteins were assigned on 
Gene Ontology based on biological processes they involve in. 
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Figure 4.29: Canonical pathway analysis on KEGG showing most altered pathways in the 51 
significantly synthesized proteins in 24 hpi THP-1.  
The highly synthesized proteins identified in uninfected and 48 hpi were analysed on DAVID with 
links to KEGG to identify the pathways they involve in (p ≤ 0.01; Fisher’s exact test). 
 
Gamma-interferon-inducible protein 16 was on top of the list with the biggest fold 
change of RIA synthesis in 24 hpi (RIA = 0.06) as compared to uninfected cells (RIA 
= 0.31). Carbonic anhydrase 2 showed high synthesis rate in 24 hpi (RIA synthesis 
= 0.05) compared to uninfected cell (RIA synthesis = 0.21). Galectin-9 showed 
RIA synthesis value of 0.18 in uninfected cell while 0.36 in 24 hpi. Another 
interesting protein showed increased turnover in infected cells was interferon-
induced GTP-binding protein Mx1 which is involved in the innate immune response 
and apoptotic processes and has been shown to have antiviral activities (Andersson 
et al. 2004). Hypoxia up-regulated protein 1 and Signal transducer and activator 
of transcription 1-alpha/beta (STAT1) also showed increased synthesis rate in 24 
hpi compared to control with 2.3 and 1.5-fold change, respectively. 14-3-3 protein 
beta/ alpha, also known as protein kinase C inhibitor protein 1, has increased 
synthesis p.i. As the name suggests, it is involve in the MAP kinase cascade by 
interacting with a variety of Akt substrates, thereby regulating diverse biological 
processes including signal transduction, cell cycle uninfected, and apoptosis (Fu 
et al. 2000; Jang et al. 2009).  
On the other hand, 84 proteins were significantly showed increased synthesis in 
48 hpi THP-1 (Table 4.3). These included histone H1.5 that had increased synthesis 
rate p.i by more than 3-fold, catalase (2.8-fold), gelsolin (1.6-fold), L-lactate 
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dehydrogenase A (2.1-fold) and Interferon-induced GTP-binding protein Mx1 (2-
fold). 
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Table 4.2: Proteins significantly synthesized in 24 hpi groups.  
Replicates from both uninfected and 24 hpi THP-1 were grouped. Light (L) and heavy (H) monoisotopic intensities were averaged. RIA synthesis was calculated using 
formula in section 2.10.4. Only proteins that have been quantified in all biological replicates were considered for this statistical test. Two-sample t-test was performed on 
the filtered data and gave rise to 51 differentially synthesized proteins (FDR value = 0.05).  
 
Protein names 
Gene 
names 
RIA (synthesis) 
Uninfected24h 
RIA 
(synthesis) 
24hpi 
RIA (synthesis) 
Uninfected48h 
RIA 
(synthesis) 
48hpi 
Peptides 
Unique 
peptides 
Mol. 
weight 
[kDa] 
Score 
Gamma-interferon-inducible protein 16 IFI16 0.06 0.31 0.35 0.37 6 6 88.255 53 
Carbonic anhydrase 2 CA2 0.05 0.21 0.11 0.17 16 16 29.246 233 
Proliferation-associated protein 2G4 PA2G4 0.05 0.17 0.20 0.22 9 9 43.786 189 
Calcium-binding protein 39 CAB39 0.13 0.32 0.38 0.35 4 4 39.869 13 
Elongation factor Tu, mitochondrial TUFM 0.12 0.29 0.16 0.16 15 15 49.541 323 
Hypoxia up-regulated protein 1 HYOU1 0.13 0.30 0.21 0.21 27 27 111.33 323 
Serine/arginine-rich splicing factor 1 SRSF1 0.13 0.30 0.30 0.41 6 6 27.744 51 
Hippocalcin-like protein 1; Neuron-specific 
calcium-binding protein hippocalcin 
HPCAL1; 
HPCA 
0.15 0.32 0.55 0.41 7 7 22.313 68 
Inorganic pyrophosphatase 2, mitochondrial PPA2 0.05 0.11 0.14 0.13 10 10 37.92 175 
Galectin-9 LGALS9 0.18 0.36 0.41 0.37 4 4 26.152 165 
Ras-related protein Rab-1b RAB1B 0.14 0.27 0.38 0.44 7 7 23.897 89 
Brain acid soluble protein 1 BASP1 0.22 0.39 0.32 0.30 15 15 22.693 190 
Interferon-induced GTP-binding protein Mx1, N-
terminally processed 
MX1 0.14 0.24 0.24 0.49 7 4 75.519 58 
116 kDa U5 small nuclear ribonucleoprotein 
component 
EFTUD2 0.28 0.26 0.40 0.31 12 12 109.43 180 
Phosphate carrier protein, mitochondrial SLC25A3 0.16 0.27 0.22 0.24 8 8 40.094 41 
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RIA 
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RIA (synthesis) 
Uninfected48h 
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Mol. 
weight 
[kDa] 
Score 
Heterogeneous nuclear ribonucleoprotein U-like 
protein 1 
HNRNPU
L1 
0.21 0.35 0.36 0.39 7 7 95.737 51 
Small nuclear ribonucleoprotein Sm D1 SNRPD1 0.03 0.04 0.14 0.15 4 4 13.281 45 
ATP-citrate synthase ACLY 0.13 0.22 0.22 0.28 16 16 120.84 251 
Glutathione S-transferase P GSTP1 0.13 0.21 0.22 0.24 7 7 23.356 114 
Histone H3.3 H3F3A 0.05 0.08 0.04 0.03 6 1 15.328 37 
40S ribosomal protein S3 RPS3 0.17 0.27 0.31 0.23 10 10 26.688 88 
Signal transducer and activator of transcription 1-
alpha/beta 
STAT1 0.25 0.38 0.43 0.53 8 8 87.334 21 
Cytosol aminopeptidase LAP3 0.18 0.27 0.33 0.35 9 9 56.166 278 
Isoleucine--tRNA ligase, mitochondrial IARS2 0.12 0.18 0.23 0.30 14 14 113.79 126 
Prostaglandin E synthase 3 PTGES3 0.16 0.23 0.24 0.21 3 3 18.697 60 
Splicing factor U2AF 65 kDa subunit U2AF2 0.23 0.33 0.34 0.56 8 8 53.5 80 
Heat shock 70 kDa protein 1B; Heat shock 70 kDa 
protein 1A 
HSPA1B; 
HSPA1A 
0.25 0.36 0.22 0.38 10 4 70.051 30 
Bifunctional glutamate/proline--tRNA ligase; 
Glutamate--tRNA ligase; Proline--tRNA ligase 
EPRS 0.13 0.18 0.35 0.22 28 28 170.59 213 
F-actin-capping protein subunit beta CAPZB 0.16 0.22 0.35 0.29 7 7 31.35 211 
Catalase CAT 0.06 0.08 0.05 0.14 14 14 59.755 182 
RNA-binding motif protein, X chromosome; RNA-
binding motif protein, N-terminally processed; 
RNA binding motif protein, X-linked-like-1 
RBMX; 
RBMXL1 
0.18 0.24 0.27 0.23 8 7 42.331 50 
14-3-3 protein beta/alpha;14-3-3 protein 
beta/alpha, N-terminally processed 
YWHAB 0.15 0.21 0.25 0.28 11 8 28.082 323 
T-complex protein 1 subunit delta CCT4 0.14 0.19 0.23 0.19 9 9 57.924 81 
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Endoplasmic reticulum metallopeptidase 1 ERMP1 0.16 0.21 0.17 0.33 7 7 100.23 23 
40S ribosomal protein S12 RPS12 0.18 0.24 0.21 0.32 6 6 14.515 189 
Prohibitin PHB 0.15 0.19 0.12 0.22 8 8 29.804 186 
60S ribosomal protein L3 RPL3 0.14 0.18 0.33 0.31 12 12 46.108 57 
Multifunctional protein ADE2; 
Phosphoribosylaminoimidazole-
succinocarboxamide 
synthase;Phosphoribosylaminoimidazole 
carboxylase 
PAICS 0.25 0.32 0.20 0.21 6 6 47.079 10 
Vesicle-fusing ATPase NSF 0.20 0.26 0.27 0.44 8 8 82.593 82 
Inorganic pyrophosphatase PPA1 0.11 0.14 0.17 0.12 9 9 32.66 43 
Adenylate kinase 2, mitochondrial;Adenylate 
kinase 2, mitochondrial, N-terminally processed 
AK2 0.07 0.09 0.14 0.09 10 10 26.477 323 
Sulfide:quinone oxidoreductase, mitochondrial SQRDL 0.30 0.38 0.46 0.36 24 24 49.96 323 
Serpin H1 SERPINH
1 
0.12 0.15 0.21 0.10 7 7 46.44 47 
Phosphoglucomutase-2 PGM2 0.11 0.14 0.10 0.22 11 11 68.283 323 
Cytochrome c oxidase subunit 6A1, 
mitochondrial 
COX6A1 0.22 0.27 0.32 0.32 1 1 12.155 79 
60S ribosomal protein L5 RPL5 0.15 0.19 0.21 0.43 8 8 34.362 68 
Transitional endoplasmic reticulum ATPase VCP 0.25 0.30 0.44 0.39 20 20 89.321 271 
Ras-related protein Rab-2A; Ras-related protein 
Rab-2B 
RAB2A; 
RAB2B 
0.25 0.31 0.43 0.41 9 9 23.545 372 
Calumenin CALU 0.16 0.20 0.43 0.40 8 8 37.106 73 
Stress-induced-phosphoprotein 1 STIP1 0.21 0.26 0.37 0.30 17 17 62.639 133 
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Extended synaptotagmin-1 ESYT1 0.17 0.20 0.11 0.24 16 16 122.85 196 
 
Table 4.3: Proteins significantly synthesized in 48 hpi groups.  
Replicates from both uninfected and 48 hpi THP-1 were grouped. Light (L) and heavy (H) monoisotopic intensities were averaged. RIA synthesis was calculated using 
formula in section 2.10.4. Only proteins that have been quantified in all biological replicates were considered for this statistical test. Two-sample t-test was performed on 
the filtered data and gave rise to 84 differentially synthesized proteins (FDR value = 0.05).  
 
Protein names 
Gene 
names 
RIA (synthesis) 
Uninfected24h 
RIA 
(synthesis) 
24hpi 
RIA (synthesis) 
Uninfected48h 
RIA 
(synthesis) 
48hpi 
Peptides 
Unique 
peptides 
Mol. 
weight 
[kDa] 
Score 
Histone H1.5 HIST1H1B 0.09 0.03 0.03 0.11 6 6 23 85 
Electron transfer flavoprotein subunit beta ETFB 0.37 0.11 0.10 0.29 6 6 28 70 
Leukotriene A-4 hydrolase LTA4H 0.13 0.12 0.21 0.61 9 9 69 55 
Catalase CAT 0.06 0.08 0.05 0.14 14 14 60 183 
Annexin A6 ANXA6 0.08 0.06 0.06 0.15 16 16 76 225 
Histone H4 HIST1H4A 0.10 0.04 0.03 0.08 12 12 11 185 
Dolichyl-diphosphooligosaccharide--protein 
glycosyltransferase subunit 1 
RPN1 0.12 0.13 0.16 0.40 25 25 69 323 
Dolichyl-diphosphooligosaccharide--protein 
glycosyltransferase 48 kDa subunit 
DDOST 0.16 0.12 0.19 0.45 10 10 51 182 
Dihydropyrimidinase-related protein 2 DPYSL2 0.25 0.20 0.19 0.45 10 10 62 174 
Extended synaptotagmin-1 ESYT1 0.17 0.20 0.11 0.24 16 16 123 196 
153 
 
Protein names 
Gene 
names 
RIA (synthesis) 
Uninfected24h 
RIA 
(synthesis) 
24hpi 
RIA (synthesis) 
Uninfected48h 
RIA 
(synthesis) 
48hpi 
Peptides 
Unique 
peptides 
Mol. 
weight 
[kDa] 
Score 
Protein S100-A4 S100A4 0.18 0.15 0.13 0.30 5 5 12 19 
L-lactate dehydrogenase A chain LDHA 0.21 0.15 0.17 0.37 24 23 37 323 
Acyl-CoA-binding protein DBI 0.16 0.12 0.13 0.27 5 5 10 17 
Phosphoglucomutase-2 PGM2 0.11 0.14 0.10 0.22 11 11 68 323 
Endoplasmic reticulum resident protein 29 ERP29 0.10 0.07 0.07 0.14 8 8 29 56 
60S ribosomal protein L5 RPL5 0.15 0.19 0.21 0.43 8 8 34 68 
Liver carboxylesterase 1 CES1 0.13 0.05 0.05 0.11 20 20 63 323 
Interferon-induced GTP-binding protein Mx1, N-
terminally processed 
MX1 0.14 0.24 0.24 0.49 7 4 76 58 
T-complex protein 1 subunit epsilon CCT5 0.17 0.14 0.24 0.49 16 16 60 193 
Ezrin EZR 0.14 0.17 0.21 0.40 17 9 69 245 
Endoplasmic reticulum metallopeptidase 1 ERMP1 0.16 0.21 0.17 0.33 7 7 100 23 
Dihydrolipoyl dehydrogenase, mitochondrial DLD 0.15 0.14 0.20 0.39 7 7 54 54 
Prohibitin PHB 0.15 0.19 0.12 0.22 8 8 30 186 
Trifunctional enzyme subunit beta, mitochondrial;3-
ketoacyl-CoA thiolase 
HADHB 0.26 0.12 0.18 0.32 8 8 51 173 
Ubiquitin-conjugating enzyme E2 L3 UBE2L3 0.39 0.19 0.27 0.46 5 5 18 53 
Heat shock 70 kDa protein 1B; Heat shock 70 kDa 
protein 1A 
HSPA1B; 
HSPA1A 
0.25 0.36 0.22 0.38 10 4 70 30 
Lysosome-associated membrane glycoprotein 2 LAMP2 0.21 0.13 0.27 0.46 3 3 45 36 
60S acidic ribosomal protein P0;60S acidic ribosomal 
protein P0-like 
RPLP0; 
RPLP0P6 
0.19 0.15 0.23 0.40 8 8 34 146 
Histone H2B type 1-L; Histone H2B type 1-M;Histone 
H2B type 1-N;Histone H2B type 1-H;Histone H2B type 
2-F;Histone H2B type 1-C/E/F/G/I 
HIST1H2BL
; 
HIST1H2B
0.06 0.03 0.03 0.06 7 2 14 168 
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M;HIST1H2
BN;HIST1H
2BH;HIST2
H2BF 
Heat shock protein 105 kDa HSPH1 0.15 0.16 0.34 0.56 12 12 97 128 
Heat shock 70 kDa protein 4 HSPA4 0.20 0.13 0.29 0.48 15 15 94 323 
Histone H2B type 2-E; Histone H2B type 1-B;Histone 
H2B type 1-O;Histone H2B type 1-J;Histone H2B type 
3-B 
HIST2H2BE
;HIST1H2B
B;HIST1H2
BO;HIST1H
2BJ;HIST3H
2BB 
0.06 0.03 0.04 0.06 7 2 14 30 
Heat shock 70 kDa protein 6; Putative heat shock 70 
kDa protein 7 
HSPA6; 
HSPA7 
0.28 0.24 0.26 0.42 8 1 71 11 
Splicing factor U2AF 65 kDa subunit U2AF2 0.23 0.33 0.34 0.56 8 8 54 80 
Vesicle-fusing ATPase NSF 0.20 0.26 0.27 0.44 8 8 83 83 
Gelsolin GSN 0.33 0.24 0.31 0.49 26 10 86 323 
Triosephosphate isomerase TPI1 0.11 0.11 0.25 0.39 13 13 31 262 
Lactoylglutathione lyase GLO1 0.17 0.08 0.15 0.24 14 14 21 244 
78 kDa glucose-regulated protein HSPA5 0.15 0.15 0.24 0.38 30 29 72 323 
Prostaglandin G/H synthase 1 PTGS1 0.24 0.21 0.19 0.29 6 6 69 76 
Macrophage-capping protein CAPG 0.20 0.10 0.14 0.22 7 7 38 258 
Glucose-6-phosphate isomerase GPI 0.18 0.15 0.21 0.32 15 11 63 302 
Beta-actin-like protein 2 ACTBL2 0.22 0.18 0.23 0.34 8 1 42 3 
Protein disulfide-isomerase A4 PDIA4 0.12 0.07 0.15 0.22 24 23 73 303 
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Carbonic anhydrase 2 CA2 0.05 0.21 0.11 0.17 16 16 29 233 
40S ribosomal protein S12 RPS12 0.18 0.24 0.21 0.32 6 6 15 190 
Peroxiredoxin-5, mitochondrial PRDX5 0.17 0.09 0.17 0.26 7 7 22 139 
Deoxynucleoside triphosphate triphosphohydrolase 
SAMHD1 
SAMHD1 0.10 0.11 0.14 0.20 21 21 72 323 
Procollagen galactosyltransferase 1 COLGALT1 0.21 0.13 0.17 0.25 10 10 72 60 
Peroxisomal multifunctional enzyme type 2;(3R)-
hydroxyacyl-CoA dehydrogenase;Enoyl-CoA hydratase 
2 
HSD17B4 0.10 0.10 0.15 0.21 17 17 80 195 
UTP--glucose-1-phosphate uridylyltransferase UGP2 0.13 0.08 0.14 0.20 3 3 57 235 
Endoplasmin HSP90B1 0.15 0.09 0.12 0.16 37 33 92 323 
Fructose-bisphosphate aldolase A ALDOA 0.20 0.16 0.26 0.37 27 22 39 323 
Trifunctional enzyme subunit alpha, 
mitochondrial;Long-chain enoyl-CoA hydratase;Long 
chain 3-hydroxyacyl-CoA dehydrogenase 
HADHA 0.17 0.11 0.19 0.27 22 22 83 323 
Peroxiredoxin-2 PRDX2 0.13 0.07 0.12 0.17 7 6 22 69 
Serine/arginine-rich splicing factor 1 SRSF1 0.13 0.30 0.30 0.41 6 6 28 51 
Puromycin-sensitive aminopeptidase NPEPPS 0.21 0.12 0.20 0.27 10 10 103 58 
Pyruvate kinase PKM PKM 0.31 0.22 0.39 0.52 33 32 58 323 
Isoleucine--tRNA ligase, mitochondrial IARS2 0.12 0.18 0.23 0.30 14 14 114 127 
Heat shock protein HSP 90-alpha HSP90AA1 0.15 0.16 0.24 0.32 38 24 85 323 
Isocitrate dehydrogenase [NADP], mitochondrial IDH2 0.15 0.07 0.16 0.21 14 14 51 169 
ATP-citrate synthase ACLY 0.13 0.22 0.22 0.28 16 16 121 251 
Alpha-enolase ENO1 0.20 0.13 0.21 0.28 27 27 47 323 
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Very-long-chain 3-oxoacyl-CoA reductase HSD17B12 0.17 0.11 0.15 0.20 7 7 34 151 
ATP-dependent RNA helicase DDX39A DDX39A 0.15 0.10 0.19 0.25 13 6 49 45 
Actin, cytoplasmic 1;Actin, cytoplasmic 1, N-terminally 
processed 
ACTB 0.25 0.17 0.24 0.30 27 2 42 323 
Histone H1.4 HIST1H1E 0.16 0.09 0.14 0.18 6 2 22 26 
Ras-related protein Rab-7a RAB7A 0.31 0.22 0.42 0.53 11 11 23 312 
Alpha-soluble NSF attachment protein NAPA 0.22 0.23 0.36 0.46 5 5 33 80 
Thymosin beta-4; Hematopoietic system regulatory 
peptide 
TMSB4X 0.38 0.18 0.33 0.41 9 7 5 140 
Programmed cell death 6-interacting protein PDCD6IP 0.42 0.22 0.42 0.53 14 14 96 72 
Peroxiredoxin-6 PRDX6 0.27 0.15 0.22 0.28 12 12 25 177 
40S ribosomal protein S20 RPS20 0.16 0.17 0.24 0.30 3 3 13 57 
Fatty acid synthase; [Acyl-carrier-protein] S-
acetyltransferase;[Acyl-carrier-protein] S-
malonyltransferase;3-oxoacyl-[acyl-carrier-protein] 
synthase;3-oxoacyl-[acyl-carrier-protein] reductase;3-
hydroxyacyl-[acyl-carrier-protein] dehydratase;Enoyl-
[acyl-carrier-protein] reductase;Oleoyl-[acyl-carrier-
protein] hydrolase 
FASN 0.21 0.15 0.22 0.27 36 36 273 323 
Phosphoglycerate kinase 1 PGK1 0.17 0.13 0.25 0.31 22 22 45 323 
Signal transducer and activator of transcription 1-
alpha/beta 
STAT1 0.25 0.38 0.43 0.53 8 8 87 21 
Endoplasmic reticulum resident protein 44 ERP44 0.18 0.15 0.24 0.30 8 8 47 65 
ERO1-like protein alpha ERO1L 0.17 0.11 0.22 0.27 9 9 54 44 
Tripeptidyl-peptidase 1 TPP1 0.29 0.21 0.31 0.37 4 4 61 31 
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L-lactate dehydrogenase B chain LDHB 0.15 0.07 0.14 0.17 11 10 37 280 
Cytochrome b-c1 complex subunit 1, mitochondrial UQCRC1 0.26 0.22 0.28 0.34 9 9 53 80 
60 kDa heat shock protein, mitochondrial HSPD1 0.10 0.07 0.10 0.12 32 32 61 323 
Protein disulfide-isomerase A6 PDIA6 0.12 0.08 0.14 0.17 19 19 48 323 
Succinate dehydrogenase [ubiquinone] flavoprotein 
subunit, mitochondrial 
SDHA 0.21 0.14 0.23 0.28 8 8 73 109 
  
Figure 4.30: Determination of protein synthesis rate of proteins identified in uninfected and 
infected THP-1.  
RIA synthesis was calculated for several proteins and plotted against time (n = 3). Values represent 
mean ± SD of three replicates. 
 
Figures 4.30 and 4.31 showed RIA synthesis for several proteins with significant 
change in synthesis rate between uninfected, 24 h and 48 h infected cells. It was 
evident from the graphs that these proteins were synthesized more in infected 
cell compared to uninfected. For example, interferon-induced GTP-binding 
protein Mx1 had an increase of synthesis after 48 hpi by 2.5-fold. Although 
carbonic anhydrase 2, elongation factor Tu and hypoxia upregulated protein 1 had 
reduced synthesis from 24 to 48 hpi, the rate of synthesis were still higher than 
the uninfected cell.  
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Figure 4.31: Determination of protein synthesis rate of proteins identified in uninfected and 
infected THP-1.  
RIA synthesis was calculated for several proteins and plotted against time (n = 3). Values represent 
mean ± SD of three replicates. 
 
Some of the proteins showed reduced synthesis following infection as compared 
to uninfected THP-1, including moesin, purine nucleoside phosphorylase, CD44, 
and gelsolin (Figure 4.32).  
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Figure 4.32: Determination of protein synthesis rate of proteins identified in uninfected and 
infected THP-1. 
RIA synthesis was calculated for several proteins and plotted against time (n = 3). Values represent 
mean ± SD of three replicates. 
 
We also investigate the synthesis rate of several metabolic enzymes involve in 
glycolysis, oxidative phosphorylation, and others. It appears that some of the 
enzymes had decreased synthesis during 24 h of infection but increased their 
synthesis rate after 48 h of infection. These include alpha-enolase, fatty acid 
synthase, fructose-bisphosphate aldolase A, isocitrate dehydrogenase, L-lactate 
dehydrogenases, glucose-6-phosphate isomerase, and phosphoglycerate kinase 1 
(Figure 4.33).  
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Figure 4.33: Determination of protein synthesis rate of metabolic proteins identified in 
uninfected and infected THP-1.  
RIA synthesis was calculated for several metabolic proteins and plotted against time (n = 3). Values 
represent mean ± SD of three replicates. 
 
Several ribosomal proteins such as 40S ribosomal protein S12, 40S ribosomal 
protein S20 and 60S ribosomal protein L5 had increased synthesis following 
infection (compared to uninfected), except 60S acidic ribosomal protein P0 which 
had decreased synthesis after 24 h of infection then increased its synthesis after 
48 h of infection (Figure 4.34). Furthermore, we looked at several proteins involve 
in stress response and found that proteins including peroxiredoxin-2, 
peroxiredoxin-5 and peroxiredoxin-6 had decreased synthesis rate after 24 h of 
infection but later increased their synthesis after 48 h of infection (Figure 4.35).  
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Figure 4.34: Determination of protein synthesis rate of ribosomal proteins identified in 
uninfected and infected THP-1.  
RIA synthesis was calculated for several ribosomal proteins and plotted against time (n = 3). Values 
represent mean ± SD of three replicates. 
 
 
Figure 4.35: Determination of protein synthesis rate of stress response proteins identified in 
uninfected and infected THP-1.  
RIA synthesis was calculated for several proteins involve in stress response and plotted against time 
(n = 3). Values represent mean ± SD of three replicates. 
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Gelsolin was one of the proteins that showed significant decreased of synthesis in 
infected cells. Gelsolin is well recognised for its involvement in the actin 
cytoskeleton dynamics by interacting with actin filaments and membrane during 
a variety of forms of cell motility (Kwiatkowski 1999). As expected, when we 
mapped the proteins found in our data onto KEGG pathways, gelsolin was found 
in two important pathways: regulation of actin cytoskeleton and FcᵧR-mediated 
phagocytosis (Figure 4.36 and 4.37). Gelsolin works with other proteins in the 
protein network to regulate actin cytoskeleton and phagocytosis. In one of the 
pathways, gelsolin also interacts with actin that was similarly significantly 
decreased p.i.  
 
Figure 4.36: Regulation of actin cytoskeleton KEGG pathway. 
All proteins identified in this study were analysed on DAVID. The pathways linked to KEGG were 
chosen and gelsolin was found in actin cytoskeleton pathway (blue circle). The red stars represent 
the proteins found in our data. 
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Figure 4.37: FcᵧR-mediated phagocytosis KEGG pathway. 
All proteins identified in this study were analysed on DAVID. The pathways linked to KEGG were 
chosen and gelsolin was found in FcᵧR-mediated phagocytosis (blue circle). The red stars represent 
the proteins found in our data. 
 
Table 4.4: Summary of identified and quantified proteins in uninfected, 24 hpi and 48 hpi THP-
1.  
Following 2-D LCMS/MS, raw data were analysed on MaxQuant and Perseus. 
 Proteins 
identified 
Proteins 
quantified 
Proteins with 
significant 
increased 
synthesis 24 
hpi 
Proteins with 
significant 
increased 
synthesis 48 
hpi 
Uninfected THP-1*  1472 652   
24 hpi THP-1*  1653 739   
Uninfected 48h THP-1* 1929    
48 hpi THP-1* 1183    
Uninfected, 24 hpi & 48 hpi 
THP-1# 
2280 761 51 84 
*Analysed separately on MaxQuant. 
# Combined on MaxQuant. 
 
In addition, KEGG analysis reveals that we found quite a lot of proteins in essential 
subunits of complex I, III, IV and V of oxidative phosphorylation pathway 
(represented by red star in Figure 4.38). Amongst them are NADH dehydrogenase, 
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succinate dehydrogenase, cytochrome c oxidase, cytochrome c reductase and 
ATPase. However, some of these proteins were not quantified (have missing 
values). 
 
Figure 4.38: Oxidative phosphorylation KEGG pathway. 
In the upper part are shown the five respiratory chain complexes with the corresponding E.C. 
numbers. In the bottom part are the subunits of each respiratory chain complex. All proteins identified 
in this study were mapped onto KEGG pathway. Several proteins were found in this pathway are 
represented by the red star. 
 
To better understand how biological pathways were modulated in infected cells, 
we performed protein-protein interaction (PPI) network analysis on these proteins 
using the STRING database and visualizing results with Cytoscape. Highly 
modulated proteins showed very complex interactions among each other, although 
there are several proteins with no interaction within the network such as CD109, 
though it may interact with other proteins not in this list (figure not shown). They 
also demonstrate a more centralized and tightly connected interaction with each 
other. A subset of 84 statistical significant proteins (from 48 hpi data) showed high 
protein-protein interaction (Figure 4.39). For example, proteins involve in 
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cytoskeleton such as β-tubulin (TUBB4B), actin (ACTB), gelsolin (GSN) and meosin 
(MSN) appeared to be interacting with each other. Recent data from Mazur et al. 
(2016) showed gelsolin interacts with several components of the cytoskeleton 
including actin and β-tubulin. 
 
Figure 4.39: Protein network of 84 significant proteins (p=0.05). 
A total of 84 proteins were statistically significant upon t-test analysis. These proteins were analysed 
on the STRING database to determine the protein-protein interactions between them. Proteins in red 
circles represented those involve in metabolic processes. 
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Of those 84 statistically significant proteins, 40 are implicated in metabolic 
processes. These include glyceraldehyde-3-phosphate dehydrogenase (GAPDH), 
peroxiredoxin 2 (PRDX2) and beta-2-microglobulin (BM2). GADPH is also involved 
in the immune response, together with MHC class I, C (HLA-C), cathepsin B (CTSB), 
CD44 and CD109. GADPH seems to have interactions with several other proteins 
such as CCT7 and superoxide dismutase 2 (SOD2). This observation suggests that 
in many metabolic enzymes interact with each other to produce small compounds 
or other macromolecules.  
4.3.4 Validation of proteomic data 
Proteomic data was validated by immunoblotting (Western blot) technique 
performed according to section 2.11.1. Following two sample t-test analysis, 
proteins that were shown to be differentially synthesized significantly at p-value 
of 0.05 including galectin-9 and gelsolin were chosen to be validated by Western 
blot to represent proteins with significant changes in infected cells. Gelsolin 
showed an intense band at the expected molecular weight of 86 kDa while 
galectin-9 showed two bands at the molecular weight of 38 and ~36 kDa (Figure 
4.40). The presence of two bands on galectin-9 was probably due to alternate 
splicing variants that has been reported in Spitzenberger et al. (2001). Anti-alpha 
tubulin (52 kDa) was used as loading control.  
 
Figure 4.40: Immunoblot profile of gelsolin and galectin-9. 
Protein lysates from uninfected and infected samples were separated on polyacrylamide gel and 
blotted onto membrane and analysed using specific antibodies against gelsolin and galectin-9. The 
position of molecular mass standards is indicated at the left. 
168 
 
4.4 Discussions 
In this work, a comprehensive SILAC-based proteome analysis of the response of 
THP-1 cell to infection with L. mexicana is presented. The effect of parasite 
infection on the cellular proteome was investigated to gain insights into regulatory 
modulations associated with a productive infection cycle. Inarguably, analysing 
the data generated using multiple bioinformatics tools could unravel numerous 
important players in the complex molecular interplay of host and parasite.  
Central to the host-Leishmania relationship is the macrophage. Some of the major 
functions of macrophages include maintaining tissue homeostasis, recognising and 
destroying pathogens through phagocytosis, alerting the immune system to foreign 
invasion through various signalling pathways, as well as apoptotic roles (Teo & 
Hughes 2003). Macrophages mediate innate immune responses and contribute to 
adaptive immunity to the host. There are three distinct populations of 
macrophages recognised to date: classical activated macrophages (M1), 
alternatively activated macrophages (M2) and type-2 activated macrophages. 
When macrophages are exposed to IFN-γ and TNF, along with exposure to 
microbial product such as LPS, T-cell induces Th1 responses that will induce IL-12 
and upregulate MHC class II. This in turn upregulate the production of NO via 
inducible nitric oxide synthase (iNOS) gene. Together with toxic oxygen species, 
these will kill intracellular pathogen (Mosser 2003). These describe the 
characteristic of M1 macrophages. In M2 macrophages, exposure to IL-4 induced 
Th2 responses that will upregulate IL-10 and arginase production instead of NO. 
Arginase lead to polyamine biosynthesis that promotes cell growth and tissue 
repair (Hesse et al. 2001; Mosser 2003). Type-2 activated macrophages occur when 
they expose to FCγRs that will unexpectedly turned off IL-12 synthesis and induce 
IL-10. However, ligation of FCγR requires a macrophage stimulatory signal through 
any TLRs such as CD44 (Sutterwala et al. 1997; Sutterwala et al. 1998; Mosser 
2003). Many pathogens such as Leishmania and Mycobacterium spp have been 
reported to evade host and have the ability to interfere with host signalling 
pathways to prevent macrophage activation in order to favour their survival 
(Nandan et al. 2000). Therefore, the macrophage response to infection will 
determine the susceptibility or resistance of Leishmania in host. 
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While there are numerous sources of macrophages from animals and from 
immortalized cell lines available for in vitro studies, we chose the monocytic THP-
1 cell line as it provides a homogeneous population of macrophages, in comparison 
to those isolated from animals or humans, e.g. primary human peripheral blood 
monocyte (PBMC) derived macrophages (Auwerx 1991; Tsuchiya et al. 1982; Mehta 
et al. 2011). Numerous earlier studies on THP-1 cells have indicated that the cells 
resemble primary monocytes and macrophages in terms of macrophage 
differentiation, regulation of macrophage-specific genes as well as morphological 
and functional properties of macrophages (Kramer & Wray 2002; Tsuchiya et al. 
1982; Chanput et al. 2014; Daigneault et al. 2010). Furthermore, THP-1 has been 
shown to respond well to infection by several intracellular pathogens including 
some Leishmania species such as L. donovani, L. infantum and L. braziliensis 
(Ogunkolade et al. 1990; Kang et al. 2006; Jain et al. 2012; Oveland et al. 2009; 
Millar et al. 2015). Inarguably, it is easier to perform SILAC approach on cell-lines 
as they can grow indefinitely in in vitro culture.  
Quantitative proteomics techniques have been extensively used to define changes 
between control and experimental groups. Despite the labelling techniques 
straightforwardly available, interpretation of datasets derived from these 
experiments is challenging. Nevertheless, in this study, we established a pulse-
chase SILAC approach (pcSILAC), in an attempt to shed some light on the dynamics 
of protein expression in macrophages infected with Leishmania. This chapter 
focuses on the establishment of pcSILAC in THP-1, comparing uninfected with 24 
hour- and 48 hour-infected cells, as well as determination of synthesis rate, before 
expanding the set up for protein degradation rate in order to define turnover 
(chapter 5).  
pcSILAC has the power to measure changes in protein production between   
conditions integrated over time after the pulse. At the beginning of chase starting 
point, all proteins are universally labelled, in this case with heavy Lys and Arg. 
During the chase period, exogenous amino acids are exclusively light labelled, so 
that newly synthesized proteins will contain light Lys and Arg, while proteins that 
persist from the pulse period will be heavy labelled. The rate at which heavy 
labelled proteins are replaced by light labelled equivalents is a reflection of the 
proteins turnover rate under the conditions employed. This rate can be measured 
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by MS analysis of tryptic peptides, in a workflow that infers the relative abundance 
of light and heavy labelled peptides. 
As it is crucial that the growth rate of THP-1 in heavy and light-labelled SILAC 
media be as similar as possible to minimise dilution rate, we adapted THP-1 in 
SILAC media with dFCS and assessed the growth profiles over time. Moreover, we 
used pcSILAC approach to specifically investigate the proteome dynamics when 
host’s cells were infected with L. mexicana. Since we did not use another heavy 
isotope (heavy, medium and light isotope) in SILAC media, the infected samples 
are compared with mock-uninfected.  
Employing high-resolution 2-D LC/MS coupled with pcSILAC technique, we have 
successfully identified 2016 proteins in uninfected THP-1 (control) and L. 
mexicana-infected THP-1. Our study was conducted at 24 hpi to assess cellular 
proteomics modulations associated with the establishment of infection. All 
biological replicates gave Pearson coefficient values of greater than 0.5, meaning 
that they are highly reproducible. Consistently, heat map and profile plot reflect 
this reproducibility.  
Here, we report protein expression changes in several GO annotation terms and 
cellular pathways. Overall, the majority of the proteins in our dataset were 
primarily associated with metabolic process, transport, apoptosis and cell death, 
protein regulation, biosynthetic process, catabolic process and protein 
localisation. Global pathways modulated are metabolic pathway, constituent of 
ribosome, spliceosome, lysosome, regulation of actin cytoskeleton, leukocyte 
transendothelial migration, proteasome, Fcγ-R-mediated phagocytosis, TCA 
cycle, antigen processing and presentation, glycolysis/ gluconeogenesis and 
several signalling pathways. 
Of those 2016 proteins, 761 were quantified in at least one replicate. Stringent 
filtering of the dataset to have at least values in all replicates with minimum 
quantification ratio at 2 yielded only 521 quantified proteins. This is a common 
issue in SILAC studies as one of the labelled pairs might not be detected by MS. Of 
those, 400 were considered for determination of protein synthesis rates that were 
selected based on stringent criteria as described earlier. These include PKM, L-
lactate dehydrogenase, moesin, several glycolytic enzymes such as glucose-6-
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phosphate isomerase and alpha enolase, gelsolin, galectin-9, catalase and lamin-
B. Remarkably, several proteins involved in immune response such as HLA 
complexes, interleukins, CD44 antigen and Toll-like receptor were observed to 
have higher synthesis rates. This observation was to be expected as macrophages 
increased the expression of proteins involved in immune response when they sense 
intruders (Giudice et al. 2012).  
Interestingly, there was a striking contrast in GO functional annotation terms 
between the proteins with increased synthesis in 24 and 48 hpi. While both 24 and 
48 hpi harbours more metabolic enzymes, proteins with increased synthesis in 24 
hpi were most highly associated to apoptosis and translation while proteins with 
increased synthesis in 48 hpi were mostly involved in response to stimulus and 
nucleosome, chromatin and protein-DNA assembly. This observation clearly 
showed that during early infection, macrophages upregulate expression of 
proteins involved in cellular processes that are fundamental to cells, involving 
complex cascades of biochemical reactions and signalling pathways. These include 
communication between a cell and the environment, cell recognition in which a 
cell interprets its surrounding, cell cycle, cell growth, cell proliferation to 
increase population size, DNA repair, protein targeting and apoptosis or 
programmed cell death. This is not surprising as the host presumably increases 
these proteins when they sense intruders at the early stage of infection. Following 
infection, Leishmania induce IL-8, a known chemotactic factor, from the host 
neutrophils to upsurge neutrophil recruitment to the site of infection (Van 
Zandbergen et al. 2002). IL-8 induces phagocytosis and a series of signalling 
pathway that causes oxidative burst that is lethal to the pathogen (Dixit & Simon 
2012). Our dataset included several other interleukins such as IL-1β, IL-10 and 
interleukin-enhancer-binding factor (ILF). IL-1β, also known as leukocytic 
endogenous mediator, produced by macrophages as a mediator of the 
inflammatory responses. It is also involved in various cellular activities namely cell 
proliferation, differentiation and apoptosis (Dinarello 2009; Dinarello 2011). Th2 
activation stimulates the production of IL-10 that downregulates the expression 
of Th1 cytokines such as IL-12 while inhibiting NF-κB activity (Aste-Amezaga et al. 
1998). Notably, IL-10 has been shown to be produced by an M2 type (Mosser 2003). 
However, the function of IL-10 in tumour cells remains controversial as it has both 
tumour-suppressive and oncogenic roles (Fujii et al. 2001). 
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In addition, several anti- and pro-apoptosis proteins were found in this study 
including TNF-α-induced protein, cofilin, Bcl-2-associated transcription factor, 
programmed cell death protein, apoptosis-inducing factor-1, mitochondria, 
apoptosis regulator BAX and caspase 3. There are increased apoptosis activities in 
neutrophils and macrophages where the host eliminate infected cells. Various 
intracellular pathogens modulate apoptosis that favours their survival (Koziel et 
al. 2009). Of note, certain pathogens such as Staphylococcus aureus and 
Chlamydia spp appeared to repress apoptosis to allow them to replicate while 
silently persist in the host (Fischer & Häcker 2003). Apoptosis, a form of 
programmed cell death, is implemented by a series of signal transduction 
pathways and is employed as part of host defence mechanism against 
environmental stimuli which threatens the organism’s integrity. Central in this 
pathway are Bcl-2 family members and caspase family. Bcl-2 is an intracellular 
protein that interfere with apoptosis and prolong survival of the cell (Hockenbery 
et al. 1990). Karsan et al. (1996) found that Bcl-2 is specifically induced by 
proinflammatory cytokines. Increase in Bcl-2 was orchestrated through TLR2-MEK-
ERK signalling, and changes in TLR-2 levels affected parasite uptake (Pandey et 
al. 2016). Recent work by Pandey et al. (2016) demonstrated that L. donovani 
infection increased Bcl-2 expression in macrophage and more importantly, the 
inhibition of Bcl-2 accelerated the clearance of parasite, suggesting potential anti-
leishmanial agents. In contrast to Bcl-2, apoptosis regulator BAX accelerates 
apoptosis (Noble et al. 1999). TNF-α is a cytokine that have a myriad of functions 
in the inflammatory responses. Stimulation of TNF in monocytes causes induction 
of IL-10 which reduce the overexpression of Bcl-2 homolog (Noble et al. 1999). 
The release of cytochrome c from mitochondria also stimulates apoptosis via the 
activation of caspase-9 which in turn activate caspase-3 (Rolland & Conradt 2006). 
Enhanced expression of caspase-9 and caspase-3 in CL patients suggested 
mechanisms associated with the progression of tissue damage observed in lesions 
(Santos et al. 2015). Bcl-2 family members exert anti-apoptotic activity by 
preventing the release of cytochrome c from mitochondria while Bak1 stimulates 
cell death (Cory & Adams 2002). Furthermore, overexpression of this anti-
apoptotic proteins has been experimentally verified to abrogate the function of 
pro-apoptotic proteins, thereby eliciting a protective outcome on host cells 
(Koziel et al. 2009; Hockenbery et al. 1990). 
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Even though apoptosis is indispensable for host’s defence against intracellular 
pathogens, several pathogens are known to modulate apoptotic machinery in 
order for them to replicate inside macrophages (Bruchhaus et al. 2007). Studies 
on several Leishmania species suggested that they manage to prevent host cell 
from undergoing apoptosis. This allow parasites to invade the host silently without 
triggering immune response from host (Getti et al. 2008). Apoptosis cells have 
been reported to recruit macrophages to the site of infection (Lauber et al. 2003) 
and this was taken advantage by Leishmania to recruit uninfected macrophages, 
allowing them to spread and establish infection (Getti et al. 2008). A study by 
Getti et al. (2008) confirmed that the induction of apoptosis after infection 
increased the number of infected macrophages thereby intensify infection. 
Likewise, it has been shown that phagocytosis of apoptotic neutrophils by L. 
major-infected BALB/c mice leads to an increase in parasite burden (Ribeiro-
Gomes et al. 2004). 
Other protein with increased synthesis p.i. in our dataset involving in cellular 
process specifically cell-cell communication is STAT1. STAT1 is a latent 
cytoplasmic TFs that mediate various biological responses, including cell 
proliferation, survival, apoptosis, and differentiation (Kim & Lee 2007). Activation 
of STAT1 by different cytokines resulted in modulation of broad spectrum of cell 
death, comprising both apoptotic and non-apoptotic pathways (Kim & Lee 2007). 
This activation is dependent upon phosphorylation of conserved tyrosine and 
serine residues in their C-terminal transactivation domain through JAK/STAT 
pathway and mitogen-activated protein kinases (MAPKs) (Rawlings et al. 2004). 
Interestingly, STAT1 may play an important role in the regulation of the cell death 
response through caspase-mediated cleavages (Kim & Lee 2007). Moreover, 
dephosphorylation of STAT1 abrogates IL-12 expression (de Morais et al. 2015). 
Particularly, STAT1 was upregulated/has increased turnover following infection 
by up to 10-fold. Taken together, proteins involve in cellular processes including 
apoptosis, cell communication and cell recognition were highly produced by THP-
1 after infection with L. mexicana. Similar findings were also reported by Singh et 
al. (2015) where proteins involved in cell survival and signal transduction were 
more abundant in response to L. donovani infection. 
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In contrast, most of the proteins with reduced synthesis during early infection (24 
h) were mostly involves in metabolic process. Subversion of host cell metabolism 
by intracellular pathogens has been proposed to play a key role in microbial 
growth and persistence by accessing essential nutrients (McConville & Naderer 
2011; McConville et al. 2007; Liévin-Le Moal & Loiseau 2016). 
Glycolysis, a major route of carbohydrate breakdown in eukaryotes, metabolizes 
glucose to pyruvate which enters the mitochondria where it is converted to acetyl-
coA. Acetyl-coA also used in fatty acid biosynthesis and cholesterol synthesis. 
Glucose 6-phosphate isomerase (GPI), GAPDH, triosephosphate isomerase (TPI or 
TIM) (EC 5.3.1.1), isocitrate dehydrogenase (IDH) and pyruvate kinase (PKM) are 
some of the isoenzymes essential to glycolysis. In glycolysis and gluconeogenesis, 
GPI (E.C. 5.3.1.9) interconverts glucose-6-phosphate (G6P) and fructose-6-
phosphate (F6P). However, this protein has different roles as well, including 
neuroleukin, autocrine motility factor, maturation factor and major surface 
antigen in sperm agglutination (Read et al. 2001; Yakirevich & Naot 2000). G6PDH 
(EC 1.1.1.49) is a housekeeping enzyme that catalyzes the chemical reaction 
between G6P and 6-phospho-D-glucono-1,5-lactone in pentose phosphate pathway 
(PPP). This pathway supplies reducing energy to cells by maintaining the level of 
the NADPH which provides pentoses for nucleic acid synthesis. NADPH not only 
important in protecting cells from oxidative damage, it is also essential for tissues 
actively engaged in biosynthesis of fatty acids such as liver (Kotaka et al. 2005; 
Liaud et al. 2000). Rabhi et al. (2012) reported that GPI and GADPH transcripts 
were upregulated in mice macrophage infected with L. major at 12 hpi but were 
downregulated at 24 hpi. PKM enzyme catalyzes the final step of glycolysis, in 
which pyruvate and ATP are formed. Pyruvate then enters TCA cycle to produce 
more ATP. Exposure of A549 human lung cancer cells to sources of ROS resulted 
in decreased in PKM activity (Anastasiou et al. 2012). Consequently, glucose flux 
is no longer converted into pyruvate, but is instead utilized in the PPP, resulting 
in the detoxification of ROS. They concluded that the regulatory mechanisms in 
PKM may be responsible for aiding cancer cell resistance to oxidative stress and 
enhanced tumorigenesis (Anastasiou et al. 2012). The reduced synthesis of PKM in 
THP-1 infected with L. mexicana may be due to the increased production of ROS 
by macrophages to kill the parasites. Our data showed that several of glycolysis 
and TCA cycle proteins had decreased synthesis rate in 24 hpi. This notion is in 
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agreement with several reported data such as Kelly & O’Neill (2015) and Singh et 
al. (2015). 
Mitochondria are vital eukaryotic cell organelles involved in several metabolic 
pathways, calcium and iron homeostasis, ROS production and programmed cell 
death (Newmeyer & Ferguson-Miller 2003). Oxidative phosphorylation takes place 
inside mitochondria in most eukaryotes. Although both glycolysis and oxidative 
phosphorylation produce ATP, the latter is much more efficient in releasing more 
energy (Rich 2003). While oxidative phosphorylation is a vital part of metabolism, 
it also produces ROS that causes oxidative damage to the cells (Figure 4.41). We 
found several important respiratory enzymes in our dataset including NADH 
dehydrogenase, succinate dehydrogenase, cytochrome c oxidase, cytochrome c 
reductase and ATP synthase. Of these, only one of the ATP synthases showed 
increased synthesis in infected cells while the rest were not quantified in this 
work.  
 
Figure 4.41: Representative scheme of metabolic processes in mitochondria. 
Lipid, carbohydrates and amino acids metabolisms takes place in the cyrosol while TCA cycle and 
oxidative phosphorylation occurs in mitochondria.  
176 
 
To detect differentially expressed proteins between groups, two-sample t-test of 
uninfected and infected groups were applied. Among the 394 quantified proteins, 
135 proteins achieved nominal significance at a 5% level.  Of these, 51 proteins 
showed increased synthesis in 24 hpi. They were galectin-9, interferon-induced 
GTP-binding protein Mx1, 14-3-3 protein beta/alpha, ras-related protein Rab-1B 
and many more. On the other hand, 84 proteins have increased synthesis in 48 hpi 
including STAT-1, ras-related protein Rab-1B, catalase, gelsolin and moesin.  
Pattern recognition receptors (PRRs) on the surfaces of these macrophages can 
recognize pathogen-associated molecular patterns (PAMPs) present in the invaders 
to activate intracellular signalling cascades for pro-inflammatory response (Kelly 
& O’Neill 2015a). Galectin-9 can bind to L. major in a species-specific manner 
through L. major-specific poly-β-galactose and promote macrophage interaction 
(Pelletier et al. 2003). Galectins are a family of mammalian lectins and are 
released under stress condition such as infection. It has been overexpressed in 
many types of immune cells, such as Th cells, cytotoxic T lymphocytes, DCs, 
macrophages and NK cells (Vasta 2009). Galectin-9 has been reported to be 
induced in HIV infection, hepatitis B infection as well as in M. tuberculosis-
infected macrophage to inhibit pathogen growth (Liu et al. 2016; T et al. 2016).  
Apart from that, few of proteins involved in amino acid pathway, nucleotides 
pathway and cell redox pathway showed significant decreased synthesis p.i. These 
include PNP, calreticulin and CD44. PNP is an enzyme involved in purine 
metabolism where it metabolizes inosine into hypoxanthine and guanosine into 
guanine, in each case creating ribose phosphate (Freitas et al. 2015). 
Interestingly, Leishmania are purine auxotroph that obtain their purines from 
exogenous sources through purine salvage pathways (Freitas et al. 2015). Millar et 
al. (2015) reported that several genes involving in purine biosynthesis or salvage 
pathways were significantly overexpressed in L. mexicana infected THP-1 cells. 
The decreased production of PNP p.i. in our data might be a way for the host to 
prevent Leishmania from using purine for their purine metabolism.  
The oxidative stress response pathway elicited in response to infection primarily 
involved proteins with antioxidant properties. The core response proteins 
associated with these annotation terms include SOD, thioredoxin, peroxiredoxin 
and cathepsin.  SOD, which is crucial in the breakdown of ROS (Bresciani et al. 
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2015), had decreased in production by 1.3-fold in infected cells. We hypothesized 
that Leishmania modulated the expression of SOD to protect them from 
microbicidal ROS produced in macrophages. This is in accordance with the 
decreased activity of PKM when high level of ROS were present (Anastasiou et al. 
2012).  
14-3-3 proteins are a family of conserved regulatory molecules ubiquitously 
expressed in eukaryotic cells (Fu et al. 2000). They have a distinct feature which 
is the ability to bind to a multitude of signalling proteins, from kinases, 
phosphatases to transmembrane receptors. They have multifunctional properties 
such as modulating various cellular proteins, modulating signal transduction 
activities and regulating biochemical processes (Obsil & Obsilova 2011a). The 
general accepted classification of 14-3-3 is based on the following modes of 
action: (i) direct conformational change of the target protein; (ii) physical 
occlusion of sequence-specific or structural features; and (iii) scaffolding that 
anchors proteins within close proximity of one another (Figure 4.42) (Jang et al. 
2009; Tzivion & Avruch 2002; Aitken et al. 2002; Obsil & Obsilova 2011b). 14-3-3 
protein also involves in cell cycle control, survival signalling, cell adhesion and 
several microorganism pathogenesis (Fu et al. 2000). Given the plethora of 
functions and broad participation of 14-3-3 in diverse processes, it is no surprise 
that this protein has increased synthesis during infection. 14-3-3 has been found 
to interact with a pro-apoptotic member of the Bcl-2 family, Bad, by antagonizing 
its function to promote cell death (Zha et al. 1996). 14-3-3s are present in the 
central nervous system (CSF) of patients with HIV and could be a potential 
biomarkers for HIV-related neurodegeneration (Morales et al. 2012). Monroy 
(2012) speculated that infection of intestinal epithelial cells may result in T. 
gondii-induced regulation of 14-3-3 proteins expression leading to increased cell 
survival and proliferation, and suppression of apoptosis of parasitized cells.  
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Figure 4.42: Modes of 14-3-3 protein action. 
The 14-3-3 protein binding can: (i) induce a conformational change of the target protein; (ii) mask a 
specific region in the target protein; or (iii) facilitate the interaction between two other proteins. 
(adapted from Jain et al. 2012; Obsil & Obsilova 2011). 
 
Gelsolin is an actin-binding protein that is a key regulator of actin filament 
assembly and disassembly (capping protein) that plays a role in podosome (actin-
rich structures found on the outer surface of the plasma membrane of animal 
cells) formation (Koya et al. 2000; Kwiatkowski 1999). Not only It involves in 
cytoskeletal remodelling, gelsolin also involves in phagocytosis and ion channel 
regulation (Nag et al. 2009; Koya et al. 2000). Interestingly, gelsolin has both anti- 
and pro-apoptotic functions depending on the cell types, tissues and pathological 
conditions involved (Koya et al. 2000). Guerfali et al. (2008) has reported that 
mRNA expression level of gelsolin was downregulated in macrophage infected with 
L. major. Increased in gelsolin may contributes to fight Group B Streptococcus 
(GBS) induction in macrophages (Fettucciari et al. 2015). We postulated that the 
decreased of gelsolin in L. mexicana 24 h-infection might be a way of modulation 
by this parasite to survive during early infection.  
Another significant protein that we found had decreased synthesis in 24 hpi is 
moesin (membrane-organizing extension spike protein) which belongs to ezrin-
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radixin-moesin (ERM) family of cytoskeletal proteins that is essential for actin 
assembly by phagosomes  (Defacque et al. 2000; Hirata et al. 2012). ERM proteins 
are key elements linking actin filaments with plasma membrane. They are 
important for maintenance of cell morphology, cell migration, tissue structure and 
invasion of intracellular pathogens (Defacque et al. 2000). More importantly, 
moesin have been implicated in signalling pathways which incorporate 
extracellular signals into intracellular mechanisms (Zawawi et al. 2010). Previous 
publications suggested a role for moesin in LPS-induced immune responses 
(Iontcheva et al. 2004; Zawawi et al. 2010) in which moesin is expressed on the 
surface of monocytes/macrophages and surface expression is increased after LPS 
stimulation. As LPS is associated with M1 macrophages, this means that moesin is 
downregulated in M2 type of macrophages, possibly subverted by pathogens to 
their advantage. To date, there was no report on infection with Leishmania.  
One of the challenges we faced in data analysis is the occurrence of missing values 
in the data (no L/H ratio values in either uninfected or 24 hpi or both). This 
genuine phenomenon is rather frequent in global discovery proteomic studies. 
There are several approaches reported in dealing with missing values when 
applying statistical data for better interpretation of proteomic datasets (Donders 
et al. 2006; Zhang et al. 2011; Karpievitch et al. 2012; Wiberg et al. 2016). Some 
of the options are (i) ignoring the missing value proteins, (ii) impute missing values 
with a constant (i.e. zero), (iii) impute missing values from normal distribution, 
(iv) replace missing values based on transcript data or GO terms (Lazar et al. 2016; 
Zhang et al. 2011). Perseus offers several imputation techniques including a 
method that draws random values from a distribution meant to simulate 
expression below the detection limit. The width and the down shift of the 
distribution can be set to closely represent the missing population (Tyanova et al. 
2016). Using Perseus, we imputed the missing values from Gaussian normal 
distribution using default parameters (width relative to the sd of measured values 
= 0.3, the amount by which the distribution used for the random numbers is shifted 
downwards = 1.8). However, we only performed imputation on proteins with 
missing values in all replicates (other than the 521 proteins).  
Of interest, we discovered that proteins involved in oxidative phosphorylation in 
which we were previously not able to quantify namely NADH dehydrogenases (e.g. 
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NDUFB6, NDUFB8), succinate dehydrogenase, cytochrome c oxidase, acyl carrier 
protein, fumarate hydratase and several subunits of ATP synthases were all have 
increased synthesis within 24 h of infection. This suggests that following infection, 
glycolysis and TCA cycle were reduced while oxidative phosphorylation increased. 
Activation of macrophage by LPS were reported to have increased glycolysis, high 
ROS production by the electron transport chain and reduced oxidative 
phosphorylation (Kelly & O’Neill 2015b). In this cascade, LPS induced iNOS to 
produce more NO (Figure 4.43). This causes nitrosylation of electron transport 
chain complexes which resulted in reduced oxidative phosphorylation (Kelly & 
O’Neill 2015b). Arginine is the substrate for iNOS. Recycling of arginine is achieved 
via argininosuccinate synthase which is important for controlling mycobacterial 
infection (Qualls et al. 2013). Some pathogens have mechanisms to deplete 
arginine. Helicobacter pylori and Leishmania express arginase that inhibit NO 
production by activated macrophage (Gobert et al. 2001; Kropf et al. 2005). The 
imputed data revealed that argininosuccinate synthase was decreased upon early 
infection with L. mexicana. Moreover, TNF-α-induced protein 8 that inhibit iNOS 
was increased p.i. Cumulatively, the downregulation of argininosuccinate 
synthase and the upregulation of TNFα-induced protein 8 may be modulated by L. 
mexicana to establish infection. This is accompanied by the decreased of glycolysis 
and increased of oxidative phosphorylation. Similarly, L. infantum-infected 
macrophage demonstrated to induced a switch towards mitochondrial oxidation 
phosphorylation favouring its own growth (Moreira et al. 2015). 
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Figure 4.43: Cascade involving in oxidative phosphorylation affected by LPS. 
LPS induced iNOS (inducible nitric oxide synthase) to produce more nitric oxide (NO). This causes 
nitrosylation of electron transport chain complexes which resulted in reduced oxidative 
phosphorylation. iNOS can be abrogated by TNFAIP8 which impairs NO production, thereby 
increasing oxidative phosphorylation. 
 
Another intriguing finding derived from the imputed data was that proteins 
involved in lipid or fatty acids metabolism such as long chain fatty acid CoA ligase, 
3-hydroxyacyl-CoA dehydrogenase, 3-oxoacyl-CoA reductase, acetyl-CoA acetyl 
transferase and prostaglandin E synthase had increased synthesis in 24 hpi THP-1.  
It is known that M2 macrophages are fuelled by fatty acid β-oxidation in the 
mitochondria (Kelly & O’Neill 2015b). Macrophages secrete lipoprotein lipase 
(LPL), the key enzyme responsible for extracellular release of fatty acids from 
triglyceride-rich lipoproteins (Zhu et al. 2015; Dinasarapu et al. 2013). IL-4-
activated mouse M2 macrophages showed a significant upregulation of fatty acids 
uptake and fatty acid oxidation (Odegaard & Chawla 2012).  
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4.5 Conclusion 
In general, global proteomics is challenging due to the complexity and dynamic 
range of the proteome. In practise, we are trying to identify and characterise as 
many of the proteins as we can. In order to detect more proteins, global coverage 
need to be increased, for instance, using better MS instruments and applying 
different data acquisition as well as improve data analysis using different 
bioinformatics tool. Of note, these will increase cost substantially. Given with 
what we have, results generated in the present work enabled us to use it to infer 
the biological response of human macrophage when interacting with parasite. 
Notably, we were able to employ pcSILAC in THP-1 infected with L. mexicana.   
The mechanisms employed by Leishmania to survive in host are highly complex. 
They rely on both pathogen effector molecules and distinct functional activities 
in host cells. The nature of the changes in metabolic pathways suggested changes 
in the cellular requirement for energy metabolism, nucleic acid synthesis and anti-
oxidants when facing threat from pathogens. Although there is considerable 
amount of data available on the mechanisms deployed by Leishmania to survive 
in the host, to our knowledge, this study is the first study employing proteomics 
with SILAC labelling on L. mexicana-infected macrophage.  
Collectively, we observed that THP-1 have general suppression of gene expression 
during L. mexicana infection. Of particular interest, infection switches the host 
metabolism from glycolysis to oxidative phosphorylation and fatty acid oxidation, 
contrary to the Warburg effect (Warburg et al. 1926; Kelly & O’Neill 2015). Most 
of the proteins significantly modulated in the present study have been associated 
with M2 macrophages. Although, there are some conflicting results from what 
have been reported in literatures as it has been noted that different species of 
Leishmania react differently in the human host (Singh et al. 2015; DaMata et al. 
2015; Menezes et al. 2013). Nevertheless, these observations contribute a 
foundation for future studies to define the mechanisms involved in host-parasite 
interaction.  
 
 Chapter 5 
 
5 Turnover of the proteome in macrophages after 
infection with L. mexicana  
5.1 Introduction 
The proteome is a dynamic system in which proteins are interacting to contribute 
the phenotype of a cell. Protein properties including protein abundance, protein 
expression, protein synthesis and degradation, subcellular localisation, 
posttranslational modifications and protein-protein interactions are highly 
complex. Presently, most global quantitative proteomics investigations are 
focused on the changes in protein abundance or steady-state protein expression 
differences between samples. However, such approaches are unable to give any 
information on protein dynamics which is vital to understanding physiological 
changes and processes. Advances in MS-based proteomics have enabled the 
measurement of these properties. Understanding proteome dynamics contributes 
in deciphering how cells deploy regulatory processes to accomplish physiological 
changes in different conditions.  
Protein turnover refers to the balance between protein synthesis and protein 
degradation processes (net changes) that are continually occurring in cells. It is 
the rate at which the proteins are replaced. When the rate of protein synthesis is 
equal to the rate of protein degradation, the cells are said to be in steady-state. 
However, when the cells are growing, the rate of protein synthesis is greater than 
the rate of protein degradation (anabolism), while the opposite is called 
catabolism. This balancing act allows a cell to regulate its function to quickly 
respond to challenges (Doherty & Whitfield 2011). Various factors influence the 
rates of protein synthesis including mRNA transcript concentration and ribosomal 
activity. Of note, most proteins do not exist for extended periods of time. Instead, 
they will be renewed, and existing protein recycled or degraded. Although, there 
are some proteins that live for as long as the organism itself, example being human 
collagen (Verzijl et al. 2000). Half-life relates to the time it takes to replace half 
of the molecules (in this case, proteins). The half-life of proteins within cells 
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varies from minutes to several days. The differences in synthesis and degradation 
rates are important for cell regulation. Most regulatory molecules such as 
transcription factors are rapidly degraded. This is to allow them to change 
accordingly in response to external stimuli (Pratt et al. 2002).  
Protein degradation is one of the fundamental cellular processes involved in gene 
expression. In eukaryotic cells, there are two major pathways that mediate 
protein degradation: the ubiquitin-proteasome system and lysosomal proteolysis. 
The ubiquitin-proteasome system selects proteins that have been tagged by a 
polyubiquitin chain and directs them to the 26S proteasome to be degraded 
(Ciechanover 2005). Lysosomes contains a huge number of proteases used for 
degrading proteins including cathepsins and aspartic proteases (Xu & Ren 2015). 
Protein degradation is important in the regulation of some physiological and 
cellular processes to prevent the accumulation of unwanted or damaged proteins 
in cells thus ensuring a functional proteome throughout the cell’s lifetime. Most 
cellular proteins are rapidly degraded and replaced with newly synthesized copies. 
More importantly, degradation is also triggered by stress such as starvation 
(Doherty & Whitfield 2011). Consequently, a better understanding of degradation 
rates of specific proteins particularly in different conditions would facilitate drug 
development for various diseases (Bedford et al. 2011).  
Many studies have attempted to address protein degradation, synthesis and 
ultimately protein turnover rates in cells. The application of pulse-chase 
experiments has begun more than 30 years ago. In essence, isotopic tracers were 
introduced in cells to measure the level of the tracers incorporated in tissues of 
interest. Early studies measured the half-life of a specific protein by pulse 
labelling cells with radioisotope (e.g., 35S-methionine, 59Fe-transferrin), 
followed by immunoprecipitation with a specific antibody during a chase period, 
to reveal the rate at which labelled protein was depleted (Roberts & Bomford 
1988; Rotundo et al. 1989). Radioactive labelling while sensitive, it is not suitable 
for high-throughput studies (Fierro-Monti et al. 2013). Later, the technique was 
progressed by the use of tags with cycloheximide treatment to block protein 
translation (Belle et al. 2006; Bojkowska et al. 2011) and imaging-based 
approaches combined with photobleaching (Eden et al. 2011; Geva-Zatorsky et al. 
2012). In a study conducted by Belle et al. (2006), the half-life of several thousand 
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yeast proteins was measured by utilising an epitope-tagged fusion protein with 
tandem affinity purification (TAP) tag and cycloheximide. The degradation rates 
of the TAP-tagged proteins were quantified by Western blotting at 0, 15 and 45 
min after cyclohexamide treatment. They reported that proteins that are stable 
are mainly involved in protein production including ribosomal proteins, as well as 
enzymes involved in amino acid metabolism and biosynthesis. In contrast, proteins 
that have regulatory flexibility (i.e. rapidly degrading) are proteins associated 
with cell cycle and transcriptional regulation. However, despite these remarkable 
studies, the use of tags can potentially impair protein stability and interfere with 
protein function (Christiano et al. 2014). Moreover, blocking translation can 
induce stress response (MacGurn et al. 2011). Besides that, due to cellular toxicity 
of the applied drugs, turnover is measured when overall protein synthesis is 
abrogated and thus may not reflect the actual turnover rate under physiological 
growth conditions.  
In this regard, MS-based proteomics approaches are promising as researchers can 
investigate global protein turnover of an organism at the level of individual gene 
products. Recently, variants of these approaches utilizing non-radioactive tracers 
have been developed that allow for global analysis of protein turnover (Pratt et 
al. 2002; Beynon & Pratt 2005). Motivated by the lack of methods to explicitly 
explore changes in protein dynamics in different cellular conditions, a modified 
version of the classic SILAC approach was established, namely pulse-chase SILAC 
(pcSILAC) (Gustavsson et al. 2005; Fierro-Monti et al. 2013; Schmidt et al. 2010). 
In contrast with the classic SILAC, the labelling in pcSILAC is conducted for a 
selected period of time where all proteins will be labelled with heavy (H) amino 
acids, hence the word ‘pulse’. The medium is exchanged with light (L) amino acids 
following perturbation where the L amino acids will be ‘chased’ into the cells. 
During this phase, all newly synthesized proteins will appear in the L form. As the 
strategy exclusively labels newly synthesized proteins, relative changes in protein 
translation rates between two cellular conditions can be accurately quantified. 
Nevertheless, as this is both pulse and chase experiments, linking these two 
parameters together is very complex. 
In the simplest experimental design, there are two strategies that could be 
employed using stable isotope to determine protein turnover. Cells are exposed 
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to a stable isotope precursor where it could be incorporated into proteins and the 
rate of incorporation is determined. This is called “labelling” experiment. The 
other way is called “unlabelling” experiment where the cells are pre-labelled with 
stable isotope-labelled precursor before being transferred to an unlabelled 
condition, and the rate of loss of label is determined (Figure 5.1). 
Although the ratio of H to L peptides indicates the turnover rate of the respective 
protein, it does not directly provide information on the translation rate. This is 
due to the fact that protein turnover is affected by both synthesis and 
degradation. To illustrate, a high H/L ratio could either indicate a high translation 
rate of a stable protein or a low translation rate of a protein that is rapidly 
degraded (Schwanhäusser et al. 2009).  
Protein degradation rates by MS has been widely applied on several cell lines or 
organisms including yeast model, mouse, chicken and human A549 
adenocarcinoma cell line (Pratt et al. 2002; Doherty et al. 2005; Doherty et al. 
2009; Belle et al. 2006; Price et al. 2010; Christiano et al. 2014). Schwanhäusser 
et al. (2009) applied the method with HeLa cells to investigate a model of iron 
homeostasis. Bunner & Williamson (2009) also used pcSILAC to explore E. coli 30S 
ribosome assembly dynamics.  
To understand the underlying mechanisms of cellular functions it is critical to 
monitor protein abundance and their changes over time. This will allow us to 
investigate the intrinsic dynamic processes governing life that causes physiological 
responses, including regulatory networks. Given that proteins exhibit vastly 
different turnover rates, changes in gene expression induced by different 
treatment will affect steady-state protein levels with different kinetics and by 
different magnitudes. Incidentally, we are using pcSILAC on THP-1 where the cells 
were prelabelled with heavy isotopes until full incorporation before changing the 
media to light label media (unlabelling experiment) and infected with L. mexicana 
for 24 and 48 h. This media change will deplete the labelled pool, thus decreasing 
the precursor relative isotope abundance (RIA) so that the loss of RIA can be 
monitored to dictate degradation. Pre-labelled proteins could have two fates: to 
be degraded or to be diluted into daughter cells through cell growth. In this work, 
we assume that amino acids derived from protein degradation will not be used for 
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protein synthesis. Cell were then subjected to protein extraction, proteolysis and 
MS analysis. The strategy employed was illustrated in detail in Figure 5.2. 
 
 
Figure 5.1: Strategies for turnover analysis.  
Turnover studies using stable isotopes measures either the rate of entry of precursor into the protein 
pool (“labelling” experiment) (B) or the rate of exit of label from previously labelled proteins 
(“unlabelling” experiment) (A). (A) In “unlabelling” experiment, proteins (Pf, Pi, Ps: fast, intermediate, 
and slow turnover proteins, respectively) are pre-labelled through a combination of turnover and pool 
expansion through growth, as the cells are usually undergoing exponential growth. Irrespective of 
the turnover rate, all proteins will be fully labelled after several doubling times. Subsequently, the 
medium is changed to medium containing no label, and the rate of loss of label from proteins is 
assessed by means of mass spectrometry. Because the cells continue to divide, label is lost from 
proteins through a combination of growth and intracellular degradation. (B) Labelling experiments 
are more common in animal studies, in which tissue growth might be much lower. Here the stable 
isotope label is administered at the start of the experiment, and mass spectrometry is used to monitor 
the rate of label incorporation into proteins. These experiments are often conducted in the absence 
of significant tissue growth, and the exponential rise to plateau yields a reliable measure of the 
turnover rate. In both experimental modalities, the extent and rate of labelling of the precursor amino 
acid pool (dotted lines) is critical (adapted from (Claydon & Beynon 2012). 
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Figure 5.2: Schematic outline of pulse-chase SILAC approach for 24 and 48 hpi THP-1.  
(a) Uninfected and infected THP-1 were cultivated in heavy (H) SILAC medium until full incorporation 
was achieved (the pulse-labelling phase). Concomitantly with differential treatment (infection), cells 
are transferred to culture medium containing light (L) isotope-coded amino acids. Therefore, cells 
are 'chased' with L amino acids, thus all newly synthesized proteins will incorporate the L amino 
acids. The cell populations are further processed separately and analysed by MS. (b) The mass 
spectrum shows a gradual shift from fully H labelled to towards fully L labelled over 48 h period. At 
the pulse-chase starting point, only H peptides are present. During time, the intensities of L peptides 
continuously increase until H peptides are not detected against the vast majority of L peptides. 
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5.2 Aims 
The aims of this work were to: 
❖ Extend the application of pulse-chase SILAC to investigate the dynamic 
proteome degradation in human macrophage cell line THP-1 infected with 
L. mexicana for 24 and 48 hours, compared with uninfected THP-1. 
❖ Determine protein half-life and turnover in human macrophage cell line 
THP-1 infected with L. mexicana for 24 and 48 hours, compared with 
uninfected THP-1. 
❖ Undertake a statistical analysis of the protein modulations observed. 
By quantifying protein half-lives, turnover times, and the degradation rate 
constant of proteins in large scale, we hope to get insights to the physiological 
nature of these parameters thereby deepen our understanding of cellular 
processes occurring during parasite infection. 
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5.3 Results 
5.3.1 Global characterisation of protein degradation using pulse-
chase SILAC, in response to L. mexicana infection. 
Following complete incorporation of heavy isotope labelled amino acids into the 
THP-1 proteome (RIA ~ 1) (as described in section 4.3.2), THP-1 were activated 
with PMA to become macrophage-like cells. Next, heavy SILAC medium was 
exchanged for light SILAC medium (RPMI 1640 containing 12C-Arg and 12C-Lys 
isotope) and the macrophages were exposed to metacyclic promastigotes, at the 
ratio of 8 parasites/macrophage that we have previously shown (Figure 4.6 and 
4.7) to result in a high prevalence of infection. In parallel, similar labelled but 
uninfected THP-1 cultures were chased with light SILAC media, as control. Both 
infected and uninfected cultures were washed at 6 h to remove extracellular 
parasites from infected cultures. At 24 and 48 h post-infection, uninfected and 
infected cells were harvested by scraping the adhered cells into cold PBS and cell 
lysis was performed followed by trypsinization and 2D LC-MS/MS analysis on an 
Orbitrap Velos instrument. All raw LC/MS files of a time series experiment were 
then processed on MaxQuant, generating proteinGroup.txt output file which was 
further analysed on Perseus.  
Triplicates of uninfected THP-1, 24 hpi and 48 hpi THP-1 were grouped and 
analysed together on MaxQuant and Perseus. Using the same parameters as 
describe in previous chapter, a total of 2280 proteins were identified in all groups. 
To identify rapidly degraded proteins, we measure the rate of loss of heavy Arg 
and Lys at 24 and 48 hours after infection with the parasites. For this purpose, all 
proteins with no L/H ratio in either one of the replicates were omitted, leaving 
400 proteins. The value of relative isotope abundance (RIA) of the proteins 
changes over the 48 h period. Average RIA values from the three replicates in 
control, 24 hpi and 48 hpi were calculated for each peptide at each time-point. 
These data were then processed using an R script and RIA equation as described 
in section 2.10.6 (Pratt et al. 2002). The dilution rate (kdil) over 160 h of 
cultivation of THP-1 in SILAC media was calculated from the doubling time of THP-
1, which is 0.006 h-1. Therefore, the dilution rate is negligible since over 99% of 
the arginine and leucine in the cells would be the stable isotope-labelled form. 
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We minimised the dilution rate by using dialyzed serum and auxotrophic amino 
acids during cultivation. 
To identify rapidly degraded proteins with high statistical significance, p values 
were calculated using t test analysis. A significance cutoff value of p < 0.05 (-
Log10(p) > 1.2) was used, producing 50 proteins in 24 hpi (Figure 5.3, Table 5.1) 
and 38 proteins in 48 hpi THP-1 (Figure 5.6, Table 5.2). 
 
Figure 5.3: Volcano plot showing proteins with different degradation rate in uninfected and 
24 h infected THP-1 with FDR = 0.05.  
Conventional data were normalized and proteins with no quantification report were removed from all 
samples. t-test was performed on the remaining data to produce statistically significant proteins with 
p-value < 0.05 (red circle). The proteins were assigned with gene names. FDR of 0.05 was applied 
on the data producing 50 proteins with differential degradation rate. 
 
The protein Uniprot ID of significant proteins in 24 hpi and 48 hpi were uploaded 
on DAVID database and PANTHER for functional analysis. PANTHER was used when 
DAVID could not give more annotation. A Fisher Exact test (Benjamini-Hochberg 
FDR < 0.02) was applied to highlight significant enrichment in ontology (Benjamini 
& Hochberg 1995). It was observed that most of the proteins with different 
degradation rates p.i. were involved in cellular process, metabolic, localisation, 
and antigen processing and presentation (Figure 5.4). Pathway analysis based on 
KEGG showed that proteins associated with apoptosis, followed by the antigen 
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processing and presentation, and aminoacyl-tRNA biosynthesis predominated 
(Figure 5.5). Many proteins with significant degradation rates in 48 hpi were also 
involved in metabolic processes, but also in oxidation reduction and immune 
system process (Figure 5.7). Additionally, pathway analysis revealed that most 
rapidly degraded proteins involve in ribosomal pathway, glycolysis, TCA cycle, and 
oxidative stress response (Figure 5.8). 
 
Figure 5.4: Gene Ontology of proteins with significantly changing degradation rates post 24 
h infection.  
The total number of proteins (UniProt identifiers) identified in the uninfected and 24 hpi were ranked 
according to fold changes and analysed on DAVID based on biological processes they involve in. 
Pie chart showed that most proteins involved in cellular process, metabolic process, localisation, and 
antigen processing and presentation. 
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Figure 5.5: Canonical pathway analysis on KEGG showing most altered pathways in the 50 
significantly degraded proteins in 24 hpi THP-1.  
The highly degraded proteins identified in uninfected and 24 hpi were analysed on DAVID with links 
to KEGG to identify the pathways they involve in (p ≤ 0.01; Fisher’s exact test). 
 
 
Figure 5.6: Volcano plot showing proteins with different degradation rate in uninfected and 
48 h infected THP-1 with FDR = 0.05.  
Conventional data were normalized and proteins with no quantification report were removed from all 
samples. t-test was performed on the remaining data to produce statistically significant proteins with 
p-value < 0.05 (blue font). The proteins were assigned with gene names. FDR of 0.05 was applied 
on the data producing 38 proteins with differential degradation rate. 
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Figure 5.7: Gene Ontology of proteins with significantly changing degradation rates post 48 
h infection.  
The total number of proteins (UniProt identifiers) identified in the uninfected and 48 hpi were ranked 
according to fold changes and analysed on DAVID based on biological processes they involve in. 
Pie chart showed that most proteins involved in metabolic processes, oxidation reduction and 
immune system process. 
 
 
Figure 5.8: Canonical pathway analysis on KEGG showing most altered pathways in the 38 
significantly degraded proteins in 48 hpi THP-1.  
The highly degraded proteins identified in uninfected and 48 hpi were analysed on DAVID with links 
to KEGG to identify the pathways they involve in (p ≤ 0.01; Fisher’s exact test). 
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We choose several pathways that appear to be highly degradable p.i. to overlay 
onto KEGG pathway diagrams: the ribosome pathway (Figure 5.9), aminoacyl-tRNA 
biosynthesis (Figure 5.10), and antigen processing and presentation (Figure 5.11). 
Of note, the remaining proteins represented by red star found in this data have 
missing values in either the uninfected, 24 hpi or 48 hpi group, hence we could 
not determine the modulation on these proteins between uninfected, 24 hpi and 
48 hpi.  
 
Figure 5.9: Ribosome pathway derived from KEGG with the proteins found in this work.  
All proteins identified in this study were analysed on DAVID. The pathways linked to KEGG was 
chosen with Homo sapiens as the reference organism and most proteins found were involved in 
ribosome pathway. Red star represented the proteins found in this data. Blue circle represented the 
significantly degraded proteins in 24 hpi while orange circle represented the significantly degraded 
proteins in 48 hpi. 
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Figure 5.10: Aminoacyl tRNA biosynthesis pathway derived from KEGG contains proteins 
found in this data.  
All proteins identified in this study were analysed on DAVID. The pathways linked to KEGG was 
chosen. Red star represented the proteins found in this data. Blue circle represented the significantly 
degraded proteins in 24 hpi while orange circle represented the significantly degraded proteins in 48 
hpi. Abbreviations: 6.1.1.17 – glutamate-tRNA ligase, 6.1.1.18 – glutamine-tRNA ligase, 6.1.1.7 – 
alanine-tRNA ligase, 6.1.1.12 – aspartate-tRNA ligase, 6.1.1.22 – asparagine-tRNA ligase, 6.1.1.14 
– glycine-tRNA ligase, 6.1.1.3 – threonine-tRNA ligase, 6.1.1.16 – cysteine-tRNA ligase, 6.1.1.10 – 
methionine-tRNA ligase, 6.1.1.9 – valine-tRNA ligase, 6.1.1.4 – leucine-tRNA ligase, 6.1.1.5 – 
isoleucyl-tRNA synthetase, 6.1.1.6 – lysine-tRNA ligase, 6.1.1.19 – arginine-tRNA ligase, 6.1.1.15 – 
proline-tRNA ligase, 6.1.1.21 – histidine-tRNA ligase, 6.1.1.20 – phenylalanine-tRNA ligase, 6.1.1.1 
– tyrosine-tRNA ligase, 6.1.1.2 – tryptophan-tRNA ligase.  
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Figure 5.11: Antigen processing and presentation pathway (KEGG) with proteins found in this 
data.  
All proteins identified in this study were analysed on DAVID. The pathways linked to KEGG was 
chosen and most proteins with statistically degraded proteins p.i. involved in antigen processing and 
presentation pathway. Red star represented the proteins found in this data. Blue circle represented 
the significantly degraded proteins in 24 hpi while orange circle represented the significantly 
degraded proteins in 48 hpi. 
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Table 5.1: Proteins significantly degraded upon 24 h infection.  
Replicates from both uninfected, 24 hpi and 48 hpi THP-1 were grouped and averaged for statistical analysis. Only proteins that had been quantified in all biological 
replicates were considered for this statistical test. Two-sample t-test was performed on the filtered data and gave rise to 50 differentially degraded proteins (FDR value 
= 0.05).  
 
Protein names 
Gene 
names 
RIA 
(degradation) 
Uninfected24h 
RIA 
(degradation) 
24hpi 
RIA 
(degradation) 
Uninfected48h 
RIA 
(degradatio
n) 48hpi 
Peptides 
Mol. 
weight 
[kDa] 
Score 
Receptor-type tyrosine-protein phosphatase C PTPRC 0.19 0.82 0.65 0.72 13 147 63 
Ras-related protein Rap-1b; Ras-related protein Rap-
1A; Ras-related protein Rap-1b-like protein 
RAP1B; 
RAP1A 0.40 0.77 0.56 0.66 8 21 205 
26S proteasome non-ATPase regulatory subunit 2 PSMD2 0.45 0.83 0.58 0.66 10 100 28 
Glutathione S-transferase omega-1 GSTO1 0.44 0.76 0.51 0.64 7 28 33 
Adenine phosphoribosyltransferase APRT 0.52 0.88 0.81 0.82 6 20 142 
Coronin-1A CORO1A 0.47 0.77 0.62 0.64 9 51 117 
Glycine--tRNA ligase GARS 0.57 0.81 0.62 0.72 11 83 135 
Electron transfer flavoprotein subunit beta ETFB 0.63 0.89 0.90 0.71 6 28 70 
Small nuclear ribonucleoprotein Sm D3 SNRPD3 0.66 0.89 0.66 0.92 4 14 39 
Ubiquitin-conjugating enzyme E2 L3 UBE2L3 0.61 0.81 0.73 0.54 5 18 53 
Programmed cell death 6-interacting protein PDCD6IP 0.58 0.78 0.58 0.47 14 96 72 
Prothymosin alpha;Prothymosin alpha, N-terminally 
processed;Thymosin alpha-1 PTMA 0.64 0.85 0.71 0.69 6 12 279 
Thymosin beta-4; Hematopoietic system regulatory 
peptide TMSB4X 0.62 0.82 0.67 0.59 9 5 140 
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Protein names 
Gene 
names 
RIA 
(degradation) 
Uninfected24h 
RIA 
(degradation) 
24hpi 
RIA 
(degradation) 
Uninfected48h 
RIA 
(degradatio
n) 48hpi 
Peptides 
Mol. 
weight 
[kDa] 
Score 
Tubulin beta chain TUBB 0.69 0.89 0.78 0.78 20 50 155 
40S ribosomal protein S7 RPS7 0.64 0.84 0.72 0.79 7 22 129 
Plectin PLEC 0.58 0.74 0.57 0.50 40 532 248 
HLA class I histocompatibility antigen, A-2 alpha chain HLA-A     0.85  0.50 0.35 0.22 10 41 196 
HLA class I histocompatibility antigen, B-35 alpha chain HLA-B     0.17  0.08 0.15 0.17 7 40 142 
HLA class I histocompatibility antigen, Cw-15 alpha 
chain HLA-C     0.37  0.08 0.25 0.14 4 41 74 
Tubulin beta-4B chain TUBB4B 0.70 0.90 0.80 0.77 21 50 323 
Palmitoyl-protein thioesterase 1 PPT1 0.55 0.70 0.46 0.47 8 34 74 
Proteasome activator complex subunit 1 PSME1 0.65 0.82 0.70 0.77 10 29 137 
Lamin-B1 LMNB1 0.79 0.99 0.94 0.93 25 66 323 
Niban-like protein 1 FAM129B 0.59 0.72 0.47 0.51 16 84 170 
Tubulin alpha-1C chain;Tubulin alpha-8 chain 
TUBA1C; 
TUBA8 0.72 0.88 0.79 0.79 21 50 323 
KH domain-containing, RNA-binding, signal 
transduction-associated protein 1 KHDRBS1 0.65 0.79 0.65 0.67 5 48 223 
Cytoskeleton-associated protein 4 CKAP4 0.75 0.91 0.78 0.76 6 66 96 
Apoptosis-associated speck-like protein containing a 
CARD PYCARD 0.90 0.88 0.76 0.90 3 22 296 
60S ribosomal protein L15 RPL15 0.79 0.84 0.69 0.78 5 24 19 
Superoxide dismutase (Mn) SOD2 0.70 0.73 0.77 0.86 11 25 273 
Cytochrome b-c1 complex subunit 7 UQCRB 0.75 0.80 0.64 0.70 3 14 64 
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Protein names 
Gene 
names 
RIA 
(degradation) 
Uninfected24h 
RIA 
(degradation) 
24hpi 
RIA 
(degradation) 
Uninfected48h 
RIA 
(degradatio
n) 48hpi 
Peptides 
Mol. 
weight 
[kDa] 
Score 
Phenylalanine--tRNA ligase beta subunit FARSB 0.84 0.85 0.79 0.86 5 66 24 
Galectin-9 LGALS9 0.82 0.64 0.59 0.63 4 26 65 
Fatty acid-binding protein, epidermal FABP5 0.66 0.77 0.70 0.74 13 15 148 
Fumarate hydratase, mitochondrial FH 0.85 0.89 0.85 0.90 9 55 165 
Thioredoxin-related transmembrane protein 1 TMX1 0.80 0.82 0.66 0.69 4 32 15 
Vimentin VIM 0.60 0.68 0.51 0.54 48 54 323 
Malate dehydrogenase, mitochondrial MDH2 0.80 0.84 0.77 0.79 12 36 302 
Peroxiredoxin-4 PRDX4 0.85 0.87 0.81 0.81 8 31 138 
Cytochrome b-c1 complex subunit 2, mitochondrial UQCRC2 0.81 0.83 0.75 0.76 8 48 61 
Purine nucleoside phosphorylase PNP 0.76 0.84 0.73 0.72 15 32 216 
Fatty acid-binding protein, adipocyte FABP4 0.59 0.65 0.66 0.64 7 15 323 
Calreticulin CALR 0.86 0.91 0.84 0.82 22 48 323 
14-3-3 protein beta/alpha;14-3-3 protein beta/alpha, 
N-terminally processed YWHAB 0.85 0.79 0.75 0.72 11 28 323 
Glyceraldehyde-3-phosphate dehydrogenase GAPDH 0.80 0.85 0.73 0.71 17 36 323 
L-lactate dehydrogenase B chain LDHB 0.85 0.93 0.86 0.83 11 37 280 
Moesin MSN 0.73 0.81 0.68 0.65 39 68 323 
Peroxiredoxin-2 PRDX2 0.87 0.93 0.88 0.83 7 22 69 
Lysine--tRNA ligase KARS 0.82 0.84 0.73 0.69 9 68 208 
Isocitrate dehydrogenase [NADP], mitochondrial IDH2 0.85 0.93 0.84 0.79 14 51 169 
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Table 5.2: Proteins significantly degraded upon 48 h infection.  
Replicates from both uninfected, 24 hpi and 48 hpi THP-1 were grouped and averaged for statistical analysis. Only proteins that had been quantified in all biological 
replicates were considered for this statistical test. Two-sample t-test was performed on the filtered data and gave rise to 38 differentially expressed proteins (FDR value 
= 0.05).  
 
Protein names 
Gene 
names 
RIA 
(degradation) 
Uninfected24h 
RIA 
(degradation) 
24hpi 
RIA 
(degradation) 
Uninfected48h 
RIA 
(degradation) 
48hpi 
Peptides 
Unique 
peptides 
Mol. 
weight 
[kDa] 
Score 
Electron transfer flavoprotein subunit alpha, 
mitochondrial ETFA 0.89 0.88 0.44 0.79 8 8 35 77 
Heterogeneous nuclear ribonucleoprotein A0 HNRNPA0 0.75 0.80 0.54 0.78 7 7 31 135 
Small nuclear ribonucleoprotein Sm D3 SNRPD3 0.66 0.89 0.66 0.92 4 4 14 39 
Annexin A11 ANXA11 0.69 0.72 0.52 0.71 6 6 54 72 
Casein kinase II subunit alpha;Casein kinase II 
subunit alpha 3 
CSNK2A1; 
CSNK2A3 0.72 0.76 0.49 0.65 4 4 45 7 
Cytoplasmic FMR1-interacting protein 1 CYFIP1 0.67 0.72 0.58 0.77 9 9 145 20 
Hippocalcin-like protein 1; Neuron-specific 
calcium-binding protein hippocalcin 
HPCAL1; 
HPCA 0.85 0.68 0.45 0.59 7 7 22 69 
Glutathione S-transferase omega-1 GSTO1 0.44 0.76 0.51 0.64 7 7 28 33 
Polyadenylate-binding protein 1 PABPC1 0.77 0.78 0.59 0.74 8 4 71 127 
UDP-glucose:glycoprotein glucosyltransferase 1 UGGT1 0.87 0.85 0.65 0.81 15 14 177 156 
Pyridoxal kinase PDXK 0.80 0.76 0.61 0.76 7 7 35 260 
Nodal modulator 1; Nodal modulator 3; Nodal 
modulator 2 
NOMO1; 
NOMO3; 
NOMO2 0.68 0.74 0.53 0.66 7 7 134 85 
NADH-cytochrome b5 reductase 3; NADH-
cytochrome b5 reductase 3 membrane-bound CYB5R3 0.79 0.82 0.67 0.83 7 7 34 11 
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Protein names 
Gene 
names 
RIA 
(degradation) 
Uninfected24h 
RIA 
(degradation) 
24hpi 
RIA 
(degradation) 
Uninfected48h 
RIA 
(degradation) 
48hpi 
Peptides 
Unique 
peptides 
Mol. 
weight 
[kDa] 
Score 
form; NADH-cytochrome b5 reductase 3 
soluble form 
60S ribosomal protein L23a RPL23A 0.71 0.83 0.58 0.71 8 8 18 48 
CTP synthase 1 CTPS1 0.81 0.84 0.68 0.83 8 7 67 140 
Cystatin-B CSTB 0.60 0.69 0.53 0.64 6 6 11 147 
2-oxoglutarate dehydrogenase, mitochondrial OGDH 0.75 0.79 0.65 0.78 10 10 116 63 
Signal transducer and activator of transcription 
1-alpha/beta STAT1 0.61 0.68 0.49 0.59 4 4 40 52 
Choline-phosphate cytidylyltransferase A; 
Choline-phosphate cytidylyltransferase B 
PCYT1A; 
PCYT1B 0.67 0.71 0.58 0.70 2 2 42 4 
Eukaryotic translation initiation factor 6 EIF6 0.72 0.75 0.58 0.70 5 5 27 68 
Osteoclast-stimulating factor 1 OSTF1 0.77 0.77 0.63 0.75 3 3 24 81 
HLA class I histocompatibility antigen, A-2 alpha 
chain HLA-A     0.85  0.50 0.35 0.22 10 41 196 196 
HLA class I histocompatibility antigen, B-35 
alpha chain HLA-B     0.17  0.08 0.15 0.17 7 40 142 142 
HLA class I histocompatibility antigen, Cw-15 
alpha chain HLA-C     0.37  0.08 0.25 0.14 4 41 74 72 
Apoptosis-associated speck-like protein 
containing a CARD PYCARD 0.90 0.88 0.76 0.90 3 3 22 296 
Superoxide dismutase (Mn) SOD2 0.70 0.73 0.77 0.86 11 11 25 273 
Cytochrome b-c1 complex subunit 7 UQCRB 0.75 0.80 0.64 0.70 3 3 14 64 
Phenylalanine--tRNA ligase beta subunit FARSB 0.84 0.85 0.79 0.86 5 5 66 24 
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Protein names 
Gene 
names 
RIA 
(degradation) 
Uninfected24h 
RIA 
(degradation) 
24hpi 
RIA 
(degradation) 
Uninfected48h 
RIA 
(degradation) 
48hpi 
Peptides 
Unique 
peptides 
Mol. 
weight 
[kDa] 
Score 
Galectin-9 LGALS9 0.82 0.64 0.59 0.63 4 4 26 65 
Vimentin VIM 0.60 0.68 0.51 0.54 48 48 54 323 
Peroxiredoxin-4 PRDX4 0.85 0.87 0.81 0.81 8 8 31 138 
Purine nucleoside phosphorylase PNP 0.76 0.84 0.73 0.72 15 15 32 216 
Glyceraldehyde-3-phosphate dehydrogenase GAPDH 0.80 0.85 0.73 0.71 17 17 36 323 
L-lactate dehydrogenase B chain LDHB 0.85 0.93 0.86 0.83 11 11 37 280 
Moesin MSN 0.73 0.81 0.68 0.65 39 39 68 323 
Peroxiredoxin-2 PRDX2 0.87 0.93 0.88 0.83 7 7 22 69 
Lysine--tRNA ligase KARS 0.82 0.84 0.73 0.69 9 9 68 208 
Isocitrate dehydrogenase [NADP], 
mitochondrial IDH2 0.85 0.93 0.84 0.79 14 14 51 169 
 
 
 
 
 
  
 Based on RIA (degradation) values, we plotted graphs for several proteins over the 
duration of 48 hours of infection. Gamma-interferon-inducible protein 16 and 
carbonic anhydrase 2 had lower RIA degradation in infected THP-1 (24 hpi and 48 
hpi) compared to the uninfected THP-1 (Figure 5.12). Whereas, proteins such as 
histone H1.5 and histone H4 had no significant differences of RIA degradation in 
both uninfected and infected THP-1. Heat shock 70 kDa protein and STAT1 had 
bigger RIA values in infected THP-1 than the uninfected THP-1 (Figure 5.13). 
 
Figure 5.12: Relative isotope abundance (RIA) degradation for several significantly changing 
proteins.  
RIA, t for several proteins were calculated and plotted against time of infection. Each point 
corresponds to the mean values ± SD of three biological replicates. 
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Figure 5.13: Relative isotope abundance (RIA) degradation for several significantly changing 
proteins.  
RIA, t for several proteins were calculated and plotted against time of infection. Each point 
corresponds to the mean values ± SD of three biological replicates. 
 
Interestingly, HLA complexes showed much lower RIA values in infected cells 
compared to uninfected cells (Figure 5.14). Furthermore, most metabolic enzymes 
had almost the same RIA values in uninfected, 24 hpi and 48 hpi THP-1 (Figure 
5.15). This clearly showed that proteins with the same function behave similarly 
in cells.  
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Figure 5.14: Relative isotope abundance (RIA) degradation for proteins involve in antigen 
processing and presentation.  
RIA, t for several proteins were calculated and plotted against time of infection. Each point 
corresponds to the mean values ± SD of three biological replicates. 
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Figure 5.15: Relative isotope abundance (RIA) degradation for proteins involve in metabolic 
process.  
RIA, t for several proteins were calculated and plotted against time of infection. Each point 
corresponds to the mean values ± SD of three biological replicates. 
 
60S ribosomal proteins and 40S ribosomal proteins such as the ones depicted in 
Figure 5.16 showed no change in uninfected cell and 24 hpi, but the RIA values in 
48 hpi were slightly increased compared to uninfected cells.  
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Figure 5.16: Relative isotope abundance (RIA) degradation for proteins involve in translation.  
RIA, t for several proteins were calculated and plotted against time of infection. Each point 
corresponds to the mean values ± SD of three biological replicates. 
 
The RIA, t values were then used to derive the degradation rate constant, kdeg. 
Degradation rate constants (kdeg) were calculated from the exponential decay 
formula as RIA = exp (kdeg*time). Overall, we observed that most proteins were 
quite stable and not degrading rapidly. As shown in Figure 5.17, the highest kdeg 
value is 0.04 h-1. The data also indicated that 23.5% of the 400 proteins were 
degraded at a rate of 4% every hour. The degradation rates were not normally 
distributed (Figure 5.19). Global analysis of protein degradation revealed that the 
majority of the proteins were relatively stable as most have relatively low kdeg 
values. The kdeg values less than 0.04 h-1 reflected proteins slowly decayed.  
Examples included ATP-dependent RNA helicase, myosin-IF, succinate 
dehydrogenase and actin related protein 2/3 complex subunit (Figure 5.20). The 
lowest kdeg value is 0.01 h-1. Slowly degraded proteins with kdeg of 0.01 h-1 included 
gamma-interferon-inducible protein 16, gelsolin and galectin-9 (example in 
Appendix 8.3). Interestingly, several proteins that are implicated in the immune 
response, such as HLA complexes demonstrated marked differences of 
degradation rate between infected and uninfected samples (Figure 5.21). HLA 
complexes had a relatively high degradation rate after infection (90% decayed 
after 48 h) compared to uninfected.  
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Figure 5.17: Global degradation profile.  
The change in relative isotope abundance (RIA) for each protein was assessed. The rate constant 
kdeg for 400 proteins was calculated. Graph showed the distribution of degradation rate constants for 
400 proteins.  
 
 
Figure 5.18: Global analysis of protein degradation.  
The change in relative isotope abundance (RIA) for each protein was assessed during the unlabelled 
‘chase’ period. The RIA data were fitted to a single exponential decay curve and the degradation rate 
constant (kdeg) was calculated. 
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Figure 5.19: Identification of rapidly depleted proteins.  
R script was used to generate degradation plot over 48 h between uninfected and infected THP-1. 
 
 
Figure 5.20: Analysis of protein degradation profile.  
R script was used to generate degradation plot over 48 h between uninfected and infected data. 
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Figure 5.21 depicts kdeg graphs of several statistically significant proteins that 
show differences in degradation rate constant between uninfected and infected 
groups. Proteins involved in glycolysis including lactate dehydrogenase, fructose-
bisphosphate aldolase A, fumarate hydratase, and glucose-2-phosphate isomerase 
had similar kdeg in all groups (Figure 5.22 a). Although it has been shown previously 
that most metabolic enzymes are stable, this graph showed that kdeg values were 
significantly reduced in 48 hpi compared to 24 hpi and uninfected THP-1. HLA 
complexes also showed similar pattern as metabolic enzymes (Figure 5.22 b). 
Next, we investigate the kdeg value of stress proteins and ribosomal proteins 
(Figure 5.23 a and b). Some of the stress proteins and ribosomal proteins have 
quite striking changes in degradation after 48 h of infection as opposed to 24 h of 
infection.  
 
Figure 5.21: The degradation rate constant (kdeg) over time for statistically significant proteins.  
RIA, t values were used to derive the degradation rate constant for each protein and plotted for 
uninfected 24h, 24 hpi, uninfected 48h and 48 hpi. Each point corresponds to the mean values ± SD 
of three biological replicates. 
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Figure 5.22: The degradation rate constant (kdeg) over time for proteins involve in metabolic 
process and antigen processing and presentation.  
RIA, t values were used to derive the degradation rate constant for each protein and plotted for 
uninfected 24h, 24 hpi, uninfected 48h and 48 hpi. Each point corresponds to the mean values ± SD 
of three biological replicates. 
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Figure 5.23: The degradation rate constant (kdeg) over time for proteins involve in stress 
response and ribosome.  
RIA, t values were used to derive the degradation rate constant for each protein and plotted for 
uninfected 24h, 24 hpi, uninfected 48h and 48 hpi. Each point corresponds to the mean values ± SD 
of three biological replicates. 
 
Most proteins in infected samples have kdeg differences than the uninfected 
samples, even more differences in 24 and 48 hpi (Figure 5.24). For example, 
carbonic anhydrase 2 had kdeg of 0.04 h-1 in uninfected 24h but slightly increased 
to 0.03 h-1 in 24 hpi. However, the kdeg in both uninfected 48h and 48 hpi remained 
the same (0.02 h-1). Catalase, histones, annexins, and several ribosomal proteins 
had reduced kdeg following 48 h of infection.  
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Figure 5.24: The distribution of degradation rate constant (kdeg) for 400 proteins in uninfected, 
24 hpi and 48 hpi THP-1.  
RIA, t values were used to derive the degradation rate constant for each protein and plotted for 24 
hpi and 48 hpi. Proteins with high and low kdeg were highlighted.  
 
Protein networks of the significantly changing rates of degradation were 
constructed in the STRING database with interaction confidence > 0.5 and 
visualized using Cytoscape. Figure 5.25 showed the protein network involving the 
highly-regulated proteins (p-value < 0.05).  
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Figure 5.25: Protein network of proteins with significant change in degradation rates (p=0.05).  
Significantly degraded proteins were analysed on STRING database to determine the protein-protein 
interactions between them. (a) Proteins with changes in degradation rate in 24 hpi (b) Proteins with 
changes in degradation rate in 48 hpi.    
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5.3.2 Protein turnover of human cell lines THP-1 in response to L. 
mexicana infection 
Our workflow permitted us to determine intracellular protein replacement rates 
(turnover) on a large scale. For this purpose, we measured the half-life of 400 
proteins that met the criteria as described in chapter 4, with MOWSE score and 
ion score of < 0.05. We filtered the data to have L/H values for each group by 
removing the proteins with missing values. Half-lives were calculated using the 
formula in section 2.10.6. For the 400 proteins, the mean half-life for uninfected 
24 h, 24 hpi, uninfected 48h and 48 hpi were 21.74 h, 20.51 h, 47.39 h and 47.33 
h, respectively. Half-lives of proteins in uninfected 24h range from 16.63 to 85.44 
h, 16.80 to 30.36 h in 24 hpi, 34.34 to 75.22 h in uninfected 48h, and 34.23 to 
85.18 h in 48 hpi (summarized in Table 5.3). All calculations were derived from 3 
replicates that have been averaged in Excel spreadsheet. Figure 5.26 illustrate 
the distribution of protein half-lives in all 4 groups. Interestingly, almost all 
proteins have relatively increased half-life from 24 to 48 h of infection. These 
includes 26S proteasome non-ATPase regulatory subunit (19.55 h in 24 hpi to 42.59 
h in 48 hpi), several actin-related proteins (2-fold increased from 24 hpi to 48 
hpi), 14-3-3 proteins (2-fold increased from 24 hpi to 48 hpi), PNP (19.83 h in 24 
hpi to 46 h in 48 hpi), galactokinase (GALK1), fumarate hydratase (FH), ubiquitin-
conjugating enzyme E2 N (UBE2N), several subunits of 60S and 40S ribosomal 
proteins (2-fold increased from 24 hpi to 48 hpi), moesin (MSN), Ras-related 
protein (RAB1B), calmodulin (CALM1), gamma-interferon-inducible protein 16 
(IFI16), cathepsin-B (CTSB), pyruvate kinase (PKM), interferon-induced GTP-
binding protein (MX1) and STAT1. Protein with the longest half-life was 
leukotriene A-4 hydrolase (85.18 h), whereas protein with the shortest half-life 
was interleukin-8 (16.63 h).    
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Figure 5.26: Protein turnover distribution.  
RIA, t values were used to derive the degradation rate constant for each protein. From the 
measurements, protein half-lives were determined for all 400 proteins and compared between (a) 
uninfected 24h and 24 hpi, and (b) uninfected 48h and 48 hpi. 
 
To evaluate the protein half-lives that were only involved in infection groups, 
triplicates of 24 hpi and 48 hpi were grouped together and averaged. Hierarchical 
clustering heatmap for these groups was made using a feature in Perseus, 
revealing altered half-lives of several proteins between 24 and 48 hpi (Figure 
5.27). For example, peroxiredoxin 6 (PRDX6) was turnover rapidly after 24 h of L. 
mexicana infection but was turnover slowly after 48 h of infection.  
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Figure 5.27: Heatmap representation of protein expressions of 24 hpi and 48 hpi.  
Triplicates of 24 hpi and 48 hpi were grouped together and averaged. All missing values were filtered 
out from the data. Heat map showing fold change patterns of several altered genes between 24 hpi 
and 48 hpi; red = increased half-life, blue = decreased half-life. 
 
The proteins were ranked according to fold change of half-lifes. Of 400 proteins, 
368 had more than 2 FC. Gene ontolgy on DAVID demonstrated that 47% of the 
proteins were involved in metabolic processes, 13% were involved in response to 
stimulus and 10% were involved in oxidation reduction process. The protein IDs 
were also uploaded to the PANTHER database to predict gene ontology and 
pathway association. As observed on the DAVID database, the PANTHER database 
also reported that the highest number of significantly modulated proteins were 
associated with metabolic processes (Figure 5.28).  
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Figure 5.28: Gene ontology performed using PANTHER database on proteins with more than 
2-fold change in half-lives upon 24 and 48 h infection. 
Conventional data were normalized and those with no quantification report were removed from all 
samples. The half-lives were ranked according to fold changes between 48 hpi and 24 hpi, selecting 
only those with more than 2-fold change. The protein Uniprot IDs were uploaded on PANTHER 
database for functional analyses. (a) Gene ontology of significantly modulated proteins based on 
molecular function (b) Gene ontology of significantly modulated proteins based on biological process. 
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Several proteins from Table 4.2 and 4.3 were selected to observe the half-lives in 
uninfected and infected macrophage. As depicted in Figure 5.29, carbonic 
anhydrase 2 showed longer half-life after 24 h of infection and kept on increasing 
following 48 h of infection. Catalase, gamma-interferon-inducible protein 
16histone H2B type 1-B and moesin also had similar pattern. Apoptosis-associated 
speck-like protein and galectin-9 had increased half-lives in the early infection 
(24 h) but decreased their half-lives after 48 h of infection.  
 
Figure 5.29: Measurement of protein half-lives.  
RIA, t values were used to derive the degradation rate constant for each protein. From the 
measurements, protein half-lives were determined for several statistically significant proteins. Each 
point corresponds to the mean values ± SD of three biological replicates. 
 
Most proteins involved in glycolysis were rapidly turned-over during 24 h infection 
but they increased their half-lives after 48 h infection (Figure 5.30). Proteins that 
showed increased half-lives after 48 h infection compared to uninfected and 24 
hpi were phosphoglucomutase-2, very-long-chain enoyl-CoA reductase, L-lactate 
dehydrogenase B chain, isocitrate dehydrogenase [NADP], mitochondrial, 
fumarate hydratase, mitochondrial, cytochrome c1, heme protein, mitochondrial, 
and glucose-6-phosphate isomerase (Figure 5.31 a). Phosphoglycerate kinase 
(PGK) catalyzes the reversible transfer of a phosphate group from 1,3-
bisphosphoglycerate (1,3-BPG) to ADP producing 3-phosphoglycerate (3-PG) and 
ATP (Watson et al. 1982). PGK1 is secreted by tumour cells and overexpression of 
PGK1 has been associated with angiogenic process (Lay et al. 2000). Αlpha-enolase 
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(ENO1), also known as 2-phospho-D-glycerate hydrolase, is a metalloenzyme 
involved in the ninth step of glycolysis. ENO1 responsible for the catalysis of the 
conversion of 2-phosphoglycerate (2-PG) to phosphoenolpyruvate (PEP) (Ji et al. 
2016). In addition to its glycolytic function, this multifunctional enzyme also 
involved in cellular stress, bacterial and fungal infections, auto-antigen activities, 
the occurrence and metastasis of cancer, parasitic infections, as well as the 
growth, development and reproduction of organisms (Ji et al. 2016). Another 
glycolytic protein found to be turnover slowly in our data is pyruvate kinase (PKM). 
PKM irreversibly catalyzes the last step of glycolysis, where the phosphoryl group 
of PEP is transferred to ADP to form pyruvate and ATP. This final step of glycolysis 
is important as the substrates PEP and pyruvate involves in various metabolic 
process (Valentini et al. 2000).  
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Figure 5.30: Glycolysis pathway showing increased half-lives proteins.  
All proteins identified in this study were analysed on DAVID. The pathways linked to BioCarta was 
chosen and several proteins with increased half-lives were found in glycolysis pathway (red circle): 
phosphoglycerate kinase, enolase, phosphoglycerate mutase and pyruvate kinase. The red stars 
represent the remaining proteins found in our data. 
 
HLA complexes showed increased half-lives in infected cells compared to 
uninfected cells (Figure 5.31 b). They took around 37 h (average) to recover 50% 
of their proteins following 48 h of infection. This means that after 48 h infection, 
the proteins are becoming more stable.  
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Figure 5.31: Measurement of protein half-lives for metabolic enzymes and proteins involve in 
antigen processing and presentation.  
RIA, t values were used to derive the degradation rate constant for each protein. From the 
measurements, protein half-lives were determined for several (a) metabolic enzymes, and (b) 
proteins involve in antigen processing and presentation. Each point corresponds to the mean values 
± SD of three biological replicates. 
 
One of the proteins that have significant increased turnover following 48 h 
infection of THP-1 with L. mexicana is peroxiredoxin (PRDX6) which is involved in 
oxidative stress responses and cellular redox homeostasis (Whitbread et al. 2005) 
(Figure 5.32 a). In contrast, superoxide dismutase had decreased half-life in 48 
hpi, compared to 24 hpi (Figure 5.32 a). From the graph in Figure 5.32 b, it is 
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apparent that subunits of ribosomal proteins have different half-lives and do not 
show the same trend.  
 
Figure 5.32: Measurement of protein half-lives for proteins involve in stress response and 
ribosomal pathway.  
RIA, t values were used to derive the degradation rate constant for each protein. From the 
measurements, protein half-lives were determined for several (a) stress proteins, and (b) ribosomal 
proteins. Each point corresponds to the mean values ± SD of three biological replicates. 
 
Evidently, our 48-h dataset contains more missing values compared to 24-h 
dataset. This could be due to the gradual loss of H isotopes, replaced by L isotopes, 
during the chase period. Therefore, to fully understand the modulation and 
turnover of proteins after 48 h infection, data imputation was applied. Missing 
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values in the L/H values were imputed by random selection from a normal 
distribution generated at 1.8 standard deviations, subtracted from the mean, of 
the total L/H ratios distribution and a width of 0.3 sd (as described in chapter 4). 
This places the imputed values at the lower limit of the intensity scale, which 
represents the detection limit of the instrumentation used. The resulting data 
matrix was exported for further discussion.  
Table 5.3: Summary of calculated degradation rate constants and half-lives.  
RIA, t values were used to derive the degradation rate constant for each protein. From the 
measurements, protein half-lives were determined.  
 
 
Uninfected 
24h 
Infected 
24h 
Uninfected 
48h 
Infected 
48h 
Mean kdeg (h-1) 0.03 0.03 0.01 0.01 
Mean half-life (h) 21.74 20.51 47.39 47.33 
Lowest kdeg (h-1) 0.01 0.02 0.01 0.01 
Highest kdeg (h-1) 0.04 0.04 0.02 0.02 
Lowest half-life (h) 16.63 16.8 34.34 34.23 
Highest half-life (h) 84.44 30.36 75.22 85.18 
 
5.4 Discussion 
Perturbations such as infection often elicit major changes in gene and protein 
expression, reflecting the response of host to pathogen or the mechanisms 
exploited by the pathogen to establish infection. Proteins are continuously 
synthesized and degraded as cells maintain homoeostasis but challenges such as 
infection may prompt changes in both protein expression and degradation, leading 
to different turnover rates (Kristensen et al. 2013). It is difficult to study protein 
dynamics globally and to accurately measure half-lives. Degradation will, to some 
extent, effect newly synthesized proteins. Additionally, cell division can influence 
protein levels through dilution effects (Pratt et al. 2002). Dilution has been 
reported to affect degradation by 10% in human cancer cells (Eden et al. 2011; 
Doerr 2011). In non-dividing and slowly dividing cells such as mammalian cells, 
degradation is more dominant than dilution (Jovanovic et al. 2014). In addition, a 
study by Doherty et al.( 2009) did not find a correlation between degradation rate 
with MW, pI, GO classification, the presence of stabilizing residues or the presence 
of PEST sequences. 
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In this work, we employed pulse-chase SILAC to investigate the changes in host 
cell proteome after 24 and 48 h of infection with L. mexicana. Temporal 
proteomics encompasses changes in protein dynamics following infection and 
could give an insight into the physiological response of the host. Over the time-
course, the first 24 hours of infection showed transient changes in protein 
expression. However, the protein expression profiles after 48 h infection reflected 
a changing dynamic of the host-parasite interaction.  
In total, we identified 2104 proteins in control24h (mock-infected), 24 hpi, 
control48h (mock-infected) and 48 hpi groups (biological replicates, n=3). 
Evidently, 48 h datasets contain higher number of missing values due to the 
gradual loss of heavy isotopes over the period. This leaves only 400 significantly 
modulating proteins (p-value < 0.05) because proteins with missing values were 
required to be omitted when applying statistical tests in Perseus. Among the 
proteins that we found to be constantly changing (in terms of degradation and 
turnover) in 24 hpi and 48 hpi THP-1 were pyruvate kinase (PKM), superoxide 
dismutase (SOD2), L-lactate dehydrogenase, alpha-enolase, purine nucleoside 
phosphorylase (PNP), peroxiredoxin-2, succinate dehydrogenase, tubulin beta 
chain, moesin and plastin-2. More importantly, these proteins also had increased 
synthesis rates in infected 48 h compared to 24 h infected cells.  
Since turnover rate correlates with responsiveness to metabolic changes,  proteins 
with the highest turnover rates might be expected to be regulatory proteins, which 
are usually low abundance and might be missed in the analysis (Claydon & Beynon 
2012). High abundance proteins often have low rates of turnover and they perform 
more housekeeping roles in the cell (Claydon & Beynon 2012). Turnover can be 
assessed by monitoring the incorporation or loss of a label into or from the protein 
pool. Very rapid degradation would reflect high turnover proteins.  
A study on ribosomal proteins degradation undertaken by Lam et al. (2007) 
concluded that ribosomal proteins are highly regulated in cells. They found that 
the free newly synthesized ribosomal proteins are rapidly degraded in 
nucleoplasmic compartment. However, when free ribosomal proteins assembled 
into ribosomal subunits and exported to the cytoplasm they acquire long half-lives 
(Lam et al. 2007). Of note, only a subset of newly synthesized ribosomal proteins 
are assembled into ribosomes and exported to the cytoplasm (Lam et al. 2007). It 
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is known that ribosomal proteins are synthesized in excess to ensure that efficient 
ribogenesis is never limited by the available supply of protein components (Lam 
et al. 2007). As apparent in KEGG pathway (Figure 5.8), ribosomal proteins were 
enriched in our data. In line with this notion, several reports demonstrated that 
ribosomal proteins were unstable or rapidly degraded (Helbig et al. 2011a; 
Kristensen et al. 2013; Martin-Perez & Villén 2015). Our degradation data 
indicated that one of the 60 S ribosomal protein, 60S acidic ribosomal protein, 
was degraded by 30% in 24 hpi (10% in control) but further degraded up to 60% in 
48 hpi (15% in control). This suggested that the half-life of 60S subunit ribosomal 
proteins is increased in infected cells, which means that this protein was slowly 
turnover after 48 h infection. Though, Doherty et al. (2009) reported that the 
ribosome subunits do not turnover at a uniform rate. This is held true for several 
ribosomal proteins in our data that showed to be more stable in 48 h of infection, 
including 40S ribosomal protein S12, and 60S ribosomal protein L5. These two 
proteins, as well as 40S ribosomal protein S24 and 40S ribosomal protein S20 had 
longer turnover times in 48 hpi compared to uninfected and 24 hpi. Whereas, 40S 
ribosomal protein S3, 40S ribosomal protein S3a and 60S ribosomal protein L3 had 
shorter turnover times in 48 hpi compared to other groups. Further exploration of 
ribosomal subunit turnover is warranted to validate this.  
Intriguingly, newly synthesized proteins involved in immune responses, including 
HLA complexes, were also shown to be very unstable and rapidly degraded. In 24 
hpi, HLA complexes degraded up to 75% compared to 50% in control, while in 48 
hpi, they were degraded by up to 90% (average half-life 37.88 h). HLA complex is 
a gene complex encoding the MHC proteins that are responsible for the regulation 
of the immune system in humans. It has been well-documented that 
parasitophorous vacuoles of macrophages infected with L. amazonensis and L. 
mexicana contain various lysosomal enzymes including proteases, particularly 
within 48 to 72 h after infection (Antoine et al. 1990; Antoine et al. 1999). In 
addition, parasitophorous membrane contains MHC class II molecules after 
stimulation with IFN-γ. Many pathogens residing in parasitophorous vacuole 
including L. amazonensis and Salmonella internalized MHC II molecules of their 
host cells and degrade them to evade immune recognition by inhibiting 
phagolysosome biogenesis (Antoine et al. 1999; Leao et al. 1995; Mitchell et al. 
2004). These molecules were reported to be degraded by parasite cysteine 
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proteases which are critical for their survival within macrophages (Leao et al. 
1995). Furthermore, phagolysosome biogenesis is driven by complex sets of 
membrane-trafficking events involving soluble N-ethylmaleimide-sensitive factor 
attachment receptor (SNARE). The Leishmania cell surface metalloprotease GP63 
(also regulates cysteine peptidase CPB expressions) able to cleave a subset of 
SNAREs, thereby preventing phagolysosome biogenesis. This in turn inhibits 
presentation of exogenous Leishmania antigens on MHC class I molecules 
(Matheoud et al. 2013; Jaramillo et al. 2011; Casgrain et al. 2016).  
We also observed that several glycolytic proteins were shown to be resistant to 
degradation with kdeg ranges from 0.01 to 0.04 h-1. This observation  coincides with 
reports by Helbig et al. (2011) and Martin-Perez & Villén (2015). Glycolytic 
enzymes such as Hxk1p and Fba1p and TCA cycle proteins were reported to be 
very stable proteins (Helbig et al. 2011a). They also reported that proteins with 
similar function tend to present similar half-lives. Proteins involved in 
mitochondrial related functions (TCA, oxidative phosphorylation) as well as other 
energy production pathways were more stable (Martin-Perez & Villén 2015). 
Having more stable proteins could be one of the many ways for the host cells to 
conserve energy expenditure and focus on counteracting the infection threat 
(Schwanhäusser et al. 2011). Trötschel et al. (2013) reported the analysis of 
protein turnover in bacteria and found that under ideal environmental condition, 
the bacteria do not require large quantities of protein degradation to sustain 
optimal growth. Also, long-lived proteins correlates with protein lifespan and 
damage (Toyama et al. 2013).  
Protein with the shortest measured half-life in our data was interleukin-8 (16.63 
h). Interleukin-8 is a chemokine produced by macrophage and other cells. It was 
found to be significantly elevated in M. tuberculosis-infected U937 cells and may 
be critically associated with distinct host responses in tuberculosis (Song et al. 
2003). It is not surprising that proteins involve in immune response to have higher 
turnover. 
Another confounding discovery was that most of the proteins studied in our work 
only slightly increased their half-lives during early infection (the first 24 h) but 
markedly increased their half-lives during longer exposure to the parasites (48 h 
infection). These observations suggest that the host can quickly recover their 
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proteins during early infection but took longer recovery time when the host is 
exposed to threats for a longer period. Intuitively, we would expect that the half-
lives would increase in response to infection. Additionally, about 50% to 60% of 
the proteins had half-lives longer than the host growth rate (20.4 h).  
Many of the proteins reported in our work have been implicated with Leishmania 
infection (as have been discussed in previous chapter). However, interestingly, no 
report on moesin that can be relate to Leishmania infection. This newly 
synthesized protein was shown to be stable with only 25% degradation rate in 24 
hpi and 30% in 48 hpi, thereby being a low turnover protein.  
5.5 Summary 
It is difficult to understand the complete mechanistic details underpinning 
proteome dynamics, as it is influenced by many factors including localisation and 
external perturbation. Furthermore, different species and cell types exhibit 
different protein turnover rates, whereby smaller mammals have higher turnover 
than larger mammals (Nagy et al. 1999). Having said that, the determination of 
degradation rate is one of the essential parameters to understanding the 
regulation of protein turnover. By corollary, this would be another step toward 
unravelling the dynamic proteome and correlates with host-pathogen interaction. 
Overall, the pulse-chase SILAC combined with MS approach is very useful to 
investigate protein turnover, as it allows measurement of endogenous proteins 
expressed at physiological levels in large-scale without the need to use translation 
inhibitors. This is more favourable because translation inhibitors have been 
reported to affect protein stability (Belle et al. 2006). Furthermore, we observed 
a strong positive correlation (Pearson correlation coefficient close to 1) between 
all data sets, suggesting that they are highly reproducible.  
Temporal proteomics data revealed that the cells synthesized a large number of 
metabolic enzymes in 48 hpi compared to control. From the global perspective, 
the dominance of metabolic processes makes sense given the high-energy costs 
associated with protein synthesis. Our study also demonstrates that proteins with 
roles in infection tend to be rapidly degraded and have shorter half-lives, example 
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being ribosomal proteins (particularly 60S subunits), proteins involved in immune 
response and proteolytic proteins.  
For this work, we deliberately restricted the degradation analysis to relatively few 
hundred proteins due to manual calculations of protein turnover and the time-
consuming nature of this analysis. Furthermore, the data that we have gathered 
should be taken as guidelines rather than absolute measurements as turnover rates 
of individual proteins can change depending on factors including subcellular 
localisation, cell cycle stage, and PTM (Larance et al. 2013; Larance & Lamond 
2015). Nevertheless, this study was able to yield extensive data that provide an 
insight into changes upon infection at two-time points (24 and 48 h), as well as on 
the stability of several important proteins. To our knowledge, this is the first 
report of proteome dynamics in THP-1 in response to L. mexicana infection.  
Collectively, we found that the rates of protein degradation, although globally 
low, were increased in 48 h of infection compared to 24 h of infection. Moreover, 
long-lived protein became longer-lived in response to infection, while short-lived 
proteins only changed slightly.  
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6 Concluding remarks 
6.1 Comparative proteomic analysis in L. mexicana 
revealed striking differences between promastigote 
and amastigote stage 
The differentiation from promastigote to amastigote form in Leishmania species 
is triggered by several environmental changes including elevation of temperature, 
decrease of pH in the phagolysosome, exposure to oxygen and nitrogen reactive 
species, exposure to proteolytic activity as well as nutrition starvation (Besteiro 
et al. 2007). Thus, it is not surprising that these two life-stages of Leishmania 
have different expressions of proteins and metabolic pathways.  
Stable isotope Dimethyl Labelling (DiMe) coupled with MS approach has enabled 
us to investigate differentially expressed proteins in promastigote and axenic 
amastigote. We observed many identified putative proteins that were 
differentially regulated covered a diversity of functions, mainly metabolism, 
redox process, proteolysis and protein synthesis. Promastigotes rely on glycolysis, 
gluconeogenesis and oxidative phosphorylation for energy production. In contrast, 
amastigotes increased fatty acid oxidation as carbon source. Additionally, stress 
response proteins such as tryparedoxin peroxidase, heat shock proteins, and 
glutathione peroxidase were found upregulated in promastigotes. Upregulated 
amastigote proteins included ribosomal proteins, histones, and proteolytic 
enzymes. The findings reported here indicates that the parasite Leishmania 
undergo a variety of metabolic changes during the differentiation. Our results 
substantially advance our knowledge on stage-regulated proteome of Leishmania 
and could complement present data.  
6.2 Pulse-chase SILAC potential to investigate host-
parasite interaction 
Most global gene expression investigations performed to date rely on measuring 
changes in steady-state mRNA levels. However, it is very clear that mRNA 
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expression does not always correlate with protein expression. Since proteins 
mediate most biochemical transformations, there is growing interest in studies of 
gene expression at the protein level. Despite existing data on host cell-Leishmania 
interactions, changes that take place in infected macrophages remain poorly 
understood. The determination of protein degradation rate is one of the essential 
parameters for understanding the regulation of protein turnover. By corollary, this 
would be another step toward unravelling the dynamic proteome and correlating 
it with host-pathogen interaction. 
The pulse-chase SILAC approach presented in this work revealed the changes in 
proteome dynamics in macrophages upon infection with Leishmania. Of note, this 
is the first report utilising pulse-chase SILAC to investigate the proteome dynamic 
upon Leishmania infection. The primary system used here was the human THP-1 
myelomonocytic leukaemia cell line that can be differentiated from monocytes 
into macrophage-like cells by stimulation with PMA. Our aim was to characterize 
the factors affecting regulation of protein expression change during infection by 
measuring the synthesis and degradation rates of proteins, as well as protein half-
lives.  
Temporal proteomics in two time points (24 and 48 h) revealed a distinct 
clustering of modulated proteins, based on Gene Ontology. 24 hpi proteins were 
enriched in cellular process such as cell communication while 48 hpi proteins 
enriched in metabolic process. During the first 24 h of infection, THP-1 cells 
appear to respond to invading L. mexicana by increasing the production of stress 
response proteins and apoptotic proteins (based on increasing RIA synthesis). 
Additionally, proteins involve in cell communication, cell growth, phagocytosis 
and cell cycle such as IL-8, a known chemotactic factor, TNF-α-induced protein, 
apoptosis regulator BAX, caspase 3 and STAT1 were also had increased synthesis. 
Our data also suggest that L. mexicana might modulate the host to induce M2 type 
of macrophage activation due to the increased synthesis of IL-10 and TNF-α. 
Furthermore, the parasite may have used the increasing apoptosis to their 
advantage. It is known that several pathogens modulate apoptotic machinery to 
replicate inside the macrophage and hide without triggering host’s immune 
response (Bruchhaus et al. 2007; Getti et al. 2008).  
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Another key finding during the 24 hpi were protein synthesis of several glycolytic 
enzymes was lower than the uninfected cells. Instead, the synthesis of proteins 
involve in oxidative phosphorylation was increasing. TNF-α-IP8 has been shown to 
inhibit the production of nitric oxide which resulted in the increasing of oxidative 
phosphorylation (Moreira et al. 2015). Interesting, we found the opposite trends 
for these proteins in 48 hpi. Several glycolytic enzymes had higher synthesis rate 
compared to uninfected while oxidative phosphorylation proteins had decreased 
synthesis in 48 hpi. We hypothesized that this could be correlated with the time 
taken for promastigotes to differentiate to amastigotes. Further, our degradation 
data revealed that these glycolytic proteins and oxidative phosphorylation 
proteins were stable and have long half-lives. These findings were similar to the 
report by Helbig et al. (2011) and Martin-Perez & Villén (2015).  Host cells might 
trying to conserve energy expenditure and focus on counteracting the infection 
threat by having more stable proteins (Schwanhäusser et al. 2011).  
Among the proteins that we found to be significantly changing in 24 hpi and 48 hpi 
THP-1 were PKM, SOD2, LDHA, PNP, tubulin beta chain, moesin and 14-3-3 protein. 
PKM, SOD2, PNP, tubulin beta chain and moesin had lower synthesis in 24 hpi 
compared to uninfected but increased synthesis in 48 hpi. Except PKM and SOD2 
which were rapidly degraded proteins, the rest of the proteins were relatively 
stable in uninfected and infected groups. On the other hand, LDHA had higher 
synthesis in 24 hpi but was slowly synthesized in 48 hpi, while 14-3-3 protein had 
increased translation in both 24 and 48 hpi. Unlike LDHA, 14-3-3 was rapidly 
degraded upon infection. Remarkably, 14-3-3 has been found to be inhibit the 
activity of pro-apoptotic member of Bcl-2 family in macrophage infected with L. 
donovani (Gupta et al. 2016). 
Taking all of this together, pulse-chase SILAC coupled with high resolution mass 
spectrometry reveals as a promising approach to investigate global degradation 
profile and ultimately protein turnover. Comparative studies of proteome 
dynamics may contribute to elucidation of the host-pathogen relationship.  
234 
 
 
Figure 6.1: Illustration of several proteins expression in 24 and 48 hpi.  
Following 24 h infection, PKM which catalyses the final step in glycolysis to produce pyruvate and 
ATP was decreased. The decreased of PKM prevents production of pyruvate but instead used the 
glucose flux for PPP, resulted in ROS detoxification. In 48 hpi, PKM was increased. Cytochrome c 
that was released by mitochondria activates caspase-9 which activates caspase-3 and induces 
apoptosis. Activation of TNF-α induced IL-10 which reduced expression of Bcl-2 (pro-apoptotic). Bax 
also induces apoptosis.  
 
6.3 Drug targets 
Many of Leishmania virulence factors have been reported (Diniz Atayde et al. 
2016). Proteins such as GP63, cysteine peptidases and peroxiredoxins have the 
potential as molecular targets to develop new treatment approaches or as 
prognostic markers. Evidently, numerous macrophage proteins are known to be 
targeted by GP63, including PTP-1B, NF-κB, STAT1, and AP1. GP63 causes rapid 
cleavage and activation of three host phosphatases: SHP-1, PTP1B, and TCPTP, 
thereby attenuating the innate immune response against the parasite (Yao et al. 
2003; Isnard et al. 2012; Olivier et al. 2012). Moreover, parasite could evade the 
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host complement-mediated lysis as well as parasite binding and phagocytosis by 
modulating host signalling pathways through GP63 (Isnard et al. 2012). GP63 
degrades components of extra-cellular matrix (ECM) such as fibronectin to 
facilitate the migration of promastigotes (Mcgwire et al. 2003). Furthermore, 
proteins downregulated upon infection might be substrates for proteases released 
by Leishmania. Our observations detected rapid degradation of MHC molecules 
such as HLA (by up to 90% after 48 h infection). As it is well-established that 
Leishmania cysteine proteases degrade MHC molecules, these could be further 
evaluated as drug target (Leao et al. 1995).  
Intracellular degradation is tightly regulated and plays major roles in many 
pathways including cell cycle, metabolism, antigen presentation and quality 
control. Many proteins are degraded through proteasome-mediated degradation 
pathway (Bedford et al. 2011). Hence, substrates for this pathway would be an 
ideal platform for drug targeting.  
Many of the proteins discussed in this thesis have previously been implicated in a 
host response to intracellular pathogens. Such example was Bcl-2 that has been 
shown to accelerate L. donovani clearance when inhibited, therefore have anti-
leishmanial potential (Pandey et al. 2016). However, some proteins, including 14-
3-3 and moesin, have not been reported to be associated with Leishmania 
infection. Given that these proteins have a multitude of important functions in 
cells and they both have been significantly changing in 24 and 48 hpi data, these 
would be a novel target for further investigation.  
6.4 Future suggestions 
The pcSILAC approach generates data that might permit the inference of protein 
synthesis profiles and protein turnover profiles. Analysis could be extended to 
include measuring the rate of heavy isotope incorporation as well as the loss of 
heavy label at various time points prior to and after perturbation in order to get 
robust synthesis and degradation profiles. Having this together with the synthesis 
and degradation profiles generated in this study would enable calculation of the 
relative low and high turnover. This is because low turnover proteins might not 
incorporate the label whereas high turnover proteins might undergo extensive 
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replacement. Thus, having more time-points with shorter intervals could cover 
both low and high turnover proteins (Claydon & Beynon 2012). 
For specific proteins that show interesting difference in modulation between 
uninfected and infected cells, live-cell fluorescence imaging could enable 
measurement of the dynamics of specific proteins, in real time, in living cells. For 
validation, genetic perturbation (knock down or knock out) of interesting proteins 
would offer more information on the physiology of macrophages infected with 
Leishmania. 
Protein degradation is controlled by different factors such as subcellular 
localisation and PTMs (Fischer et al. 2012). For example, many nuclear proteins in 
rat tissues have low turnover and have longer life span (Toyama et al. 2013). 
Therefore, combining subcellular fractionation with protein turnover analysis 
would greatly increase the information gained compared with the analysis of total 
cell lysates. Ultimately, multidimensional analysis of the infected macrophage 
proteome, including studies of isoform expression, PTMs, and cell interactions 
(Figure 6.1) will substantially increase our understanding of the complex host-
pathogen relationship.  
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Figure 6.2: Multidimensional proteome analysis of cells.  
Proteins can have many different properties (dimensions) that are either largely physically (yellow 
shaded area), chemically (orange shaded area) or biologically (beige shaded area) relevant. Shown 
in this figure are some of the properties that are most important for cell biology research and those 
that need to be taken into consideration when developing new separation methods for 
multidimensional analysis. Adapted from Larance & Lamond (2015). 
 
Consequently, it would be ideal to link proteomics data with metabolomics data 
to obtain insight into the metabolic architecture of a cell or organism in response 
to infection at unprecedented depth and specificity.  
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8 Appendix 
8.1         Proteins quantified (upregulated) in L. mexicana promastigote 
 
Accession No. Mascot Score MW L/H ratio Protein name 
LmxM.26.0620 28 10695 19.17 10 kDa heat shock protein, putative 
LmxM.11.0350 31 29414 6.37 14-3-3 protein, putative 
LmxM.36.3210 29 29782 6.37 14-3-3 protein-like protein 
LmxM.33.4340 44 25088 4.20 20s proteasome beta 7 subunit, (putative) 
LmxM.28.2420 38 41939 1.85 
2-oxoglutarate dehydrogenase, E2 component, dihydrolipoamide 
succinyltransferase, putative 
LmxM.30.2250 31 38642 6.77 3,2-trans-enoyl-CoA isomerase, mitochondrial precursor, putative 
LmxM.32.1590 19 36460 1.08 3-ketoacyl-CoA reductase, putative 
LmxM.30.2310 59 41697 1.48 3'-nucleotidase/nuclease precursor, putative 
LmxM.22.1520 36 20201 3.50 40S ribosomal protein L14, putative 
LmxM.08_29.1800 66 14858 3.85 40S ribosomal protein S15A, putative 
LmxM.26.0880 48 16777 2.04 40S ribosomal protein S16, putative 
LmxM.28.2555 61 16398 2.72 40S ribosomal protein S17, putative 
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Accession No. Mascot Score MW L/H ratio Protein name 
LmxM.36.0930 19 17471 2.72 40S ribosomal protein S18, putative 
LmxM.19.0060 28 33009 2.48 40S ribosomal protein S2 
LmxM.15.0950 66 24741 1.36 40S ribosomal protein S3, putative 
LmxM.26.1630 41 9797 1.33 40S ribosomal protein S33, putative 
LmxM.34.0400 38 30245 1.26 40S ribosomal protein S3A, putative 
LmxM.13.1220 70 48291 3.28 40S ribosomal protein S4, putative 
LmxM.24.2070 36 24729 1.74 40S ribosomal protein S8, putative 
LmxM.19.1005 27 72621 2.66 4-coumarate:coa ligase-like protein 
LmxM.23.0543 35 117876 3.55 5'-3' exonuclease XRNC, putative 
LmxM.30.0010 118 86681 3.29 
5-methyltetrahydropteroyltriglutamate--
homocysteinemethyltransferase, putative 
LmxM.04.0750 32 24940 3.28 60S ribosomal protein L10, putative 
LmxM.08_29.2460 85 24900 4.54 60S ribosomal protein L13, putative 
LmxM.24.0040 22 19299 2.66 60S ribosomal protein L17, putative 
LmxM.18.1400 30 19368 2.38 60S ribosomal protein L34, putative 
LmxM.34.1880 75 34065 1.73 60S ribosomal protein L5, putative 
LmxM.07.0510 96 34049 1.23 60S ribosomal protein L7a, putative 
LmxM.08_29.2510 27 54602 3.68 6-phospho-1-fructokinase, putative 
LmxM.34.3340 92 52591 15.06 6-phosphogluconate dehydrogenase, decarboxylating, putative 
274 
 
Accession No. Mascot Score MW L/H ratio Protein name 
LmxM.32.1300 14 71322 5.77 ABC transporter, putative 
LmxM.33.0670 21 229070 13.24 ABC transporter-like protein 
LmxM.15.0760 22 294095 7.26 ABC1 transporter-like protein 
LmxM.18.0510 30 98265 2.20 aconitase, putative 
LmxM.04.1230 108 40685 13.21 actin 
LmxM.28.2510 38 69757 4.35 acyl-CoA dehydrogenase, putative 
LmxM.34.2730 37 44782 2.86 acyl-CoA dehydrogenase, putative 
LmxM.26.0140 29 26272 2.58 adenine phosphoribosyltransferase 
LmxM.29.0880 71 37766 6.69 adenosine kinase, putative 
LmxM.21.1250 25 30073 2.85 adenylate kinase, putative 
LmxM.19.0200 70 35520 5.75 ADP,ATP carrier protein 1, mitochondrial precursor, putative 
LmxM.19.0210 48 35536 6.70 
ADP,ATP carrier protein 1, mitochondrial precursor, putative,ADP/ATP 
translocase 1, putative 
LmxM.30.2790 56 20230 1.88 ADP-ribosylation factor, putative 
LmxM.33.2580 21 22616 9.03 ALBA-domain protein 3 
LmxM.25.1120 51 54795 4.44 aldehyde dehydrogenase, mitochondrial precursor 
LmxM.13.0280 288 61058 14.68 alpha tubulin 
LmxM.27.1310 31 78594 2.38 arginyl-tRNA synthetase, putative 
LmxM.16.0540 87 35620 1.67 aspartate carbamoyltransferase, putative 
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Accession No. Mascot Score MW L/H ratio Protein name 
LmxM.21.1770 56 34671 5.11 ATP synthase F1 subunit gamma protein, putative 
LmxM.25.1180 120 53265 8.06 ATP synthase subunit beta, mitochondrial 
LmxM.29.3600 25 20315 19.92 ATP synthase, epsilon chain, putative 
LmxM.05.0510 29 73310 13.82 ATPase alpha subunit, putative 
LmxM.05.0500 64 62845 1.90 ATPase alpha subunit, putative 
LmxM.25.1170 120 56458 8.06 ATPase beta subunit, putative 
LmxM.33.3350 14 59094 2.29 ATPase-like protein 
LmxM.11.1220 14 187925 2.18 ATP-binding cassette protein subfamily A, member 2, putative 
LmxM.11.1250 14 229693 1.69 ATP-binding cassette protein subfamily A, member 4, putative 
LmxM.34.0370 82 46678 3.91 ATP-dependent DEAD-box RNA helicase, putative 
LmxM.34.3100 51 101215 3.99 ATP-dependent RNA helicase, putative 
LmxM.34.3100 51 101215 3.99 ATP-dependent RNA helicase, putative 
LmxM.05.0360 14 66210 16.23 ATP-dependent RNA helicase, putative 
LmxM.31.0400 111 68201 10.2 ATP-dependent RNA helicase, putative 
LmxM.32.3210 26 98888 8.22 beta prime cop protein, putative 
LmxM.08.1230 725 46842 9.29 beta tubulin 
LmxM.21.1860 744 50394 11.65 beta tubulin 
LmxM.32.0794 690 55687 8.86 beta tubulin 
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Accession No. Mascot Score MW L/H ratio Protein name 
LmxM.09.0910 87 16814 28.45 calmodulin, putative 
LmxM.20.1180 35 104946 2.71 calpain-like cysteine peptidase 
LmxM.20.1185 37 73942 3.02 calpain-like cysteine peptidase, putative 
LmxM.20.1310 36 15167 5.20 
calpain-like cysteine peptidase, putative,calpain-like cysteine 
peptidase, Clan CA, family C2 
LmxM.04.0450 36 89443 3.59 
calpain-like cysteine peptidase, putative,cysteine peptidase, Clan CA, 
family C2, putative 
LmxM.32.2540 48 57378 3.63 
carboxypeptidase, putative,metallo-peptidase, Clan MA(E), Family 
M32 
LmxM.29.0710 18 62847 3.28 CDC16, putative 
LmxM.21.1080 32 34737 2.55 cell division protein kinase 2,cdc2-related kinase 
LmxM.22.1410 71 16437 1.08 centrin, putative,Ca2 -binding EF-hand protein 
LmxM.34.2980 18 51628 3.69 chaperone protein DNAj, putative 
LmxM.31.3270 20 59552 3.55 chaperonin alpha subunit, putative 
LmxM.36.2030 331 59903 6.77 chaperonin HSP60, mitochondrial precursor 
LmxM.36.2020 322 60610 5.48 chaperonin HSP60, mitochondrial precursor 
LmxM.32.1060 19 105907 2.64 chloride channel protein, putative 
LmxM.06.0120 24 20535 2.67 cyclophilin 
LmxM.34.3230 57 45102 6.70 cystathione gamma lyase, putative 
LmxM.08_29.0820 47 38009 1.53 
cysteine peptidase C (CPC),CPC cysteine peptidase, Clan CA, family 
C1, Cathepsin B-like 
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LmxM.05.0960 21 76027 4.16 
dipeptidyl-peptidase III, putative,metallo-peptidase, Clan M-, Family 
M49 
LmxM.22.1110 21 627131 1.03 dynein heavy chain, cytosolic, putative 
LmxM.17.0083 111 23325 22.56 elongation factor 1-alpha 
LmxM.17.0080 180 49575 20.27 elongation factor 1-alpha 
LmxM.17.0084 62 23439 8.12 elongation factor 1-alpha 
LmxM.36.0180 520 94852 6.29 elongation factor 2 
LmxM.36.0180 520 94852 6.29 elongation factor 2 
LmxM.09.0970 101 46514 6.29 elongation factor-1 gamma 
LmxM.14.1160 296 46743 6.90 enolase 
LmxM.01.0770 95 51225 3.10 Eukaryotic initiation factor 4A-1 
LmxM.14.0660 51 32705 7.40 fatty acid elongase, putative 
LmxM.16.0910 24 18262 9.04 flagellar calcium-binding protein, putative 
LmxM.36.1260 175 41150 9.68 fructose-1,6-bisphosphate aldolase 
LmxM.34.3700 47 25320 6.71 Gim5A protein, putative,glycosomal membrane protein 
LmxM.22.0660 23 115396 9.48 glucoamylase-like protein 
LmxM.28.1200 107 71919 3.90 glucose-regulated protein 78, putative 
LmxM.15.1010 155 115208 4.08 glutamate dehydrogenase 
LmxM.28.2910 80 49561 5.41 glutamate dehydrogenase, putative 
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LmxM.06.0370 36 42893 1.79 glutamine synthetase, putative 
LmxM.29.2980 135 39326 16.81 glyceraldehyde 3-phosphate dehydrogenase, glycosomal 
LmxM.19.0710 41 33934 6.14 glycosomal malate dehydrogenase 
LmxM.27.1810 189 58742 3.27 glycosomal phosphoenolpyruvate carboxykinase, putative 
LmxM.27.1805 144 58770 16.68 glycosomal phosphoenolpyruvate carboxykinase, putative 
LmxM.18.0900 18 95809 3.67 glycosyltransferase, putative 
LmxM.29.2460 110 69430 8.61 heat shock 70-related protein 1, mitochondrial precursor, putative 
LmxM.29.2490 165 72990 8.35 heat shock 70-related protein 1, mitochondrial precursor, putative 
LmxM.29.2470 93 37663 8.31 heat shock 70-related protein 1, mitochondrial precursor, putative 
LmxM.26.1240 49 71012 2.18 heat shock protein 70-related protein 
LmxM.32.0312 293 81035 14.52 heat shock protein 83-1 
LmxM.18.1370 40 92808 8.87 heat shock protein, putative 
LmxM.28.2770 382 71482 7.68 heat-shock protein hsp70, putative 
LmxM.21.0240 87 61385 2.94 hexokinase, putative 
LmxM.21.0250 34 52151 2.59 hexokinase, putative 
LmxM.08_29.1720 77 14066 4.46 histone H2A, putative 
LmxM.17.1220 98 11991 14.82 histone H2B 
LmxM.09.1340 188 11957 10.46 histone H2B 
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LmxM.19.0030 160 11970 7.88 histone H2B 
LmxM.10.0870 69 14848 9.10 histone H3 
LmxM.16.0570 101 14838 5.05 histone H3 
LmxM.19.0630 43 16601 2.94 histone H3 variant, putative 
LmxM.15.0010 89 11436 7.14 histone H4 
LmxM.21.0015 21 12023 7.14 histone H4 
LmxM.06.0010 46 11436 6.21 histone H4 
LmxM.25.2450 87 11485 6.14 histone H4 
LmxM.25.2450 87 11485 6.14 histone H4 
LmxM.13.0290partial 94 17294 13.07 hypothetical protein 
LmxM.08.1171 789 50319 13.06 hypothetical protein 
LmxM.02.0440 13 86359 12.97 hypothetical protein 
LmxM.28.3030 13 149181 19.92 hypothetical protein 
LmxM.19.1160 61 41571 13.41 hypothetical protein, conserved 
LmxM.04.0890 29 136979 9.05 hypothetical protein, conserved 
LmxM.22.0730 70 47352 7.43 hypothetical protein, conserved 
LmxM.36.5850 27 57706 7.24 hypothetical protein, conserved 
LmxM.22.0180 35 28357 7.14 hypothetical protein, conserved 
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LmxM.09.1010 55 67747 7.12 hypothetical protein, conserved 
LmxM.08.1100 24 42412 6.61 hypothetical protein, conserved 
LmxM.02.0460 35 32685 6.48 hypothetical protein, conserved 
LmxM.18.0240 17 43943 6.40 hypothetical protein, conserved 
LmxM.18.0390 14 181357 6.40 hypothetical protein, conserved 
LmxM.18.0110 15 164316 6.09 hypothetical protein, conserved 
LmxM.33.1520 123 14372 5.91 hypothetical protein, conserved 
LmxM.32.3090 16 159229 5.58 hypothetical protein, conserved 
LmxM.08_29.2680 13 121186 5.08 hypothetical protein, conserved 
LmxM.07.0920 14 243484 4.53 hypothetical protein, conserved 
LmxM.33.0190 36 56463 4.47 hypothetical protein, conserved 
LmxM.14.0190 41 22472 4.07 hypothetical protein, conserved 
LmxM.25.2010 83 30664 3.97 hypothetical protein, conserved 
LmxM.32.2440 92 56640 3.83 hypothetical protein, conserved 
LmxM.18.1250 18 83076 3.70 hypothetical protein, conserved 
LmxM.18.1360 17 108396 3.70 hypothetical protein, conserved 
LmxM.27.0650 46 19702 3.70 hypothetical protein, conserved 
LmxM.26.2000 26 39646 3.55 hypothetical protein, conserved 
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LmxM.26.1960 72 90388 3.38 hypothetical protein, conserved 
LmxM.15.1340 23 39975 3.17 hypothetical protein, conserved 
LmxM.19.0020 24 40574 3.01 hypothetical protein, conserved 
LmxM.23.1580 64 17008 2.88 hypothetical protein, conserved 
LmxM.34.3720 48 50938 2.80 hypothetical protein, conserved 
LmxM.29.1870 24 135476 2.72 hypothetical protein, conserved 
LmxM.17.0870 41 48831 2.55 hypothetical protein, conserved 
LmxM.18.0820 32 292990 2.53 hypothetical protein, conserved 
LmxM.18.0930 21 94529 2.53 hypothetical protein, conserved 
LmxM.36.0740 20 61499 2.53 hypothetical protein, conserved 
LmxM.18.0940 14 139924 2.34 hypothetical protein, conserved 
LmxM.18.1250 18 83076 2.34 hypothetical protein, conserved 
LmxM.21.0430 53 47692 2.23 hypothetical protein, conserved 
LmxM.21.1567 19 38082 2.18 hypothetical protein, conserved 
LmxM.22.1100 22 240267 2.18 hypothetical protein, conserved 
LmxM.24.0140 14 43131 2.18 hypothetical protein, conserved 
LmxM.17.0010 53 88600 2.17 hypothetical protein, conserved 
LmxM.36.5910 60 41601 1.93 hypothetical protein, conserved 
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LmxM.36.5250 26 373769 1.79 hypothetical protein, conserved 
LmxM.09.0190 15 14523 1.77 hypothetical protein, conserved 
LmxM.26.0740 15 91756 1.66 hypothetical protein, conserved 
LmxM.31.1800 18 25409 1.61 hypothetical protein, conserved 
LmxM.36.5160 22 65802 1.60 hypothetical protein, conserved 
LmxM.36.1500 18 97331 1.32 hypothetical protein, conserved 
LmxM.17.1270 16 36860 1.16 hypothetical protein, conserved 
LmxM.36.1520 35 57171 1.13 hypothetical protein, conserved 
LmxM.31.2850 20 70575 1.01 hypothetical protein, conserved 
LmxM.24.1470 26 306493 14.8 hypothetical protein, conserved 
LmxM.24.0260 17 357925 9.93 hypothetical protein, conserved 
LmxM.04.0740 16 82689 9.15 hypothetical protein, conserved 
LmxM.04.0050 29 58805 9.05 hypothetical protein, conserved 
LmxM.24.1580 19 42904 8.40 hypothetical protein, conserved 
LmxM.01.0430 25 82297 8.34 hypothetical protein, conserved 
LmxM.24.1910 28 13591 8.29 hypothetical protein, conserved 
LmxM.13.0450 76 13372 8.07 hypothetical protein, conserved 
LmxM.17.0100 14 71022 7.43 hypothetical protein, conserved 
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LmxM.14.1440 24 109459 2.49 hypothetical protein, conserved 
LmxM.23.1020 132 12671 7.22 hypothetical protein, unknown function 
LmxM.02.0550 74 17721 6.75 hypothetical protein, unknown function 
LmxM.29.2060 22 104057 1.46 hypothetical protein, unknown function 
LmxM.22.1460 30 23264 11.05 i/6 autoantigen-like protein 
LmxM.24.1500 58 31472 7.13 IgE-dependent histamine-releasing factor, putative 
LmxM.19.1560 27 56102 7.34 inosine-5'-monophosphate dehydrogenase 
LmxM.08.0200 15 71576 12.54 Inositol phosphosphingolipids phospholipase C 
LmxM.31.1830 107 23527 8.39 iron superoxide dismutase, putative 
LmxM.31.1820 124 21994 8.66 iron superoxide dismutase, putative 
LmxM.10.0290 56 48772 8.53 isocitrate dehydrogenase [NADP], mitochondrial precursor, putative 
LmxM.34.2220 53 11201 55.37 kinetoplastid membrane protein-11 
LmxM.34.2210 60 11271 13.99 kinetoplastid membrane protein-11 
LmxM.33.0160 62 34272 1.61 malate dehydrogenase, putative 
LmxM.24.0761 60 62922 2.48 malic enzyme 
LmxM.23.0110 81 41849 6.92 mannose-1-phosphate guanyltransferase 
LmxM.05.0380 81 89588 25.37 microtubule-associated protein, putative 
LmxM.14.0920 20 170228 1.52 mitochondrial DNA polymerase I protein C, putative 
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LmxM.34.1380 23 55120 1.76 
mitochondrial processing peptidase, beta subunit, putative,metallo-
peptidase, Clan ME, Family M16 
LmxM.30.3035 26 37629 7.09 mu-adaptin 4, putative (pseudogene) 
LmxM.19.0190 72 18454 6.22 multiprotein-bridging factor 1, putative 
LmxM.23.0360 60 39199 4.08 NADP-dependent alcohol dehydrogenase, putative 
LmxM.13.1210 36 55108 3.06 nucleobase transporter 
LmxM.31.2950 68 16891 22.67 nucleoside diphosphate kinase b 
LmxM.36.1940 182 54565 5.18 nucleoside transporter 1, putative 
LmxM.16.0550 128 50003 4.25 
orotidine-5-phosphate decarboxylase/orotate 
phosphoribosyltransferase, putative,OMPDCase-OPRTase, putative 
LmxM.05.0040 20 68912 13.4 paraflagellar rod component par4, putative 
LmxM.08_29.1750 33 69389 4.80 paraflagellar rod protein 1D, putative 
LmxM.16.1430 69 76580 9.46 paraflagellar rod protein 2C 
LmxM.16.1425partial 39 23043 7.99 paraflagellar rod protein 2C 
LmxM.02.0740 34 76921 1.31 
peptidyl dipeptidase, putative,metallo-peptidase, Clan MA(E), Family 
M3 
LmxM.23.0040 107 25585 3.50 peroxidoxin,tryparedoxin peroxidase 
LmxM.26.2400 24 25213 3.50 peroxisomal membrane protein 4, putative 
LmxM.33.0990 30 147839 3.50 p-glycoprotein 
LmxM.27.1807 125 38018 5.21 Phosphoenolpyruvate carboxykinase [ATP], glycosomal 
LmxM.20.0100 47 51986 14.48 phosphoglycerate kinase C, glycosomal 
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LmxM.09.0891 114 14962 14.8 polyubiquitin, putative 
LmxM.36.3530partial 83 8917 9.31 polyubiquitin, putative 
LmxM.36.1635 70 15594 9.31 poly-zinc finger protein 2, putative 
LmxM.24.0380 36 105916 9.31 ppg3-related protein-like protein 
LmxM.36.1600 22 29851 2.83 proteasome alpha 1 subunit, putative 
LmxM.12.0030 77 30881 8.33 proteasome beta-1 subunit, putative 
LmxM.36.6940 36 52611 5.02 protein disulfide isomerase 
LmxM.36.5090 14 31193 5.03 protein kinase ck2 regulatory subunit, putative 
LmxM.06.0640 14 321148 5.02 protein kinase, putative 
LmxM.08.0660 15 148179 4.08 protein kinase, putative 
LmxM.09.0400 15 49300 4.08 protein kinase, putative 
LmxM.28.3000 14 43321 3.84 protein kinase, putative 
LmxM.28.1760 15 174421 3.74 protein kinase, putative 
LmxM.32.2070 13 109815 3.74 protein kinase, putative 
LmxM.27.2470 35 62067 1.94 protein kinase, putative 
LmxM.20.0770 16 419591 1.65 protein kinase, putative 
LmxM.15.1200 15 289447 1.78 protein kinase, putative 
LmxM.19.0590 13 159845 1.78 protein kinase, putative 
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LmxM.25.1520 21 101474 1.65 protein kinase, putative 
LmxM.05.0280 49 25210 1.35 protein tyrosine phosphatase, putative 
LmxM.25.1710 92 38476 3.05 pyruvate dehydrogenase E1 beta subunit, putative 
LmxM.18.1380 27 43156 2.84 pyruvate dehydrogenase E1 component alpha subunit, putative 
LmxM.34.0020 24 29143 3.00 pyruvate kinase 
LmxM.34.0030 23 54842 4.16 pyruvate kinase, putative 
LmxM.11.1000 55 101685 2.26 pyruvate phosphate dikinase, putative 
LmxM.17.0191 22 154125 5.11 receptor-type adenylate cyclase a 
LmxM.36.3180 16 153406 1.94 receptor-type adenylate cyclase a-like protein 
LmxM.33.2820 54 72033 3.84 regulatory subunit of protein kinase a-like protein 
LmxM.08_29.1070 30 41195 1.50 ribosomal protein L1a, putative 
LmxM.03.0250 25 9619 3.75 ribosomal protein L38, putative 
LmxM.25.0490 58 19915 1.55 RNA-binding protein, putative, UPB1 
LmxM.36.3910 71 48525 7.38 S-adenosylhomocysteine hydrolase 
LmxM.23.1200 15 54903 10.54 S-adenosyl-methyltransferase mraW-like protein 
LmxM.20.1680 14 141265 9.33 separin, putative 
LmxM.11.0100 67 53671 3.40 seryl-tRNA synthetase, putative 
LmxM.11.0100 30 53671 5.29 seryl-tRNA synthetase, putative 
287 
 
Accession No. Mascot Score MW L/H ratio Protein name 
LmxM.10.0910 39 23629 3.09 small GTP-binding protein Rab11, putative,Rab11 GTPase, putative 
LmxM.10.0910 39 23629 3.09 small GTP-binding protein Rab11, putative,Rab11 GTPase, putative 
LmxM.14.0850 53 13055 9.85 small myristoylated protein-3, putative 
LmxM.11.0050 43 108666 34.46 SNF2/RAD54 related DNA helicase, putative 
LmxM.23.0650 16 24363 5.07 
spliceosomal U5 snRNP-specific protein, putative,DIM-like protein, 
putative 
LmxM.36.0070 47 29244 2.53 stress-inducible protein STI1 homolog 
LmxM.36.2950 87 44526 12.39 succinyl-CoA ligase [GDP-forming] beta-chain, putative 
LmxM.25.2130 42 31175 10.54 succinyl-CoA synthetase alpha subunit, putative 
LmxM.25.2140 35 31209 10.54 succinyl-CoA synthetase alpha subunit, putative 
LmxM.32.2340 142 53127 1.60 
succinyl-coA:3-ketoacid-coenzyme A transferase, mitochondrial 
precursor, putative 
LmxM.08_29.0070 14 30016 1.32 syntaxin, putative 
LmxM.21.1090 27 60294 1.74 T-complex protein 1, delta subunit, putative 
LmxM.23.1220 17 60877 1.91 T-complex protein 1, gamma subunit, putative 
LmxM.36.6910 69 58716 3.50 T-complex protein 1, theta subunit, putative 
LmxM.36.3930 33 159222 2.44 telomerase reverse transcriptase, putative 
LmxM.24.2280 16 92641 5.21 
TFIIH basal transcription factor complex helicase subunit, 
putative,RAD3/XPD protein, putative,DNA excision repair protein, 
putative 
LmxM.26.1570 26 77680 2.28 
thimet oligopeptidase, putative,metallo-peptidase, Clan MA(E), Family 
M3 
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LmxM.03.0450 24 167515 10.55 TLD domain protein, conserved 
LmxM.16.0760 94 37238 7.39 transaldolase, putative 
LmxM.24.2060 63 72496 5.18 transketolase, putative 
LmxM.36.1430 48 22940 8.00 translation elongation factor 1-beta, putative 
LmxM.33.0840 57 34278 6.34 translation elongation factor 1-beta, putative 
LmxM.22.1240 16 86462 6.34 translation initiation factor IF-2, putative 
LmxM.08_29.0680 37 81217 1.86 Triple RNA binding domain protein 3 
LmxM.05.0350 33 53710 5.18 trypanothione reductase 
LmxM.15.1040 160 22557 5.44 tryparedoxin peroxidase 
LmxM.15.1160 184 22538 1.15 tryparedoxin peroxidase 
LmxM.15.1160 184 22538 15.92 tryparedoxin peroxidase 
LmxM.08_29.1160 95 16739 9.43 tryparedoxin 
LmxM.31.2930 13 57104 11 tubulin-tyrosine ligase-like protein 
LmxM.26.0800 58 20601 1.38 type II (glutathione peroxidase-like) tryparedoxin peroxidase 
LmxM.09.0420 18 105747 9.31 tyrosine phosphatase, putative 
LmxM.34.3060 23 127523 1.77 ubiquitin-activating enzyme e1, putative 
LmxM.13.1580 22 16194 2.74 ubiquitin-conjugating enzyme-like protein 
LmxM.30.1900 138 14958 9.93 ubiquitin-fusion protein 
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LmxM.36.1620 70 21349 10.72 universal minicircle sequence binding protein 
LmxM.36.1610 61 13441 19.93 universal minicircle sequence binding protein, putative 
LmxM.13.0300 86 32748 5.05 unspecified product 
LmxM.03.0770 24 58387 5.00 unspecified product 
LmxM.03.0350 38 148740 5.00 unspecified product 
LmxM.04.0350 37 229064 3.80 unspecified product 
LmxM.08.1040b 33 39253 3.13 unspecified product 
LmxM.30.0440 30 80817 2.09 unspecified product 
LmxM.16.1010partial 19 102411 2.09 unspecified product 
LmxM.08.1040 34 55540 2.09 unspecified product 
LmxM.30.0440b 33 49733 1.37 unspecified product 
LmxM.04.0760 32 29836 1.33 unspecified product 
LmxM.29.1280 17 159199 16.23 vacuolar assembly protein vps41, putative 
LmxM.33.3670 14 68282 15.43 vacuolar ATP synthase catalytic subunit A, putative 
LmxM.28.2430 20 55837 12.31 vacuolar ATP synthase subunit b, putative 
LmxM.36.2230 15 62870 3.35 vacuolar protein sorting-associated protein 45- like protein 
LmxM.25.2180 14 67310 3.09 vacuolar protein sorting-like protein 
LmxM.21.0470 32 112525 30.15 vacuolar sorting-associated-like protein 
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LmxM.30.1220 91 84295 3.96 vacuolar-type proton translocating pyrophosphatase 1, putative 
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Accession No. Mascot Score MW L/H ratio Protein name 
LmxM.36.3210 40 29782 0.003 14-3-3 protein-like protein 
LmxM.36.6650 39 61118 0.30 2,3-bisphosphoglycerate-independent phosphoglycerate mutase 
LmxM.32.0830 40 79396 0.12 2,4-dienoyl-coa reductase fadh1, putative 
LmxM.29.0180 31 31406 0.47 2-hydroxy-3-oxopropionate reductase, putative 
LmxM.23.0690 29 47855 0.26 3-ketoacyl-CoA thiolase-like protein 
LmxM.30.2300 14 47149 0.09 3'-nucleotidase/nuclease, putative 
LmxM.13.0570 25 15810 0.82 40S ribosomal protein S12, putative 
LmxM.22.0420 22 17424 0.99 40S ribosomal protein S15, putative 
LmxM.08_29.2860 60 18313 0.51 40S ribosomal protein S19-like protein 
LmxM.21.1780 48 28302 0.97 40S ribosomal protein S6, putative 
LmxM.07.0680 15 22257 0.78 40S ribosomal protein S9, putative 
LmxM.36.5010 37 27837 0.85 40S ribosomal protein SA, putative 
LmxM.19.0995 19 69384 0.63 4-coumarate:coa ligase-like protein 
LmxM.19.0985 19 70689 0.63 4-coumarate:coa ligase-like protein 
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LmxM.29.0750 38 20885 0.37 
4-methyl-5(beta-hydroxyethyl)-thiazole monophosphate synthesis 
protein, putative 
LmxM.15.1203 37 11050 0.99 60S acidic ribosomal protein P2 
LmxM.04.0470 19 21675 0.85 60S ribosomal protein L11 (L5, L16) 
LmxM.15.0200 20 25733 0.35 60S ribosomal protein L13a, putative 
LmxM.36.4510 16 22193 0.88 60S ribosomal protein L18, putative 
LmxM.13.0560 16 22207 0.82 60S ribosomal protein L18, putative 
LmxM.16.0460 60 18098 0.85 60S ribosomal protein L21, putative 
LmxM.34.3790 17 15118 0.28 60S ribosomal protein L23, putative 
LmxM.06.0570 20 16286 0.43 60S ribosomal protein L23a, putative 
LmxM.34.3760 32 16231 0.26 60S ribosomal protein L27A/L29, putative 
LmxM.34.0240 18 11603 0.26 60S ribosomal protein L30 
LmxM.21.0730 16 11976 0.99 60S Ribosomal protein L36, putative 
LmxM.32.1955 21 10114 0.26 60S ribosomal protein L37 
LmxM.32.1955 22 10114 0.25 60S ribosomal protein L37 
LmxM.07.0500 60 29857 0.33 60S ribosomal protein L7a, putative 
LmxM.34.3340 40 52591 0.34 6-phosphogluconate dehydrogenase, decarboxylating, putative 
LmxM.26.2700 16 28690 0.29 6-phosphogluconolactonase 
LmxM.03.0160 18 82808 0.30 ABC transporter protein, putative 
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LmxM.08_29.0620 16 208833 0.25 ABC transporter, putative 
LmxM.25.0530 21 72376 0.23 ABC transporter, putative 
LmxM.11.1270 19 202022 0.08 ABC transporter, putative 
LmxM.06.0880 53 45641 0.22 acyl-coenzyme a dehydrogenase, putative 
LmxM.11.0990 18 109251 0.32 adaptin-related protein-like protein 
LmxM.13.1190 22 79189 0.25 adenylosuccinate synthetase, putative 
LmxM.29.2900 18 64615 0.47 aldehyde dehydrogenase, putative 
LmxM.34.0970 14 41987 0.25 aldose 1-epimerase, putative 
LmxM.34.0980 14 42527 0.25 aldose 1-epimerase-like protein 
LmxM.34.2350 26 54601 0.26 aminopeptidase P, putative 
LmxM.11.0620 43 29787 0.69 aminopeptidase, putative 
LmxM.11.0630 60 57922 0.49 aminopeptidase, putative,metallo-peptidase, Clan MF, Family M17 
LmxM.34.1480 68 36572 0.44 arginase 
LmxM.21.0895 24 70413 0.4 aspartyl-tRNA synthetase, putative 
LmxM.07.0340 36 46871 0.78 ATP-dependent DEAD/H RNA helicase, putative 
LmxM.31.1500 24 78552 0.59 
ATP-dependent zinc metallopeptidase, putative,metallo-peptidase, 
Clan MA(E), Family M41 
LmxM.30.1070 79 28760 0.75 biotin/lipoate protein ligase-like protein 
LmxM.21.0120 23 182271 0.19 calpain, putative,cysteine peptidase, Clan CA, family C2, putative 
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LmxM.20.1300 30 14952 0.32 
calpain-like cysteine peptidase, putative,calpain-like cysteine 
peptidase, Clan CA, family C2 
LmxM.27.0490 16 271511 0.01 
calpain-like cysteine peptidase, putative,cysteine peptidase, Clan 
CA, family C2, putative 
LmxM.27.0500 23 656104 0.95 
calpain-like cysteine peptidase, putative,cysteine peptidase, Clan 
CA, family C2, putative 
LmxM.31.0970 19 202700 0.55 
calpain-like cysteine peptidase, putative,cysteine peptidase, Clan 
CA, family C2, putative 
LmxM.27.0510 18 492173 0.37 
calpain-like cysteine peptidase, putative,cysteine peptidase, Clan 
CA, family C2, putative 
LmxM.13.0090 14 57670 0.48 
carboxypeptidase, putative,metallo-peptidase, Clan MA(E), family 
32 
LmxM.14.0180 16 54210 0.05 
carboxypeptidase, putative,metallo-peptidase, Clan MA(E), Family 
M32 
LmxM.08_29.1310 51 68933 0.92 carnitine/choline acetyltransferase, putative 
LmxM.08.1070 34 49006 0.54 cathepsin L-like protease, putative 
LmxM.08.1060 109 40038 0.41 cathepsin L-like protease, putative 
LmxM.18.1430 14 123328 0.09 chaperone DNAJ protein, putative 
LmxM.13.1660 25 59246 0.35 chaperonin TCP20, putative 
LmxM.18.0670 37 50618 0.22 citrate synthase, putative 
LmxM.08_29.1230 17 204893 0.53 COPII coat assembly protein sec16, putative (fragment) 
LmxM.25.0910 31 19010 0.74 cyclophilin a 
LmxM.19.1420 27 39177 0.18 cysteine peptidase A (CBA) 
LmxM.36.3590 36 35738 0.11 cysteine synthase, putative 
LmxM.26.1710 50 22372 0.96 cytochrome c oxidase subunit V, putative 
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LmxM.25.1130 29 19033 0.23 cytochrome c oxidase VII, putative 
LmxM.16.1310 83 12272 0.57 cytochrome c, putative 
LmxM.28.1530 16 44296 0.29 DEAD box RNA helicase, putative 
LmxM.31.1400 34 187137 0.33 DEAD/DEAH box helicase-like protein, putative 
LmxM.03.0200 40 60113 0.86 delta-1-pyrroline-5-carboxylate dehydrogenase, putative 
LmxM.21.0550 83 40435 0.27 dihydrolipoamide acetyltransferase precursor like protein 
LmxM.31.3310 39 51083 0.60 dihydrolipoamide dehydrogenase, putative 
LmxM.30.1610 27 29549 0.15 diphthine synthase-like protein 
LmxM.24.1080 20 49408 0.57 DNAJ domain protein, putative 
LmxM.13.1650 14 533823 0.04 dynein heavy chain, putative 
LmxM.26.1020 15 460992 0.20 dynein heavy chain, putative 
LmxM.07.0600 46 63739 0.11 electron transfer flavoprotein-ubiquinone oxidoreductase, putative 
LmxM.36.0180 53 94852 0.95 elongation factor 2 
LmxM.03.0980 33 47335 0.77 elongation initiation factor 2 alpha subunit, putative 
LmxM.10.0610 39 54975 0.06 endonuclease G, putative 
LmxM.23.0200 73 17122 0.65 endoribonuclease L-PSP (pb5), putative 
LmxM.16.0140 15 18681 0.31 eukaryotic translation initiation factor 1A, putative 
LmxM.18.1660 26 79380 0.97 gamma-glutamylcysteine synthetase, putative 
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Accession No. Mascot Score MW L/H ratio Protein name 
LmxM.28.2260 91 24525 0.37 glycosomal membrane protein, putative 
LmxM.10.0390 29 64893 0.03 GP63, leishmanolysin 
LmxM.10.0470 15 64758 0.77 GP63, leishmanolysin 
LmxM.08_29.2200 31 77363 0.88 GTP-binding protein, putative 
LmxM.08_29.0090 28 21128 0.16 GTP-binding protein-like protein 
LmxM.27.2400 16 44223 0.61 heat shock protein DNAJ, putative 
LmxM.21.0920 41 13938 0.61 histone H2A, putative 
LmxM.06.0010 99 11436 0.53 histone H4 
LmxM.19.0290 34 145648 0.97 hypothetical protein, conserved 
LmxM.27.0700 15 49137 0.97 hypothetical protein, conserved 
LmxM.34.1870 16 78271 0.94 hypothetical protein, conserved 
LmxM.14.0790 20 451832 0.80 hypothetical protein, conserved 
LmxM.04.0240 27 32118 0.79 hypothetical protein, conserved 
LmxM.28.0430 14 45789 0.77 hypothetical protein, conserved 
LmxM.23.0310 22 141146 0.76 hypothetical protein, conserved 
LmxM.30.0620 19 89087 0.68 hypothetical protein, conserved 
LmxM.16.0670 23 70935 0.64 hypothetical protein, conserved 
LmxM.36.3500 23 88979 0.62 hypothetical protein, conserved 
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Accession No. Mascot Score MW L/H ratio Protein name 
LmxM.17.0910 17 54951 0.59 hypothetical protein, conserved 
LmxM.36.1570 16 53016 0.58 hypothetical protein, conserved 
LmxM.17.1450 28 55199 0.53 hypothetical protein, conserved 
LmxM.02.0450 53 30392 0.49 hypothetical protein, conserved 
LmxM.02.0700 22 106856 0.42 hypothetical protein, conserved 
LmxM.02.0130 18 26777 0.41 hypothetical protein, conserved 
LmxM.03.0480 25 112548 0.41 hypothetical protein, conserved 
LmxM.03.0530 22 220559 0.41 hypothetical protein, conserved 
LmxM.03.0550 17 144069 0.39 hypothetical protein, conserved 
LmxM.03.0690 55 232774 0.39 hypothetical protein, conserved 
LmxM.20.1710 17 65912 0.36 hypothetical protein, conserved 
LmxM.25.0110 33 54063 0.35 hypothetical protein, conserved 
LmxM.33.4080 14 30096 0.31 hypothetical protein, conserved 
LmxM.32.2510 14 75441 0.28 hypothetical protein, conserved 
LmxM.24.1120 19 97608 0.26 hypothetical protein, conserved 
LmxM.30.1240 14 135840 0.21 hypothetical protein, conserved 
LmxM.31.3930 14 459570 0.16 hypothetical protein, conserved 
LmxM.30.0460 20 79485 0.15 hypothetical protein, conserved 
298 
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LmxM.30.2040 18 53381 0.15 hypothetical protein, conserved 
LmxM.32.2280 28 109548 0.15 hypothetical protein, conserved 
LmxM.32.2660 15 124536 0.15 hypothetical protein, conserved 
LmxM.33.2620 17 76235 0.15 hypothetical protein, conserved 
LmxM.08.0130 14 122717 0.13 hypothetical protein, conserved 
LmxM.31.3570 20 132687 0.03 hypothetical protein, conserved 
LmxM.34.3730 34 97046 0.02 hypothetical protein, conserved 
LmxM.34.4320 15 60949 0.02 hypothetical protein, conserved 
LmxM.34.4380 22 58147 0.02 hypothetical protein, conserved 
LmxM.34.4470 29 21880 0.02 hypothetical protein, conserved 
LmxM.34.4690 70 34780 0.02 hypothetical protein, conserved 
LmxM.34.4940 45 23700 0.02 hypothetical protein, conserved 
LmxM.34.4950 16 107500 0.02 hypothetical protein, conserved 
LmxM.34.5090 15 66283 0.02 hypothetical protein, conserved 
LmxM.34.5390 14 741481 0.02 hypothetical protein, conserved 
LmxM.34.0570 13 227054 0.02 hypothetical protein, conserved 
LmxM.34.0670 17 459091 0.02 hypothetical protein, conserved 
LmxM.34.0140 21 14494 0.02 hypothetical protein, conserved 
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LmxM.34.0850 16 59337 0.02 hypothetical protein, conserved 
LmxM.34.0170 18 38247 0.02 hypothetical protein, conserved 
LmxM.34.0190 19 27523 0.02 hypothetical protein, conserved 
LmxM.34.1090 19 115007 0.02 hypothetical protein, conserved 
LmxM.34.1100 15 71362 0.02 hypothetical protein, conserved 
LmxM.34.1490 30 30713 0.02 hypothetical protein, conserved 
LmxM.34.1620 30 214290 0.02 hypothetical protein, conserved 
LmxM.06.0720 22 180297 0.02 hypothetical protein, conserved 
LmxM.07.0320 28 111116 0.02 hypothetical protein, conserved 
LmxM.08_29.1010 28 37752 0.02 hypothetical protein, conserved 
LmxM.14.0090 13 41747 0.02 hypothetical protein, conserved 
LmxM.16.0270 33 110528 0.02 hypothetical protein, conserved 
LmxM.17.1260 22 47491 0.02 hypothetical protein, conserved 
LmxM.13.1470 30 597321 0.01 hypothetical protein, conserved 
LmxM.33.0060 31 116356 0.19 hypothetical protein, conserved 
LmxM.04.0600 19 318310 0.99 hypothetical protein, unknown function 
LmxM.02.0470 18 298701 0.85 hypothetical protein, unknown function 
LmxM.30.2410 14 22054 0.30 hypothetical protein, unknown function 
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Accession No. Mascot Score MW L/H ratio Protein name 
LmxM.21.0845 26 23712 0.22 hypoxanthine-guanine phosphoribosyltransferase 
LmxM.14.0930 17 91851 0.11 immunodominant antigen, putative,tc40 antigen-like 
LmxM.27.0930 47 44804 0.5 isovaleryl-coA dehydrogenase, putative 
LmxM.14.1110 20 254630 0.35 kinesin K39, putative 
LmxM.14.1100 20 536483 0.07 kinesin K39, putative 
LmxM.11.0870 29 149571 0.28 kinesin, putative 
LmxM.19.0680 28 126327 0.25 kinesin, putative 
LmxM.29.3060 18 134218 0.03 kinesin, putative 
LmxM.21.1040 15 231910 0.22 kinesin, putative 
LmxM.09.0800 17 156380 0.01 kinetoplast-associated protein-like protein 
LmxM.01.0530 14 171151 0.03 long-chain-fatty-acid-CoA ligase, putative 
LmxM.28.0570 20 62419 0.2 major surface protease gp63, putative,leishmanolysin, putative 
LmxM.33.0140 66 33945 0.34 malate dehydrogenase 
LmxM.13.0130 17 80921 0.01 MCAK-like kinesin, putative 
LmxM.15.1290 15 139453 0.11 mitochondrial DNA topoisomerase II 
LmxM.13.0870 49 58057 0.77 
mitochondrial processing peptidase alpha subunit, 
putative,metallo-peptidase, Clan ME, Family M16 
LmxM.23.0830 15 167118 0.02 Na/H antiporter-like protein 
LmxM.13.1060 28 34818 0.95 NADH-cytochrome b5 reductase, putative 
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LmxM.10.0850 21 14006 0.78 nuclear transport factor 2, putative,ntf2-like 
LmxM.19.0440 22 39915 0.44 nucleosome assembly protein, putative 
LmxM.36.4170 32 36526 0.05 oxidoreductase, putative 
LmxM.28.0940 13 107180 0.19 oxidoreductase-like protein 
LmxM.28.1240 17 73373 0.59 p450 reductase, putative 
LmxM.19.1530 25 48145 0.55 peptidylprolyl isomerase-like protein 
LmxM.30.1280 15 169323 0.06 p-glycoprotein e, putative 
LmxM.05.0720 25 146524 0.22 phosphatase-like protein 
LmxM.20.1120 20 360565 0.07 phosphatidylinositol 3-kinase, putative 
LmxM.02.0120 16 531677 0.04 phosphatidylinositol 3-kinase-like protein 
LmxM.08_29.2600 21 56002 0.33 poly(A) polymerase, putative 
LmxM.05.1200 16 15291 0.54 prefoldin subunit, putative 
LmxM.24.1100 24 137307 0.23 pre-mRNA splicing factor, putative 
LmxM.26.1610 19 64033 0.74 proline oxidase, mitochondrial precursor-like protein 
LmxM.06.0140 30 28120 0.26 
proteasome beta 6 subunit, putative,20S proteasome beta 6 
subunit, putative 
LmxM.06.1050 30 15144 0.63 protein disulfide isomerase 
LmxM.25.1340 18 112450 0.02 protein transport protein Sec24C, putative 
LmxM.18.1520 49 108528 0.13 P-type H -ATPase, putative 
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LmxM.32.1150 18 92908 0.07 pumilio protein, putative 
LmxM.29.1250 29 33288 0.74 Pyridoxal kinase, putative 
LmxM.18.0890 35 24345 0.55 rab7 GTP binding protein, putative 
LmxM.08_29.2160 17 50458 0.69 rab-GDP dissociation inhibitor, putative 
LmxM.15.0275 18 21629 0.77 ribonucleoprotein p18, mitochondrial precursor, putative 
LmxM.22.1290 22 44723 0.23 ribonucleoside-diphosphate reductase small chain, putative 
LmxM.08.0510 13 94211 0.87 ribose-phosphate pyrophosphokinase, putative 
LmxM.10.0070 32 16584 0.45 ribosomal protein l35a, putative 
LmxM.31.0750 38 25291 0.44 RNA binding protein, putative 
LmxM.28.0160 17 22305 0.13 RNA binding protein, putative 
LmxM.25.0620 13 183241 0.09 RNA polymerase I second largest subunit, putative 
LmxM.34.1120 17 24599 0.02 Selenoprotein T, putative 
LmxM.14.1320 15 50854 0.24 serine hydroxymethyltransferase, putative 
LmxM.08_29.2570 23 56555 0.22 serine/threonine-protein kinase, putative,protein kinase, putative 
LmxM.08_29.1330 23 63331 0.13 serine/threonine-protein kinase, putative,protein kinase, putative 
LmxM.07.0870 14 41829 0.33 splicing factor ptsr1-like protein 
LmxM.15.0990 15 22905 0.445 succinate dehydrogenase, putative 
LmxM.26.1550 17 80272 0.42 
trifunctional enzyme alpha subunit, mitochondrial precursor-like 
protein 
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LmxM.24.0850 59 27265 0.99 triosephosphate isomerase 
LmxM.36.1660 14 76635 0.99 tRNA pseudouridine synthase A, putative 
LmxM.19.1020 19 58386 0.02 tRNA pseudouridine synthase A-like protein 
LmxM.11.0400 19 122147 0.99 tubulin-tyrsoine ligase-like protein 
LmxM.24.0420 15 34761 0.24 
ubiquitin carboxyl-terminal hydrolase, putative,cysteine peptidase, 
Clan CA, family C12, putative 
LmxM.07.0280 21 670620 0.11 ubiquitin-protein ligase-like, putative 
LmxM.08_29.0780 34 67343 0.03 U-box domain protein, putative 
LmxM.08.1030a 109 58965 0.41 unspecified product 
LmxM.08.1070partial 109 41406 0.41 unspecified product 
LmxM.10.0483 15 98541 0.41 unspecified product 
LmxM.10.0935 20 93116 0.41 unspecified product 
LmxM.21.1290 13 28572 0.33 vesicule-associated membrane protein, putative 
LmxM.17.0735 22 35345 0.17 ysine decarboxylase-like protein 
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8.3   Protein degradation rate constant (kdeg) and half-lives of uninfected and infected 
THP-1 (top 50) 
Protein names ln (kdeg) 
Control24h 
Half-life 
Control24h 
ln (kdeg) 
24hpi 
Half-life 24 
hpi 
ln (kdeg) 
control48h 
Half-life 
control48h 
ln (kdeg) 
48 hpi 
Half-life 
48 hpi 
Unique 
peptides 
Score 
Leukotriene A-4 hydrolase 0.04 19.19 0.04 18.96 0.02 41.87 0.01 85.18 9 55 
Heat shock protein 105 kDa 0.04 19.47 0.03 19.88 0.01 50.45 0.01 76.16 12 128 
Splicing factor U2AF 65 kDa subunit 0.03 21.61 0.03 24.79 0.01 50.78 0.01 75.01 8 80 
Palmitoyl-protein thioesterase 1 0.02 30.24 0.03 23.91 0.01 71.82 0.01 71.53 8 74 
Signal transducer and activator of transcription 1-alpha/beta 0.03 22.17 0.03 26.77 0.01 58.63 0.01 71.47 8 21 
Ras-related protein Rab-7a 0.03 24.25 0.03 21.43 0.01 56.98 0.01 70.57 11 312 
Programmed cell death 6-interacting protein 0.02 28.52 0.03 21.31 0.01 56.92 0.01 70.04 14 72 
Pyruvate kinase PKM 0.03 24.22 0.03 21.29 0.01 54.84 0.01 69.23 32 323 
Talin-1 0.02 28.39 0.03 25.28 0.01 62.01 0.01 69.13 45 323 
F-actin-capping protein subunit alpha-2 0.03 22.15 0.03 22.35 0.01 61.87 0.01 68.88 5 39 
Splicing factor 3B subunit 1 0.03 25.44 0.03 22.74 0.01 71.44 0.01 68.78 12 141 
Neuroblast differentiation-associated protein AHNAK 0.03 23.27 0.03 21.61 0.01 58.39 0.01 68.01 45 122 
Interleukin-8;MDNCF-a;Interleukin-8;IL-8(5-77);IL-8(6-77);IL-8(7-
77);IL-8(8-77);IL-8(9-77) 
0.04 16.63 0.02 30.36 0.01 66.53 0.01 66.53 1 3 
Plectin 0.02 28.81 0.03 22.47 0.01 58.04 0.01 65.99 40 248 
Interferon-induced GTP-binding protein Mx1;Interferon-induced GTP-
binding protein Mx1, N-terminally processed 
0.04 19.28 0.03 21.76 0.02 43.95 0.01 65.76 4 58 
Cell division control protein 42 homolog 0.03 24.56 0.03 23.39 0.01 59.48 0.01 65.58 5 141 
T-complex protein 1 subunit epsilon 0.03 20.08 0.04 19.26 0.02 44.00 0.01 65.53 16 193 
Niban-like protein 1 0.02 28.26 0.03 22.99 0.01 70.26 0.01 65.33 16 170 
Gelsolin 0.03 24.92 0.03 21.89 0.01 47.92 0.01 65.23 10 323 
Heat shock 70 kDa protein 4 0.03 20.84 0.04 19.17 0.01 46.90 0.01 63.83 15 323 
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Half-life 24 
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48 hpi 
Half-life 
48 hpi 
Unique 
peptides 
Score 
Transforming protein RhoA 0.03 26.66 0.03 23.34 0.01 67.00 0.01 62.95 2 80 
Vimentin 0.03 27.62 0.03 24.44 0.01 64.80 0.01 62.10 41 323 
Ubiquitin-conjugating enzyme E2 L3 0.03 27.36 0.03 20.43 0.02 45.30 0.01 61.89 5 53 
Alpha-soluble NSF attachment protein 0.03 21.45 0.03 21.70 0.01 52.33 0.01 61.77 5 80 
Myosin light polypeptide 6 0.03 25.53 0.03 22.97 0.01 59.79 0.01 61.62 9 248 
Lysosome-associated membrane glycoprotein 2 0.03 21.11 0.04 19.06 0.02 45.31 0.01 61.43 3 36 
LIM and SH3 domain protein 1 0.03 22.87 0.03 22.41 0.01 54.37 0.01 61.26 7 12 
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa 
subunit 
0.03 19.92 0.04 18.80 0.02 40.98 0.01 60.87 10 182 
Lysosomal alpha-mannosidase;Lysosomal alpha-mannosidase A 
peptide;Lysosomal alpha-mannosidase B peptide;Lysosomal alpha-
mannosidase C peptide;Lysosomal alpha-mannosidase D 
peptide;Lysosomal alpha-mannosidase E peptide 
0.03 27.08 0.03 23.63 0.01 67.91 0.01 60.66 12 214 
Prosaposin;Saposin-A;Saposin-B-Val;Saposin-B;Saposin-C;Saposin-D 0.03 25.94 0.03 25.67 0.01 60.74 0.01 60.60 6 201 
Cathepsin B;Cathepsin B light chain;Cathepsin B heavy chain 0.02 28.22 0.03 24.17 0.01 53.97 0.01 60.50 7 309 
Dihydropyrimidinase-related protein 2 0.03 22.15 0.03 20.71 0.02 41.31 0.01 60.49 10 174 
Guanine nucleotide-binding protein subunit beta-2-like 1;Guanine 
nucleotide-binding protein subunit beta-2-like 1, N-terminally processed 
0.03 22.66 0.03 22.66 0.01 59.41 0.01 60.17 8 284 
RNA-binding protein FUS 0.03 23.53 0.03 20.69 0.01 65.98 0.01 60.03 5 33 
Vesicle-fusing ATPase 0.03 20.90 0.03 22.58 0.02 45.83 0.01 59.42 8 83 
Ras-related protein Rab-14 0.04 19.38 0.03 22.69 0.01 53.91 0.01 59.19 7 90 
Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A 
alpha isoform 
0.03 25.62 0.03 23.02 0.01 59.12 0.01 58.73 12 189 
Tropomyosin alpha-4 chain 0.03 24.96 0.03 24.46 0.01 61.88 0.01 58.51 8 118 
60S ribosomal protein L5 0.04 19.62 0.03 20.48 0.02 42.06 0.01 58.14 8 68 
Heat shock 70 kDa protein 6;Putative heat shock 70 kDa protein 7 0.03 22.98 0.03 21.91 0.02 44.76 0.01 57.54 1 11 
14-3-3 protein zeta/delta 0.03 24.41 0.03 22.19 0.01 52.19 0.01 56.94 11 323 
Thymosin beta-4;Hematopoietic system regulatory peptide 0.03 27.04 0.03 20.41 0.01 49.39 0.01 56.71 7 140 
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Half-life 24 
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Half-life 
48 hpi 
Unique 
peptides 
Score 
Heterogeneous nuclear ribonucleoprotein D-like 0.03 25.02 0.03 23.94 0.01 55.10 0.01 56.67 5 219 
Serine/arginine-rich splicing factor 1 0.04 19.21 0.03 23.80 0.01 47.79 0.01 56.55 6 51 
Ras-related protein Rab-2A;Ras-related protein Rab-2B 0.03 22.24 0.03 24.08 0.01 58.87 0.01 56.44 9 37 
Chloride intracellular channel protein 1 0.03 23.44 0.03 20.71 0.01 52.95 0.01 56.43 14 323 
Poly(rC)-binding protein 1 0.03 23.12 0.03 22.50 0.01 57.53 0.01 56.20 6 43 
Annexin A5 0.03 22.18 0.03 20.49 0.01 52.81 0.01 56.02 17 323 
Hippocalcin-like protein 1;Neuron-specific calcium-binding protein 
hippocalcin 
0.04 19.48 0.03 24.38 0.01 73.98 0.01 55.95 7 69 
Pleckstrin 0.03 27.30 0.03 24.43 0.01 67.63 0.01 55.95 4 52 
 
 
 
307 
 
8.4 Protein degradation profiles of several 
proteins. 
 
308 
 
 
309 
 
 
310 
 
 
Fig. 8.1: An R script was used to calculate and plot protein degradation of several newly 
synthesized proteins (n = 3 biological replicates). 
 
 
